https://bostonlifesciencestimes.com/2020/12/oxford-finance-provides-credit-facility-to-dcn-dx/ 2020-12-10T17:40:26+00:00 https://bostonlifesciencestimes.com/2020/12/bayer-dedicates-new-sign-to-employees-and-bayer-fund-donates-25000-to-hanover-emergency-responders/ 2020-12-10T18:12:33+00:00 https://bostonlifesciencestimes.com/2020/12/gilead-announces-racial-equity-community-impact-fund-to-support-black-communities-across-united-states/ 2020-12-10T18:12:33+00:00 https://bostonlifesciencestimes.com/2020/12/resolve-biosciences-launches-new-era-in-single-cell-spatial-analysis/ 2020-12-10T18:22:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Resolve_Biosciences_Hippocampus3.jpg https://bostonlifesciencestimes.com/2020/12/labcorp-receives-fda-authorization-to-make-at-home-covid-19-collection-kits-available-through-retail/ 2020-12-10T18:56:17+00:00 https://bostonlifesciencestimes.com/2020/12/faze-medicines-launches-with-81-million-series-a-financing-to-leverage-new-biology-of-biomolecular-condensates-to-treat-disease/ 2020-12-10T18:56:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/kendal-L4iKccAChOc-unsplash-scaled-1.jpg https://bostonlifesciencestimes.com/2020/12/tremeau-pharmaceuticals-will-advance-non-opioid-pain-program-with-investment-from-gurnet-point-capital/ 2020-12-10T18:56:54+00:00 https://bostonlifesciencestimes.com/2020/12/biolab-sciences-acquires-intellectual-property-for-transformative-wound-care-technology/ 2020-12-10T18:57:05+00:00 https://bostonlifesciencestimes.com/2020/12/tobin-scientific-and-phcbi-collaborate-on-solution-for-regional-distribution-of-covid-19-vaccine-to-address-ultra-low-temperature-requirements/ 2020-12-10T18:57:19+00:00 https://bostonlifesciencestimes.com/2020/12/nexpoint-launches-nexpoint-storage-partners-as-a-dedicated-platform-for-the-self-storage-sector/ 2020-12-10T18:57:32+00:00 https://bostonlifesciencestimes.com/2020/12/scineuro-pharmaceuticals-launches-to-bring-innovative-treatments-for-cns-diseases/ 2020-12-10T18:57:48+00:00 https://bostonlifesciencestimes.com/2020/12/tae-life-sciences-and-neuboron-medtech-announce-joint-venture-aimed-at-facilitating-boron-neutron-capture-therapy-development-for-cancer-treatment/ 2020-12-10T18:58:00+00:00 https://bostonlifesciencestimes.com/2020/12/the-embassy-of-the-state-of-qatar-usqbc-and-silicon-valley-forum-host-virtual-event-on-smart-cities-growth-and-investment-opportunities-in-qatar/ 2020-12-10T18:59:24+00:00 https://bostonlifesciencestimes.com/2020/12/nuburu-completes-20-million-series-b-funding-round-to-expand-market-leadership-in-blue-wavelength-industrial-lasers/ 2020-12-10T19:05:19+00:00 https://bostonlifesciencestimes.com/2020/12/washington-state-university-health-sciences-launches-life-sciences-incubator-sp3nw-supported-by-250000-grant-from-bank-of-america/ 2020-12-10T19:05:45+00:00 https://bostonlifesciencestimes.com/2020/12/us-venture-capital-funding-rose-by-33-during-the-covid-pandemic-only-life-sciences-and-pharmaceuticals-witnessed-growth/ 2020-12-11T17:07:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/VC-report.png https://bostonlifesciencestimes.com/2020/12/roche-teams-up-with-diabeloop-to-advance-the-management-of-insulin-pump-therapy/ 2020-12-11T17:11:46+00:00 https://bostonlifesciencestimes.com/2020/12/tychan-to-start-covid-19-phase-3-clinical-trial-for-novel-monoclonal-antibody-ty027/ 2020-12-11T19:02:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/tychan-new-logo-white.png https://bostonlifesciencestimes.com/2020/12/brooks-rehabilitation-to-open-a-rehabilitation-hospital-in-lake-nona/ 2020-12-11T19:05:00+00:00 https://bostonlifesciencestimes.com/2020/12/sciencemedia-strikes-investment-deal-with-decathlon-capital-to-accelerate-clinical-education-platform/ 2020-12-11T19:08:22+00:00 https://bostonlifesciencestimes.com/2020/12/trastuzumab-deruxtecan-recommended-for-approval-in-the-eu-by-chmp-for-her2-positive-metastatic-breast-cancer/ 2020-12-11T19:12:30+00:00 https://bostonlifesciencestimes.com/2020/12/trailblazers-vertex-ceo-reshma-kewalramani-on-leadership-stem-diversity-inclusion-and-medicine-on-chai-with-manju/ 2020-12-12T03:24:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/maxresdefault.jpg https://bostonlifesciencestimes.com/2020/12/harrison-street-and-partners-sell-three-life-sciences-properties-in-cambridge-discovery-park-for-720-million/ 2020-12-12T03:04:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Cambridge-Discovery-Park-Bulfinch-Aerial.jpg https://bostonlifesciencestimes.com/2020/12/life-sciences-boom-with-85-active-life-science-tenants-requiring-3-9-million-sf-greater-boston-life-sciences-market-is-hot/ 2020-12-12T03:07:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Julia-Georgules-e1607742428920.jpg https://bostonlifesciencestimes.com/2020/12/astrazeneca-to-acquire-alexion/ 2020-12-12T14:47:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Pascal-Soriot.jpg https://bostonlifesciencestimes.com/2020/12/quidel-corporation-ceo-douglas-bryant-named-executive-of-the-year-in-medtech-dive-awards/ 2020-12-12T14:57:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Douglas-Bryant-Twitter.jpg https://bostonlifesciencestimes.com/2020/12/pfizer-and-biontech-celebrate-historic-first-authorization-in-the-u-s-of-vaccine-to-prevent-covid-19/ 2020-12-12T15:02:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/pfizer.jpg https://bostonlifesciencestimes.com/2020/12/fda-takes-key-action-in-fight-against-covid-19-by-issuing-emergency-use-authorization-for-first-covid-19-vaccine/ 2020-12-12T15:11:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Stephen-M.-Hahn.jpg https://bostonlifesciencestimes.com/2020/12/gilead-sciences-to-acquire-myr-gmbh/ 2020-12-12T15:19:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Daniel-ODay.jpg https://bostonlifesciencestimes.com/2020/12/zebra-medical-vision-secures-a-7th-fda-clearance-for-its-patented-breakthrough-in-orthopedic-surgery-planning/ 2020-12-14T16:25:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Zebra-e1607963123679.jpg https://bostonlifesciencestimes.com/2020/12/colliers-internationals-recent-sale-assignment-demonstrates-momentum-of-life-science-market/ 2020-12-14T16:37:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Frank-Petz.jpg https://bostonlifesciencestimes.com/2020/12/edigene-appointments-bo-zhang-as-head-of-us-subsidiary-and-kehua-fan-head-of-business-development/ 2020-12-14T16:46:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Bo-Zhang.jpg https://bostonlifesciencestimes.com/2020/12/908-devices-announces-launch-of-initial-public-offering/ 2020-12-14T16:54:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/908-Devices-Inc.jpg https://bostonlifesciencestimes.com/2020/12/blackstone-real-estate-acquires-premier-lab-office-portfolio-from-brookfield-fund/ 2020-12-14T17:02:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Nadeem-Meghji.jpg https://bostonlifesciencestimes.com/2020/12/agilent-receives-multiple-innovation-awards/ 2020-12-14T19:19:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/mcmullen-1-569.jpg https://bostonlifesciencestimes.com/2020/12/robotics-specialist-german-bionic-receives-us-20-million-in-series-a-financing/ 2020-12-14T19:37:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Screenshot_2020-12-14-About-%C2%B7-German-Bionic-e1607974646189.png https://bostonlifesciencestimes.com/2020/12/heartseed-named-healthcare-company-of-the-year-2020-by-healthcare-insights-magazine-in-the-medtech-category-for-making-a-crucial-impact-in-healthcare/ 2020-12-14T19:39:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/CEO-e1607974763171.jpg https://bostonlifesciencestimes.com/2020/12/massachusetts-biotech-council-president-and-ceo-robert-coughlin-to-step-down/ 2020-12-15T03:28:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Robert-K.-Coughlin.jpg https://bostonlifesciencestimes.com/2020/12/fda-grants-io-biotech-products-breakthrough-therapy-designation/ 2020-12-15T15:37:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Mai-Britt-Zocca.jpg https://bostonlifesciencestimes.com/2020/12/aditum-bio-announces-formation-of-third-company-anteris-bio-anteris-bio-aimed-at-treating-renal-diseases/ 2020-12-15T15:43:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Joe-Jimenez.jpg https://bostonlifesciencestimes.com/2020/12/new-england-biolabs-lease-28000-sf/ 2020-12-15T15:46:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/New-england-biolabs.png https://bostonlifesciencestimes.com/2020/12/biotech-pharma-vc-deal-activity-will-likely-exceed-20-billion-for-the-second-consecutive-year-pitchbook/ 2020-12-15T16:02:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/James-Gelfer.jpg https://bostonlifesciencestimes.com/2020/12/communal-role-of-cremation-specialists-in-times-of-pandemic/ 2020-12-15T16:11:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Legacy-Cremation-Services.png https://bostonlifesciencestimes.com/2020/12/seeqc-announces-lg-technology-ventures-participation-in-series-a-funding-round/ 2020-12-15T20:01:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Dong-Su-Kim-CEO-of-LG-Technology-Ventures.jpg https://bostonlifesciencestimes.com/2020/12/as-covid-19-vaccine-is-deployed-wattiq-launches-predictive-lab-freezer-monitoring-solution/ 2020-12-15T20:03:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Screenshot_2020-12-15-Our-Team-Colorado-Bioscience-Association.png https://bostonlifesciencestimes.com/2020/12/senecio-robotics-awarded-us12-million-from-the-european-commission-to-address-mosquito-borne-diseases/ 2020-12-15T20:07:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Hanan-Lepek.jpg https://bostonlifesciencestimes.com/2020/12/remdesivir-may-be-highly-effective-against-covid-study/ 2020-12-16T02:39:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Remdesivir.jpg https://bostonlifesciencestimes.com/2020/12/san-francisco-administers-first-covid-vax-to-health-care-workers/ 2020-12-16T02:42:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Covid-Injection.jpg https://bostonlifesciencestimes.com/2020/12/21-us-adults-not-planning-to-get-covid-vaccine-survey/ 2020-12-16T02:45:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Covid-vaccine.jpg https://bostonlifesciencestimes.com/2020/12/moderna-covid-vaccine-nears-approval-fda-confirms-safety/ 2020-12-16T02:51:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Moderna.jpg https://bostonlifesciencestimes.com/2020/12/poverty-linked-to-higher-risk-of-covid-19-death-study/ 2020-12-16T16:42:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Poverty.jpg https://bostonlifesciencestimes.com/2020/12/quarter-of-world-may-not-get-covid-vaccine-until-2022-study/ 2020-12-16T16:45:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Vaccine-new.jpg https://bostonlifesciencestimes.com/2020/12/medable-named-life-sciences-innovation-champion-in-the-accenture-healthtech-innovation-challenge/ 2020-12-16T16:58:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/HealthTech.jpg https://bostonlifesciencestimes.com/2020/12/revance-therapeutics-to-relocate-global-headquarters-to-nashville-from-silicon-valley/ 2020-12-16T17:03:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Nashville.jpg https://bostonlifesciencestimes.com/2020/12/labour-report-sheds-light-on-where-graduates-find-work-in-bio-economy/ 2020-12-16T19:40:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/BioTalent_Logo_CMYK_no_tag_HighRes.jpg https://bostonlifesciencestimes.com/2020/12/aphria-and-tilray-combine-to-create-largest-global-cannabis-company-with-pro-forma-revenue-of-685-million/ 2020-12-16T19:48:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Screenshot_2020-12-16-About-Aphria-Inc-.png https://bostonlifesciencestimes.com/2020/12/digital-therapeutics-startup-s-alpha-therapeutics-raises-2-7m-in-seed-funding/ 2020-12-16T19:52:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/S-alpah.jpg https://bostonlifesciencestimes.com/2020/12/cell-isolation-separation-market-worth-15-0-billion-by-2025/ 2020-12-17T02:00:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/cell-fda.jpg https://bostonlifesciencestimes.com/2020/12/life-sciences-leaders-optimistic-about-funding-prospects-but-cautious-about-growth-outlook-new-research-finds/ 2020-12-17T02:05:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Michael-J.-Lerner.jpg https://bostonlifesciencestimes.com/2020/12/discovery-life-sciences-and-scientist-com-partner-to-advance-liquid-biopsy-development-and-immunotherapy-research/ 2020-12-17T02:41:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Kevin-Lustig.jpg https://bostonlifesciencestimes.com/2020/12/outgoing-massbio-president-and-ceo-robert-coughlin-to-join-jll-to-grow-life-sciences-industry-practice/ 2020-12-17T02:51:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Robert-Coughlin-JLL-e1608173489265.jpg https://bostonlifesciencestimes.com/2020/12/covid-19-vaccines-not-a-silver-bullet-who-official/ 2020-12-17T12:10:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Vaccine-new.jpg https://bostonlifesciencestimes.com/2020/12/covid-19-spread-linked-to-variations-in-uv-levels-study/ 2020-12-17T12:12:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Covid-Image-Better.png https://bostonlifesciencestimes.com/2020/12/extra-pfizer-vaccine-doses-can-be-used-fda-tells-pharmacists/ 2020-12-17T12:17:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/pfizer.jpg https://bostonlifesciencestimes.com/2020/12/lifex-labs-pittsburgh-life-sciences-greenhouse-teaming-up-to-fast-track-startups-and-innovators/ 2020-12-17T12:23:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Richard-King-Mellon-Foundation.jpg https://bostonlifesciencestimes.com/2020/12/nz-to-purchase-covid-19-vaccines-enough-for-every-citizen-pm/ 2020-12-17T12:29:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Jacinda-Ardern-IANS.jpg https://bostonlifesciencestimes.com/2020/12/virios-therapeutics-announces-pricing-of-initial-public-offering/ 2020-12-17T12:49:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Virios-Therapeutics.jpg https://bostonlifesciencestimes.com/2020/12/amalgam-rx-appoints-new-president-chris-bergstrom/ 2020-12-17T12:59:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Amalgam.png https://bostonlifesciencestimes.com/2020/12/carlsmed-raises-10-million-to-commercialize-aprevo-devices/ 2020-12-17T13:03:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Mike-Cordonnier.jpg https://bostonlifesciencestimes.com/2020/12/ginkgo-bioworks-acquires-biotechnology-startup-novogy/ 2020-12-17T17:51:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Patrick-Boyle-Ginco.jpg https://bostonlifesciencestimes.com/2020/12/cedar-gate-technologies-acquires-lexington-based-deerwalk/ 2020-12-17T18:00:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Rudra-Pandey.jpg https://bostonlifesciencestimes.com/2020/12/ecs-awarded-28-8-million-usmc-it-service-and-support-contract/ 2020-12-17T18:35:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Screenshot_2020-12-17-Luis-Colon-Castro-%E2%80%94-ECS.png https://bostonlifesciencestimes.com/2020/12/verily-announces-700-million-investment-round-to-accelerate-key-businesses-including-baseline-and-verily-health-platforms/ 2020-12-17T18:52:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Verily.png https://bostonlifesciencestimes.com/2020/12/cirtec-medical-announces-acquisition-of-novelcath/ 2020-12-17T19:30:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Screenshot_2020-12-17-OUR-TEAM-NovelCath.png https://bostonlifesciencestimes.com/2020/12/higher-intake-of-ultra-processed-foods-may-up-death-risk/ 2020-12-18T15:27:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Food-Processed.jpg https://bostonlifesciencestimes.com/2020/12/study-reveals-why-women-face-less-severe-covid-19-complications/ 2020-12-18T15:29:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Covid-Indian-women-with-masks.jpg https://bostonlifesciencestimes.com/2020/12/india-to-produce-300-million-doses-of-the-russian-sputnik-v-vaccine-in-2021-report/ 2020-12-18T15:32:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Covid-vaccine-1.jpg https://bostonlifesciencestimes.com/2020/12/new-study-strongly-suggests-covid-19-enters-brain/ 2020-12-18T15:35:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Covid-Image-Better.png https://bostonlifesciencestimes.com/2020/12/global-covid-19-cases-surpass-74-8-million-johns-hopkins/ 2020-12-18T15:39:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Covid-Global.jpg https://bostonlifesciencestimes.com/2020/12/new-medtech-company-working-to-bring-travel-and-businesses-back-to-life/ 2020-12-18T15:46:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/David-Fetter.png https://bostonlifesciencestimes.com/2020/12/allterum-therapeutics-completes-series-seed-offering/ 2020-12-18T15:54:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Philip-P.-Breitfeld.jpg https://bostonlifesciencestimes.com/2020/12/collaborative-drug-discovery-selected-by-curve-therapeutics-to-digitalize-its-drug-discovery-platform/ 2020-12-18T16:01:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Ali-Tavassoli.jpg https://bostonlifesciencestimes.com/2020/12/amgen-awards-two-biotech-start-ups-with-golden-ticket-to-labcentral/ 2020-12-18T16:11:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Isaac-Stoner.jpg https://bostonlifesciencestimes.com/2020/12/flex-office-sector-to-emerge-as-a-key-component-in-evolution-of-workplaces-says-cbre/ 2020-12-18T16:20:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Julie-Whelan.jpg https://bostonlifesciencestimes.com/2020/12/sigma-analytical-partners-with-ecolab-to-help-ensure-safe-production-of-cannabis-products/ 2020-12-18T19:25:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Ashton-Abrahams.png https://bostonlifesciencestimes.com/2020/12/fda-authorizes-ecolabs-bioquell-technology-system-for-n95-respirator-decontamination/ 2020-12-18T19:29:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Screenshot_2020-12-18-Ecolab-Leadership.png https://bostonlifesciencestimes.com/2020/12/biocom-california-supports-life-science-industry-with-new-return-to-work-guide-for-2021/ 2020-12-18T19:33:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/fultz-1024x1024-1-e1608319980287.jpg https://bostonlifesciencestimes.com/2020/12/us-approves-moderna-covid-19-vaccine-for-emergency-use/ 2020-12-19T01:38:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Moderna.jpg https://bostonlifesciencestimes.com/2020/12/unicef-to-transport-up-to-850-tons-of-covid-19-vaccine-per-month/ 2020-12-19T01:44:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Vaccine-Generic.jpg https://bostonlifesciencestimes.com/2020/12/indian-pharma-companies-to-benefit-from-improving-us-demand-report/ 2020-12-19T18:12:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Pharma.jpg https://bostonlifesciencestimes.com/2020/12/hospitalized-male-covid-patients-at-30-higher-risk-of-dying/ 2020-12-19T18:17:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Covid-US-Outside.jpg https://bostonlifesciencestimes.com/2020/12/study-finds-high-risk-factors-of-mortality-from-covid-19/ 2020-12-20T18:58:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Covid-full-gear.jpg https://bostonlifesciencestimes.com/2020/12/new-lethal-covid-variant-puts-world-on-high-alert/ 2020-12-21T14:26:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/COVID-Variant.jpg https://bostonlifesciencestimes.com/2020/12/new-uk-covid-19-strain-detected-in-australia-italy/ 2020-12-21T14:31:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Covid-Image-Better-1.png https://bostonlifesciencestimes.com/2020/12/motility-medical-starts-human-trials-for-new-medical-device-to-treat-constipation/ 2020-12-21T14:48:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Amol-Soin.jpg https://bostonlifesciencestimes.com/2020/12/servier-to-acquire-cambridge-based-agios-pharmaceuticals-oncology-business/ 2020-12-21T14:55:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Jackie-Fouse.jpg https://bostonlifesciencestimes.com/2020/12/aceto-establishes-chemical-manufacturing-and-rd-capabilities-in-the-u-s-through-acquisition-of-islechem/ 2020-12-21T18:29:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Gilles.jpg https://bostonlifesciencestimes.com/2020/12/nordic-capital-and-astorg-invest-in-pharmaceutical-technology-and-advanced-analytics-company-cytel/ 2020-12-21T18:32:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Screenshot_2020-12-21-josh-webp-WEBP-Image-600-%C3%97-600-pixels.png https://bostonlifesciencestimes.com/2020/12/tagrisso-approved-in-the-us-for-the-adjuvant-treatment-of-patients-with-early-stage-egfr-mutated-lung-cancer/ 2020-12-21T18:34:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Dave-Fredrickson-Executive-Vice-President.jpg https://bostonlifesciencestimes.com/2020/12/house-panel-subpoenas-documents-from-trump-officials-over-interference-with-cdc/ 2020-12-22T02:18:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Trump-desk.jpg https://bostonlifesciencestimes.com/2020/12/covid-situation-in-germany-continues-to-deteriorate/ 2020-12-22T14:19:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Covid-street.jpg https://bostonlifesciencestimes.com/2020/12/parents-sweat-it-out-over-screen-time-emotional-health-of-kids/ 2020-12-22T14:23:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Mind-black.jpg https://bostonlifesciencestimes.com/2020/12/astrazenecas-fasenra-gets-dcgi-nod-for-asthma-treatment-in-india/ 2020-12-22T14:26:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/AstraZeneca-India.jpg https://bostonlifesciencestimes.com/2020/12/model-for-flu-spread-may-not-work-in-covid-19-study/ 2020-12-22T14:29:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Covid-nose.jpg https://bostonlifesciencestimes.com/2020/12/amgen-submits-sotorasib-marketing-authorization-application-to-the-european-medicines-agency/ 2020-12-22T14:41:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/David-M.-Reese.jpg https://bostonlifesciencestimes.com/2020/12/ajinomoto-bio-pharma-and-revance-therapeutics-announce-manufacturing-agreement-for-supply-of-daxibotulinumtoxina-for-injection/ 2020-12-22T14:45:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Revance-logo.jpg https://bostonlifesciencestimes.com/2020/12/cecilia-jones-joins-logicbio-therapeutics-as-chief-financial-officer/ 2020-12-22T14:49:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Cecilia-Jones.jpg https://bostonlifesciencestimes.com/2020/12/q32-bio-appoints-biopharmaceutical-leader-mark-iwicki-as-chairman-of-board-of-directors/ 2020-12-22T14:56:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Mark-Iwicki.jpg https://bostonlifesciencestimes.com/2020/12/finalists-selected-in-6-million-xprize-rapid-covid-testing-competition-to-help-restart-global-economy/ 2020-12-22T19:07:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Screenshot_2020-12-22-XPRIZE-Foundation-Bio-Anousheh-Ansari.png https://bostonlifesciencestimes.com/2020/12/deerfield-launches-a-novel-funding-mechanism-the-x-seed-award-to-support-early-stage-life-sciences-and-underrepresented-company-founders/ 2020-12-22T19:16:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Screenshot_2020-12-22-People.png https://bostonlifesciencestimes.com/2020/12/dr-reddys-laboratories-global-response-aid-and-appili-therapeutics-announce-the-filing-of-an-application-for-reeqonus-favipiravir-tablets-for-the-treatment-of-covid-19-under-health-can/ 2020-12-22T19:19:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Screenshot_2020-12-22-Vinod-Ramachandran-Ph-D-Vice-President-and-General-Manager-Dr-Reddys-Laboratories-Canada-Googl....png https://bostonlifesciencestimes.com/2020/12/indias-bharat-biotech-again-applies-for-vaccines-emergency-approval/ 2020-12-23T15:01:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Covid-vaccine-1.jpg https://bostonlifesciencestimes.com/2020/12/women-suffering-more-than-men-due-to-covid-19-isolation/ 2020-12-23T15:04:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Woman-suffering.jpg https://bostonlifesciencestimes.com/2020/12/us-sues-walmart-for-fueling-opioid-crisis-in-the-country/ 2020-12-23T15:08:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Walmart.jpg https://bostonlifesciencestimes.com/2020/12/skincare-company-dupes-instagram-creators-into-buying-products/ 2020-12-23T15:13:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Skincare.jpg https://bostonlifesciencestimes.com/2020/12/life-sciences-leaders-optimistic-about-funding-prospects-but-cautious-about-growth-outlook-new-research-finds-2/ 2020-12-23T15:17:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Michael-Lerner-e1608736663467.jpg https://bostonlifesciencestimes.com/2020/12/innovative-drug-carrimycin-receives-fda-approval-for-international-multi-country-phase-iii-clinical-trial-for-the-treatment-of-severe-covid-19-in-hospitalized-patients/ 2020-12-23T18:13:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Tonglian-Group.jpg https://bostonlifesciencestimes.com/2020/12/pfizer-and-biontech-to-supply-the-u-s-with-100-million-additional-doses-of-covid-19-vaccine/ 2020-12-23T18:16:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Albert-Bourla-Chairman-and-Chief-Executive-Officer.jpg https://bostonlifesciencestimes.com/2020/12/franklin-street-properties-corp-announces-the-sale-of-4820-emperor-boulevard-in-durham-north-carolina-for-89-7-million/ 2020-12-24T17:04:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Screenshot_2020-12-24-Franklin-Street-Properties-Corp-.png https://bostonlifesciencestimes.com/2020/12/covaxx-and-aurobindo-pharma-announce-covid-19-vaccine-partnership/ 2020-12-24T17:07:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Screenshot_2020-12-24-People-%E2%80%94-COVAXX.png https://bostonlifesciencestimes.com/2020/12/indias-first-fully-indigenous-pneumococcal-vaccine-launched/ 2020-12-28T18:26:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/pneumococcal.jpg https://bostonlifesciencestimes.com/2020/12/european-nations-begin-covid-19-vaccinations/ 2020-12-28T18:29:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Vaccine-new.jpg https://bostonlifesciencestimes.com/2020/12/this-condition-makes-it-hard-for-people-to-draw-a-mental-picture/ 2020-12-28T18:32:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Mind-aphantasia.jpg https://bostonlifesciencestimes.com/2020/12/who-chief-calls-for-more-investments-in-public-health/ 2020-12-28T18:36:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Tedros-Adhanom-Ghebreyesus-WHO.jpg https://bostonlifesciencestimes.com/2020/12/a2-biotherapeutics-enters-into-collaboration-agreement-with-merck-to-develop-allogeneic-cell-therapy/ 2020-12-28T18:59:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Roger-M.-Perlmutter.jpg https://bostonlifesciencestimes.com/2020/12/ginkgo-bioworks-launches-covid-19-pooled-classroom-testing-pilot-for-k-12-schools/ 2020-12-28T19:04:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Jason-Kelly.jpg https://bostonlifesciencestimes.com/2020/12/new-dermatology-company-resilia-pharmaceuticals-begins-operations/ 2020-12-28T19:14:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Harsha-Murthy.png https://bostonlifesciencestimes.com/2020/12/virginia-bio-will-direct-new-virginia-bio-connect-statewide-consortium-to-strengthen-competitiveness-of-virginias-life-science-ecosystem/ 2020-12-28T19:22:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/John-Newby.jpg https://bostonlifesciencestimes.com/2020/12/pfizer-and-biontech-to-supply-the-european-union-with-100-million-additional-doses-of-comirnaty/ 2020-12-29T19:53:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Albert-Bourla-Chairman-and-Chief-Executive-Officer.jpg https://bostonlifesciencestimes.com/2021/01/model-n-completes-acquisition-of-deloittes-life-sciences-pricing-and-contracting-solutions-business/ 2021-01-04T19:39:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/jason-blessing.jpg https://bostonlifesciencestimes.com/2021/01/the-law-offices-of-frank-r-cruz-reminds-investors-of-looming-deadline-in-the-class-action-lawsuit-against-neovasc-inc/ 2021-01-04T19:43:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Frank-Cruz-e1609789381597.jpg https://bostonlifesciencestimes.com/2021/01/neogen-acquires-food-quality-diagnostics-company/ 2021-01-04T19:47:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Screenshot_2021-01-04-headshot-jason-lilly-webp-WEBP-Image-353-%C3%97-402-pixels.png https://bostonlifesciencestimes.com/2021/01/white-oak-healthcare-mob-reit-acquires-3-class-a-medical-office-buildings-in-southern-florida/ 2021-01-05T18:40:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/David-Lynn-Headshot.jpg https://bostonlifesciencestimes.com/2021/01/new-national-partnership-strengthens-talent-within-canadas-life-science-industry/ 2021-01-05T18:44:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/rob-henderson.jpg https://bostonlifesciencestimes.com/2021/01/ikena-oncology-closes-120-million-series-b-financing-led-by-omega-funds/ 2021-01-05T18:49:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Screenshot_2021-01-05-Biomarker-Driven-Cancer-Drugs-Ikena-Oncology-Leadership.png https://bostonlifesciencestimes.com/2021/01/nanomix-selected-as-finalist-in-xprize-rapid-covid-testing-competition/ 2021-01-05T18:58:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/elab.jpg https://bostonlifesciencestimes.com/2021/01/linesight-leads-collaboration-of-major-pharmaceutical-companies-on-benchmarking-data/ 2021-01-06T20:38:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Linesight_Logo.jpg https://bostonlifesciencestimes.com/2021/01/purdue-partners-with-colorado-company-to-offer-rapid-testing-for-students-ahead-of-spring-2021-semester/ 2021-01-06T20:43:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/perdue.jpg https://bostonlifesciencestimes.com/2021/01/w2o-acquires-swoop-and-ipm-ai-fueling-new-health-technology-business/ 2021-01-07T19:12:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Screenshot_2021-01-07-Team.png https://bostonlifesciencestimes.com/2021/01/lifemine-therapeutics-appoints-nobel-laureate-william-g-kaelin-jr-m-d-to-board-of-directors/ 2021-01-07T19:14:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Screenshot_2021-01-07-LifeMine.png https://bostonlifesciencestimes.com/2021/01/ghz-class-nmr-opens-new-scientific-research-window-for-discoveries-and-novel-insights-in-functional-structural-biology-and-disease-biology/ 2021-01-07T19:18:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Picture-Bruker-MPIGoettingen-GHz-NMR-PR-1.jpg https://bostonlifesciencestimes.com/2021/01/booz-allen-invests-in-industry-leading-digital-forensics-and-incident-response-company-tracepoint/ 2021-01-08T17:53:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Bill-Phelps-executive-vice-president.jpg https://bostonlifesciencestimes.com/2021/01/affinivax-announces-226-million-series-c-financing-to-advance-its-pipeline-of-novel-maps-vaccines-targeting-infectious-diseases/ 2021-01-08T17:57:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Affinivax.png https://bostonlifesciencestimes.com/2021/01/komodo-health-acquires-mavens-creating-the-first-data-driven-enterprise-platform-for-life-sciences/ 2021-01-11T20:20:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Screenshot_2021-01-11-Komodo-Health-Values-and-Mission.png https://bostonlifesciencestimes.com/2021/01/receptor-life-sciences-receives-fda-guidance-for-development-of-rls-103-designed-for-the-treatment-of-acute-panic-attack/ 2021-01-11T20:29:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Screenshot_2021-01-11-Home-Receptor-Life.png https://bostonlifesciencestimes.com/2021/01/talkspace-awarded-over-6-95-million-in-grants-by-the-national-institutes-of-health-to-explore-the-efficacy-and-impact-of-tele-therapy/ 2021-01-11T20:34:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Screenshot_2021-01-11-Neil-Leibowitz-Aspen-Ideas.png https://bostonlifesciencestimes.com/2021/01/cardea-bio-adds-6-5-million-to-series-a-early-stage-financing-now-totals-more-than-20-million/ 2021-01-12T21:10:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Screenshot_2021-01-12-Rob-Lozuk-Cardea.png https://bostonlifesciencestimes.com/2021/01/gilead-and-vir-biotechnology-establish-clinical-collaboration-to-explore-combination-strategies-for-functional-cure-for-chronic-hepatitis-b-virus/ 2021-01-12T21:16:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/PhilPang.jpg https://bostonlifesciencestimes.com/2021/01/white-oak-healthcare-mob-reit-announces-acquisition-of-commonwealth-medical-park-in-petersburg-virginia/ 2021-01-12T21:18:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/David-Lynn-Headshot.jpg https://bostonlifesciencestimes.com/2021/01/oxford-finance-leads-107-million-upsize-financing-for-specialty-dental-brands/ 2021-01-13T20:01:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/scales.png https://bostonlifesciencestimes.com/2021/01/leo-pharma-initiates-head-to-head-study-to-evaluate-brodalumab-vs-guselkumab-in-adult-patients-with-moderate-to-severe-psoriasis-who-have-inadequate-response-to-ustekinumab/ 2021-01-13T20:04:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Per_Sproegel.jpg https://bostonlifesciencestimes.com/2021/01/28th-annual-emerald-groundhog-day-investment-forum-goes-virtual-as-pandemic-casts-a-long-shadow/ 2021-01-14T20:21:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/emerald_adv_DRIVEN_hor.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Screenshot_2021-01-14-Our-Team-Emerald-Asset-Management.png https://bostonlifesciencestimes.com/2021/01/lifenet-health-launches-newly-expanded-lifesciences-division-with-innovative-solutions-for-researchers/ 2021-01-14T20:28:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/life-net-health.jpg https://bostonlifesciencestimes.com/2021/01/covid-19-warnings-on-twitter-spread-well-before-pandemic-outbreak/ 2021-01-25T14:09:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Twitter-screen.jpg https://bostonlifesciencestimes.com/2021/01/california-covid-19-vaccine-recipient-dies-after-inoculation/ 2021-01-25T14:12:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Vaccine-California.jpg https://bostonlifesciencestimes.com/2021/01/australia-gives-provisional-approval-to-pfizer-covid-19-vaccine/ 2021-01-25T14:14:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Covid-pfizer.jpg https://bostonlifesciencestimes.com/2021/01/moderna-says-its-covid-19-vaccine-works-against-new-variants/ 2021-01-25T14:18:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Stephane-Bancel-Twitter.jpg https://bostonlifesciencestimes.com/2021/01/mexican-president-tests-positive-for-covid-19/ 2021-01-25T14:32:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Andres-Manuel-Lopez-Obrador.jpg https://bostonlifesciencestimes.com/2021/01/babson-diagnostics-first-to-conduct-full-blood-panel-testing-from-a-finger-sample-in-a-retail-setting/ 2021-01-25T20:03:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Screenshot_2021-01-25-david-stein-jpg-JPEG-Image-200-%C3%97-200-pixels.png https://bostonlifesciencestimes.com/2021/01/aerobiotix-announces-fda-510k-clearance-of-medical-ultraviolet-air-filtration-system/ 2021-01-25T20:09:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Aerobiotix.jpg https://bostonlifesciencestimes.com/2021/01/craig-a-hodges-ph-d-awarded-sensory-sentinel-grant-by-turner-scientific/ 2021-01-26T20:13:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Craig-A.-Hodges-Ph.D..jpg https://bostonlifesciencestimes.com/2021/01/merck-presents-interim-findings-from-phase-2a-clinical-trial-evaluating-investigational-once-monthly-oral-islatravir-for-the-prevention-of-hiv-1-infection/ 2021-01-26T20:16:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Screenshot_2021-01-26-Antimicrobial-resistance-a-problem-without-a-simple-answer-Merck-com.png https://bostonlifesciencestimes.com/2021/01/outcome-capital-advises-evergreen-systems-in-its-sale-to-sunstone-partners/ 2021-01-26T20:22:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/evergreen.jpg https://bostonlifesciencestimes.com/2021/01/life-sciences-firm-oncorus-leases-88184-sf-in-andover-ma/ 2021-01-27T13:35:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Innovation-Park-Andover-Lease.jpg https://bostonlifesciencestimes.com/2021/01/bharat-biotech-to-make-antigen-for-first-ever-anti-malaria-vaccine/ 2021-01-27T13:40:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Bharat-Biotech-image.jpg https://bostonlifesciencestimes.com/2021/01/this-immune-cell-in-blood-may-up-severe-covid-risk/ 2021-01-27T13:45:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Covid-Jan.jpg https://bostonlifesciencestimes.com/2021/01/samsung-health-tracking-app-soon-in-31-more-countries/ 2021-01-27T13:48:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Samsung.jpg https://bostonlifesciencestimes.com/2021/01/200-million-extra-doses-biden-led-covid-19-turnaround-kicks-off/ 2021-01-27T13:53:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/BidenPresident.jpg https://bostonlifesciencestimes.com/2021/01/global-covid-19-cases-surpass-100mn-johns-hopkins-university/ 2021-01-27T14:01:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Covid-Global-Brazil.jpg https://bostonlifesciencestimes.com/2021/01/top-life-sciences-clusters-to-see-36-million-square-feet-of-new-construction-delivery/ 2021-01-27T15:26:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Boston-Skyline-Night.jpg https://bostonlifesciencestimes.com/2021/01/perkinelmer-launches-industry-leading-solus-one-e-coli-o157-pathogen-detection-assay-for-beef-beef-trim-testing/ 2021-01-27T19:42:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/1200px-PerkinElmer_logo.svg_.png https://bostonlifesciencestimes.com/2021/01/as-patient-concerns-linger-over-possible-covid-19-vaccine-risks-us-healthcare-professionals-believe-80-will-get-the-flu-vaccine-this-year/ 2021-01-27T19:46:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Caleb-Costa_2017-scaled.jpg https://bostonlifesciencestimes.com/2021/01/waters-otto-specialist-positive-pressure-manifold-improves-reproducibility-and-reliability-of-solid-phase-extraction/ 2021-01-27T19:52:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Waters-Otto-SPEcialist.jpg https://bostonlifesciencestimes.com/2021/01/why-so-many-people-overuse-antibiotics/ 2021-01-28T14:43:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Medicine-antibiotics.jpg https://bostonlifesciencestimes.com/2021/01/pfizer-biontech-covid-vax-neutralises-uk-south-africa-variants/ 2021-01-28T14:46:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Pfizer-Building-logo.jpg https://bostonlifesciencestimes.com/2021/01/guterres-reiterates-call-for-equitable-access-to-covid-19-vaccines/ 2021-01-28T14:50:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Antonio-Guterres-UN-Photo-Mark-Garden.jpg https://bostonlifesciencestimes.com/2021/01/sai-life-sciences-announces-plans-to-double-headcount-and-expand-capabilities-in-manchester-uk/ 2021-01-28T15:00:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Sai-Life-Sciences-e1611845764363.jpg https://bostonlifesciencestimes.com/2021/01/white-oak-healthcare-acquires-4-class-a-medical-office-buildings-in-ohio-and-minnesota/ 2021-01-28T15:05:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/David-Lynn.jpg https://bostonlifesciencestimes.com/2021/01/cognito-therapeutics-appoints-mark-day-as-chief-business-officer/ 2021-01-28T15:14:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Cognito.png https://bostonlifesciencestimes.com/2021/01/labcorp-earns-100-percent-on-human-rights-campaign-foundations-annual-scorecard-on-lgbtq-workplace-equality/ 2021-01-28T19:38:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Labcorp1.jpg https://bostonlifesciencestimes.com/2021/01/scitara-raises-5-million-to-accelerate-digital-transformation-of-scientific-laboratories/ 2021-01-28T19:53:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Ajit-Nagral.jpg https://bostonlifesciencestimes.com/2021/01/novavax-covid-19-vaccine-found-89-3-effective/ 2021-01-29T14:19:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Stanley-C.-Erck.jpg https://bostonlifesciencestimes.com/2021/01/amazons-algorithms-boost-vaccine-misinformation-says-study/ 2021-01-29T14:22:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/amazon.jpg https://bostonlifesciencestimes.com/2021/01/jj-single-shot-covid-19-vaccine-shows-66-efficacy-overall/ 2021-01-29T14:27:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Alex-Gorsky.jpeg https://bostonlifesciencestimes.com/2021/01/construction-starts-on-a-165600-square-foot-life-science-building-in-arsenal-yards-watertown/ 2021-01-29T14:34:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/100-Forge.jpg https://bostonlifesciencestimes.com/2021/01/biotech-firm-chemgenes-corporation-buys-billerica-building-for-11-million/ 2021-01-29T14:40:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/ChemGenes.jpg https://bostonlifesciencestimes.com/2021/01/griffith-properties-to-transform-watertown-building-into-a-class-a-lab-space-in-emerging-life-science-market/ 2021-01-29T14:50:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/580-Pleasant-Street.jpg https://bostonlifesciencestimes.com/2021/01/mms-holdings-joins-decentralized-trials-research-alliance-dtra-as-a-founding-member-to-accelerate-the-adoption-of-patient-focused-clinical-trials/ 2021-01-29T19:03:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/MMS_logo_8_24_17-1.png https://bostonlifesciencestimes.com/2021/01/catabasis-pharmaceuticals-announces-acquisition-of-quellis-biosciences-inc/ 2021-01-29T19:07:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Chris-Garabedian.jpg https://bostonlifesciencestimes.com/2021/01/sonoma-pharmaceuticals-and-microderm-technologies-announce-that-dermodacyn-disinfecting-solution-is-now-available-in-hong-kong-and-thailand/ 2021-01-29T19:21:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Sonomalogo.jpg https://bostonlifesciencestimes.com/2021/01/eu-authorizes-astrazeneca-oxford-covid-19-vaccine/ 2021-01-30T19:17:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/AstraZeneca-Vaccine.png https://bostonlifesciencestimes.com/2021/01/life-science-washington-state-welcomes-new-board-chair-executive-committee-members-and-directors/ 2021-01-30T19:31:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Margaret-McCormick.jpg https://bostonlifesciencestimes.com/2021/01/thermo-fisher-scientific-to-acquire-mesa-biotech-for-550-million/ 2021-01-30T19:46:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Mark-Stevenson.jpg https://bostonlifesciencestimes.com/2021/01/microgem-acquires-jump-start-expands-manufacturing-in-new-hampshire/ 2021-01-30T19:57:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Jeff-Chapman.png https://bostonlifesciencestimes.com/2021/02/this-alternative-surgery-may-prevent-total-knee-replacement/ 2021-02-01T14:52:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Knee.jpg https://bostonlifesciencestimes.com/2021/02/us-covid-19-cases-hospitalizations-drop-deaths-still-spike/ 2021-02-01T14:55:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Covid-full-gear.jpg https://bostonlifesciencestimes.com/2021/02/us-cdc-makes-masks-mandatory-on-planes-public-transportation/ 2021-02-01T14:58:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Mask-Travel.jpg https://bostonlifesciencestimes.com/2021/02/iqhq-expands-leadership-team-to-support-rapid-growth-of-life-sciences-commercial-real-estate-portfolio/ 2021-02-01T18:57:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Fran-Federman-scaled-e1612191906870.jpg https://bostonlifesciencestimes.com/2021/02/moma-therapeutics-appoints-asit-parikh-as-president-and-chief-executive-officer/ 2021-02-01T19:46:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Asit-Parikh.jpg https://bostonlifesciencestimes.com/2021/02/fractyl-announces-publication-of-clinical-results-from-inspire-study-showing-durable-insulin-free-glycemic-control-in-majority-of-patients-treated/ 2021-02-01T19:53:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Harith-Rajagopalan-M.D.-Ph.D.jpg https://bostonlifesciencestimes.com/2021/02/moleculin-signs-agreement-with-catalyst-clinical-research-to-begin-sarcoma-trial/ 2021-02-01T20:05:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Screenshot_2021-02-01-Management-Moleculin-Biotech.png https://bostonlifesciencestimes.com/2021/02/illumina-and-sequoia-capital-china-partner-to-launch-genomics-incubator-in-china/ 2021-02-01T21:22:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Francis-deSouza.jpg https://bostonlifesciencestimes.com/2021/02/pfizer-biontech-to-produce-2-billion-doses-of-covid-vaccine-in-2021/ 2021-02-02T17:06:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Covid-pfizer.jpg https://bostonlifesciencestimes.com/2021/02/56-13-of-people-in-delhi-developed-antibodies/ 2021-02-02T17:11:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Covid-Indian-women-with-masks.jpg https://bostonlifesciencestimes.com/2021/02/bleeding-gums-may-indicate-vitamin-c-deficiency/ 2021-02-02T17:17:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/gum.jpg https://bostonlifesciencestimes.com/2021/02/mynd-life-sciences-announces-research-agreement-with-the-university-of-british-columbia-on-major-depressive-disorder/ 2021-02-02T17:25:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Lyle-Oberg.jpg https://bostonlifesciencestimes.com/2021/02/life-biosciences-appoints-joan-mannick-md-to-lead-its-research-and-development/ 2021-02-02T17:37:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Joan-Mannick.png https://bostonlifesciencestimes.com/2021/02/dr-siddhartha-kadia-to-join-nuvasive-board-of-directors/ 2021-02-02T17:49:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Siddhartha-Kadia.jpg https://bostonlifesciencestimes.com/2021/02/new-england-biolabs-and-color-partner-to-provide-covid-19-testing-to-biotech-workers-essential-to-global-pandemic-response/ 2021-02-02T17:56:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Jim-Ellard.jpg https://bostonlifesciencestimes.com/2021/02/glympse-bio-names-jessica-atkinson-senior-vice-president-of-business-development/ 2021-02-02T18:02:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Jessica-Atkinson.jpg https://bostonlifesciencestimes.com/2021/02/oxford-finance-provides-47-million-credit-facility-to-averhealth/ 2021-02-02T19:24:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Screenshot_2021-02-02-Averhealth-Leadership-Team.png https://bostonlifesciencestimes.com/2021/02/gilead-and-the-human-rights-campaign-will-work-together-to-combat-hiv-epidemic-and-promote-transgender-justice/ 2021-02-02T19:28:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Daniel-ODay.jpg https://bostonlifesciencestimes.com/2021/02/daiichi-sankyo-initiates-clinical-development-of-sixth-dxd-adc-ds-6000-with-sarah-cannon-research-institute/ 2021-02-02T19:38:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Daiichi-Sankyo.jpg https://bostonlifesciencestimes.com/2021/02/astrazeneca-says-vaccine-76-effective-for-90-days-after-single-dose/ 2021-02-03T14:21:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/AstraZeneca-Vaccine.png https://bostonlifesciencestimes.com/2021/02/too-much-sugar-intake-in-childhood-can-alter-microbiome-for-life/ 2021-02-03T14:27:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Sugar-e1612362380195.jpg https://bostonlifesciencestimes.com/2021/02/novel-injection-to-treat-skin-cancer/ 2021-02-03T14:31:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Cancer-Glass.jpg https://bostonlifesciencestimes.com/2021/02/lifenet-health-lifesciences-isolates-primary-human-lung-cells-to-aid-and-accelerate-efforts-in-covid-19-drug-development/ 2021-02-03T14:45:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Lifenet.jpg https://bostonlifesciencestimes.com/2021/02/tmrw-launches-worlds-first-automated-platform-to-safeguard-millions-of-frozen-eggs-and-embryos/ 2021-02-03T14:53:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Joshua-Abram.jpg https://bostonlifesciencestimes.com/2021/02/flywheel-secures-15m-in-series-b-funding/ 2021-02-03T19:28:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Jim-Olson-683x1024-1.jpg https://bostonlifesciencestimes.com/2021/02/eurosets-announces-the-full-commercial-release-of-its-novel-extracorporeal-life-support-system-ecmolife/ 2021-02-03T19:41:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Eurosets.jpg https://bostonlifesciencestimes.com/2021/02/perkinelmers-horizon-discovery-cell-line-supports-trinomab-biotechs-development-of-the-tetanus-toxin-mab-drug-for-clinical-trials/ 2021-02-04T15:56:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Jesus-Zurdo.jpg https://bostonlifesciencestimes.com/2021/02/genapsys-names-jason-myers-ceo/ 2021-02-04T16:06:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Jason-Myers.jpg https://bostonlifesciencestimes.com/2021/02/catamaran-bio-appoints-alvin-shih-as-president-and-ceo/ 2021-02-04T16:10:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Alvin-Shih.jpg https://bostonlifesciencestimes.com/2021/02/follett-products-llc-and-phc-corporation-of-north-america-partner-to-supply-ultra-low-temperature-freezers-to-healthcare-facilities/ 2021-02-04T21:14:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/PHCbi_Brandmark.jpg https://bostonlifesciencestimes.com/2021/02/mylung-study-launches-aiming-to-advance-use-of-precision-medicine-for-metastatic-non-small-cell-lung-cancer-patients/ 2021-02-04T21:33:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Screenshot_2021-02-04-An-Inside-Look-at-MYLUNG-McKesson.png https://bostonlifesciencestimes.com/2021/02/zinc-may-help-with-fertility-during-covid-19-pandemic/ 2021-02-05T14:59:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Fruits.jpg https://bostonlifesciencestimes.com/2021/02/flu-vaccine-may-lessen-covid-symptoms-in-children/ 2021-02-05T15:01:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Flu.jpg https://bostonlifesciencestimes.com/2021/02/dialysis-patients-at-4-fold-greater-risk-of-dying-from-covid/ 2021-02-05T15:03:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Kidney.jpg https://bostonlifesciencestimes.com/2021/02/generate-life-sciences-expands-presence-in-canada/ 2021-02-05T15:09:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Pamela-Richardson.jpg https://bostonlifesciencestimes.com/2021/02/reverie-labs-raises-25-million-series-a-round/ 2021-02-05T15:14:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Ankit-Gupta.jpg https://bostonlifesciencestimes.com/2021/02/casana-raises-14-million-in-series-a-funding-led-by-general-catalyst-for-in-home-heart-health-monitoring-device/ 2021-02-05T15:20:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Austin-McChord.jpg https://bostonlifesciencestimes.com/2021/02/seti-and-seoul-viosys-develop-portable-photon-stand-surface-disinfection-unit-that-kills-viruses-in-10-minutes/ 2021-02-05T19:49:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Photo_Seoul_Viosys_and_SETi_Photon_Stand.jpg https://bostonlifesciencestimes.com/2021/02/activ-surgical-joins-microsoft-for-startups-program/ 2021-02-05T20:06:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Tom-Calef.png https://bostonlifesciencestimes.com/2021/02/astrazenecas-anti-diabetic-drug-gets-nod-for-kidney-disease-in-india/ 2021-02-08T14:59:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/AstraZeneca-Building.jpg https://bostonlifesciencestimes.com/2021/02/uk-plans-annual-vaccinations-against-new-covid-variants/ 2021-02-08T15:02:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Vaccine-double.jpg https://bostonlifesciencestimes.com/2021/02/novel-ai-tool-to-thwart-covid-mutations/ 2021-02-08T15:05:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/AI-treatment.jpg https://bostonlifesciencestimes.com/2021/02/us-sees-drop-in-covid-cases-deaths-hospitalizations/ 2021-02-08T15:10:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Covid-US-Outside.jpg https://bostonlifesciencestimes.com/2021/02/covaxxs-covid-19-vaccine-ub-612-induced-neutralizing-antibodies-in-100-of-participants-during-phase-1-clinical-trial/ 2021-02-08T19:50:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/vax.jpg https://bostonlifesciencestimes.com/2021/02/global-anti-inflammatory-drugs-market-to-surpass-us-142223-4-million-by-2027-says-coherent-market-insights/ 2021-02-08T19:53:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/coherant.jpg https://bostonlifesciencestimes.com/2021/02/covid-virus-leak-from-lab-extremely-unlikely-says-who-team/ 2021-02-09T15:04:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Covid-Image-Better.png https://bostonlifesciencestimes.com/2021/02/bioasia-2021-to-focus-on-covid-global-health/ 2021-02-09T15:07:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Covid-Jan.jpg https://bostonlifesciencestimes.com/2021/02/hacker-changed-water-chemical-levels-to-poison-entire-us-city/ 2021-02-09T15:09:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Hacker.jpg https://bostonlifesciencestimes.com/2021/02/new-england-patriots-foundation-donates-100000-to-cape-cod-community-college-for-new-stem-building/ 2021-02-09T19:45:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/CCCC-Pats-Check-Handoff.jpg https://bostonlifesciencestimes.com/2021/02/healthgrades-announces-2021-americas-best-hospitals/ 2021-02-09T19:52:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Healthgrades.png https://bostonlifesciencestimes.com/2021/02/uk-variant-of-covid-strain-reported-in-86-countries-who/ 2021-02-10T17:11:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/WHO.jpg https://bostonlifesciencestimes.com/2021/02/new-zealand-approves-1st-covid-19-vaccine/ 2021-02-10T17:15:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Vaccine-COVID-NZ.jpg https://bostonlifesciencestimes.com/2021/02/advance-powered-by-ptce-offers-covid-19-vaccination-program-for-pharmacists-and-technicians/ 2021-02-10T19:40:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Screenshot_2021-02-10-AdvanCE-Powered-by-PTCE-Offers-COVID-19-Vaccination-Program-for-Pharmacists-and-Technicians.png https://bostonlifesciencestimes.com/2021/02/waters-redefines-laboratory-science-with-new-acquity-premier-liquid-chromatography-solution/ 2021-02-10T19:42:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Photo_ACQUITY_PREMIER_BSM_FTN_CH-A_PDA_tray_bottles_angled.jpg https://bostonlifesciencestimes.com/2021/02/bighat-biosciences-raises-19-million-in-series-a-funding-to-advance-antibody-design-and-development-for-safer-more-effective-treatments/ 2021-02-10T19:45:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/IMG_0923_cleaned.jpg https://bostonlifesciencestimes.com/2021/02/pre-built-labs-are-essential-in-established-and-emerging-life-sciences-markets/ 2021-02-11T15:20:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/95-Green-Street-Credit-Thor-Sciences-Neoscape.jpeg https://bostonlifesciencestimes.com/2021/02/205-million-in-financing-for-life-sciences-and-medical-office-building-in-manhattan/ 2021-02-11T16:28:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/619-West-54th-Street-NY.jpg https://bostonlifesciencestimes.com/2021/02/drug-topics-announces-partnership-with-inpharmacyjobs/ 2021-02-11T19:41:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/drug-topics.jpg https://bostonlifesciencestimes.com/2021/02/m6p-therapeutics-presents-promising-preclinical-data-in-lysosomal-storage-disorders-at-the-17th-annual-worldsymposium-2021/ 2021-02-11T19:46:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Lin-Liu.jpg https://bostonlifesciencestimes.com/2021/02/live-remote-supervision-of-neuroendovascular-surgery-enabled-by-olympus-medpresence/ 2021-02-11T19:48:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Picture1.jpg https://bostonlifesciencestimes.com/2021/02/bioiq-and-biomeme-announce-partnership-for-covid-testing-bringing-the-rt-pcr-laboratory-and-gold-standard-testing-to-the-worksite-for-fast-and-highly-sensitive-results/ 2021-02-12T16:18:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/BioIQ.jpg https://bostonlifesciencestimes.com/2021/02/amy-summy-chief-marketing-officer-of-labcorp-named-to-forbes-cmo-next/ 2021-02-16T18:12:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Amy-Summy.jpg https://bostonlifesciencestimes.com/2021/02/medical-device-innovation-consortium-releases-playbook-of-best-practices-for-shifting-organizations-to-a-culture-of-quality/ 2021-02-16T18:14:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Medical-Device-Innovation-Consortium.jpg https://bostonlifesciencestimes.com/2021/02/gilead-sciences-and-wake-forest-university-school-of-divinity-partner-to-address-hiv-epidemic-through-faith-based-programming-and-community-outreach/ 2021-02-16T18:50:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Daniel-ODay.jpg https://bostonlifesciencestimes.com/2021/02/agilent-announces-higher-sensitivity-xf-analysis-solution-for-low-abundant-immune-cell-metabolic-analysis/ 2021-02-17T20:07:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Katja-Weinacht-M.D.-Ph.D..jpg https://bostonlifesciencestimes.com/2021/02/cancer-researchers-can-assess-microsatellite-instability-msi-through-new-lens-with-expanded-promega-system/ 2021-02-17T20:10:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Promega-Corporation.jpg https://bostonlifesciencestimes.com/2021/02/xlife-sciences-ag-antiviral-drug-candidate-for-sars-cov-2/ 2021-02-17T20:19:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Oliver-R.-Baumann-CEO-of-Xlife.jpg https://bostonlifesciencestimes.com/2021/02/ibiopsy-median-technologies-continues-its-strong-positioning-in-early-stage-diagnosis-with-a-new-ibiopsy-clinical-development-plan-on-lung-cancer-screening/ 2021-02-17T20:23:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Fredrik-Brag-CEO-and-Founder-of-Median.png https://bostonlifesciencestimes.com/2021/02/eurofins-scientific-announces-acquisition-of-beacon-discovery-substantially-expanding-its-integrated-drug-discovery-capabilities-and-expertise/ 2021-02-18T19:43:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Eurofin.jpg https://bostonlifesciencestimes.com/2021/02/update-on-igcs-phase-1-clinical-trial-on-alzheimers-patients/ 2021-02-22T18:47:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/India-Globalization-Capital.png https://bostonlifesciencestimes.com/2021/02/anthony-nolan-cell-gene-therapy-services-and-onk-therapeutics-announce-collaboration/ 2021-02-22T18:54:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/ONK-Therapeutics.jpg https://bostonlifesciencestimes.com/2021/02/mymd-pharmaceuticals-announces-new-data-on-its-lead-compound-mymd-1-from-a-phenotypic-study-performed-by-eurofins-discovery/ 2021-02-23T19:06:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Adam-Kaplin-M.D.-Ph.D-Chief-Scientific-Officer-for-MyMD-Pharmaceuticals.png https://bostonlifesciencestimes.com/2021/02/perkinelmer-changes-covid-19-rapid-testing-landscape-with-highly-sensitive-point-of-care-antigen-test-for-mass-screening/ 2021-02-23T19:12:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/1200px-PerkinElmer_logo.svg_.png https://bostonlifesciencestimes.com/2021/02/walgreens-to-make-pixel-by-labcorp-covid-19-pcr-test-home-kit-available-over-the-counter-nationwide/ 2021-02-24T20:40:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/pixel.jpg https://bostonlifesciencestimes.com/2021/02/70-of-us-infectious-disease-doctors-support-two-doses-of-covid-19-vaccine-for-all-recipients/ 2021-02-24T20:44:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Daniel-S.-Fitzgerald.jpg https://bostonlifesciencestimes.com/2021/02/top-two-challenges-for-market-access-teams-in-2021-are-pricing-pressures-and-evidence-generation/ 2021-02-24T20:48:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Eric_Matckie.jpg https://bostonlifesciencestimes.com/2021/02/biodesix-ceo-scott-hutton-selected-as-one-of-top-25-biotech-ceos-of-2021/ 2021-02-25T19:23:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Scott-Hutton.jpg https://bostonlifesciencestimes.com/2021/02/worlds-first-personalized-spine-surgery-performed-using-spine-technology-with-fda-breakthrough-designation/ 2021-02-25T19:36:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Mike-Cordonnier-CEO-of-Carlsmed.png https://bostonlifesciencestimes.com/2021/02/beigene-closes-collaboration-with-novartis-to-develop-anti-pd-1-antibody-tislelizumab/ 2021-02-26T18:25:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/John-V.-Oyler-Co-Founder-Chairman-and-CEO-of-BeiGene.png https://bostonlifesciencestimes.com/2021/02/delays-and-discord-are-sinking-covax-says-ahf/ 2021-02-26T18:28:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/vax.jpg https://bostonlifesciencestimes.com/2021/03/saama-teams-with-oracle-to-offer-life-sciences-industry-ai-enabled-applications-to-accelerate-clinical-trials/ 2021-03-01T19:06:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/Sagar-Anisingaraju.jpg https://bostonlifesciencestimes.com/2021/03/agilent-to-acquire-resolution-bioscience-strengthening-leadership-position-in-cancer-diagnostics/ 2021-03-02T19:05:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/Agilent-Technologies.jpg https://bostonlifesciencestimes.com/2021/03/leading-sleep-medicine-expert-joins-apnimed-management-team/ 2021-03-04T21:09:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/David-P.-White-M.D..jpg https://bostonlifesciencestimes.com/2021/03/new-research-reveals-more-cros-taking-action-to-meet-urgent-need-for-faster-clinical-trials/ 2021-03-04T21:12:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/Veeva-Systems.jpg https://bostonlifesciencestimes.com/2021/03/iqvia-collaborating-with-janssen-research-development-on-their-investigational-covid-19-vaccine-trials/ 2021-03-08T20:59:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Vaccine-new.jpg https://bostonlifesciencestimes.com/2021/03/labvantage-adds-vendor-validation-to-its-software-as-a-service-lims/ 2021-03-08T21:04:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/LabVantage.jpg https://bostonlifesciencestimes.com/2021/03/reform-biologics-announces-the-issuance-of-chinese-patent-for-therapeutic-protein-formulations/ 2021-03-08T21:09:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/John-M.-Sorvillo-Ph.D..jpg https://bostonlifesciencestimes.com/2021/03/has-covid-changed-spring-cleaning/ 2021-03-09T19:30:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/aci.jpg https://bostonlifesciencestimes.com/2021/03/viiv-healthcare-presents-positive-proof-of-concept-findings-for-a-novel-maturation-inhibitor-for-the-treatment-of-hiv/ 2021-03-09T19:35:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/ViiV-Healthcare.jpg https://bostonlifesciencestimes.com/2021/03/idt-acquires-swift-biosciences/ 2021-03-12T16:55:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/Integrated-DNA-Technologies.jpg https://bostonlifesciencestimes.com/2021/03/fsd-pharma-enters-into-license-agreement-to-develop-veterinary-drugs-for-the-treatment-of-dogs-and-cats/ 2021-03-17T19:25:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/Raza-Bokhari.jpg https://bostonlifesciencestimes.com/2021/03/perkinelmer-further-expands-capabilities-in-biologics-drug-discovery/ 2021-03-18T16:27:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/1200px-PerkinElmer_logo.svg_.png https://bostonlifesciencestimes.com/2021/03/life-sciences-industry-looks-to-digital-innovation-to-help-navigate-the-pandemic-and-beyond/ 2021-03-18T16:33:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/Information-Services-Group.jpg https://bostonlifesciencestimes.com/2021/03/lendlease-and-ivanhoe-cambridge-to-develop-world-class-life-science-project-in-boston-retain-sga-to-design-the-building/ 2021-03-18T16:49:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/60-Guest-Ivanhoe-e1616086153741.jpg https://bostonlifesciencestimes.com/2021/03/waters-new-bioaccord-system-boosts-innovator-and-biosimilar-drug-development/ 2021-03-18T18:06:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/Peptide-MAM.jpg https://bostonlifesciencestimes.com/2021/03/delix-therapeutics-names-mark-rus-as-chief-executive-officer/ 2021-03-18T18:08:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/Mark-Rus.jpg https://bostonlifesciencestimes.com/2021/03/call-for-locally-sourced-medical-devices-answered-by-vonco-products/ 2021-03-18T18:17:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/Vonco-Products.jpg https://bostonlifesciencestimes.com/2021/03/komodo-health-secures-220m-in-funding-led-by-tiger-global/ 2021-03-22T19:10:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Screenshot_2021-01-11-Komodo-Health-Values-and-Mission.png https://bostonlifesciencestimes.com/2021/03/mercy-iowa-city-selects-allscripts-sunrisetm/ 2021-03-22T19:17:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/Sean-Williams.jpg https://bostonlifesciencestimes.com/2021/03/klick-health-recognized-as-a-best-workplace-for-women-for-6th-year-in-a-row/ 2021-03-23T19:52:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/Klick-Health.jpg https://bostonlifesciencestimes.com/2021/03/dr-marcia-eisenberg-chief-scientific-officer-of-labcorp-diagnostics-named-a-healthcare-businesswomans-association-luminary/ 2021-03-23T19:53:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/Dr.-Marcia-Eisenberg.jpg https://bostonlifesciencestimes.com/2021/03/white-oak-healthcare-mob-reit-acquires-7-medical-office-buildings-in-5-states/ 2021-03-23T19:55:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/David-Lynn.jpg https://bostonlifesciencestimes.com/2021/03/dassault-systemes-simulates-airflow-in-paris-hospital-to-reduce-risks-of-covid-19-exposure/ 2021-03-23T19:58:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/Dassault-Systemes.jpg https://bostonlifesciencestimes.com/2021/03/brandywine-realty-trust-open-life-science-incubator-on-14-acre-3-5-billion-schuylkill-yards-innovation-neighborhood/ 2021-03-24T19:38:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/Brandywine-Realty-Trust.png https://bostonlifesciencestimes.com/2021/03/pidc-and-ensemble-mosaic-execute-navy-yard-development-agreement-launching-2-5-billion-development-plan/ 2021-03-24T19:42:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/PIDC.jpg https://bostonlifesciencestimes.com/2021/03/new-data-show-foreign-reference-drug-pricing-proposals-would-reduce-the-development-of-new-innovative-medicines-in-california-by-88/ 2021-03-24T19:47:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/Mike-Guerra.jpg https://bostonlifesciencestimes.com/2021/03/new-compound-offers-hope-for-anti-covid-drug/ 2021-03-25T17:15:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Covid-Image-Better.png https://bostonlifesciencestimes.com/2021/03/3-common-antiviral-drugs-potentially-effective-against-covid/ 2021-03-25T17:16:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/drugs2.jpg https://bostonlifesciencestimes.com/2021/03/astrazeneca-covid-vax-76-effective-in-updated-trial-data/ 2021-03-25T17:17:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/AstraZeneca-Vaccine.png https://bostonlifesciencestimes.com/2021/03/labvantage-solutions-names-mikael-hagstroem-as-chief-executive-officer/ 2021-03-25T17:24:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/Mikael-Hagstroem.jpg https://bostonlifesciencestimes.com/2021/03/novel-technique-to-detect-biomarker-for-cancer/ 2021-03-26T17:20:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/cancer.jpg https://bostonlifesciencestimes.com/2021/03/women-accumulate-alzheimers-related-protein-faster-study/ 2021-03-26T17:21:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/Alzheimer2.jpg https://bostonlifesciencestimes.com/2021/03/california-to-expand-covid-vax-eligibility/ 2021-03-26T17:26:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/CA-Vax.jpg https://bostonlifesciencestimes.com/2021/03/novel-coronavirus-invades-mouths-cells-shows-new-evidence/ 2021-03-26T17:28:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/SARS-CoV-2.jpg https://bostonlifesciencestimes.com/2021/03/gyroscope-therapeutics-announces-148-million-raised-in-series-c-financing/ 2021-03-26T17:34:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/Khurem-Farooq.jpg https://bostonlifesciencestimes.com/2021/03/study-reveals-differences-between-men-and-womens-brains/ 2021-03-29T19:14:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/brain3.jpg https://bostonlifesciencestimes.com/2021/03/vitamin-d-deficiency-linked-to-metabolic-changes-in-patients-with-lupus/ 2021-03-29T19:15:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/vitamin.jpg https://bostonlifesciencestimes.com/2021/03/covid-19-strains-dont-appear-to-be-highly-variable-expert/ 2021-03-29T19:18:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/covid3.jpg https://bostonlifesciencestimes.com/2021/03/dr-shirin-peters-addresses-frequently-asked-questions-to-prepare-for-an-extended-allergy-season-in-2021/ 2021-03-29T19:21:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/Screenshot_2021-03-29-shirin-760x760-png-webp-WEBP-Image-760-%C3%97-760-pixels.png https://bostonlifesciencestimes.com/2021/03/pfizer-biontech-covid-vax-shows-100-efficacy-in-12-15-yrs-old/ 2021-03-31T17:18:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Pfizer-Building-logo.jpg https://bostonlifesciencestimes.com/2021/03/chile-to-obtain-covid-vaccine-from-chinas-cansino/ 2021-03-31T17:20:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/Covid-19-vaccine.jpg https://bostonlifesciencestimes.com/2021/03/charles-river-associates-cra-announces-vice-president-promotions/ 2021-03-31T17:26:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/Screenshot_2021-03-31-Christine-Dedrick-Our-People-Charles-River-Associates.png https://bostonlifesciencestimes.com/2021/04/mobile-health-tech-can-aid-elderly-with-heart-disease/ 2021-04-01T18:11:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/tech.jpg https://bostonlifesciencestimes.com/2021/04/new-portable-test-can-spot-covid-in-15-mins-track-variants/ 2021-04-01T18:12:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Covid-19.jpg https://bostonlifesciencestimes.com/2021/04/childrens-hospital-los-angeles-study-shows-diet-and-exercise-can-improve-leukemia-outcomes/ 2021-04-01T18:15:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Dr.-Etan-Orgel.jpg https://bostonlifesciencestimes.com/2021/04/seema-verma-joins-lumeris-board-of-directors/ 2021-04-01T18:17:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Seema-Verma.jpg https://bostonlifesciencestimes.com/2021/04/morehouse-college-announces-575000-endowed-life-sciences-scholarship-from-verily/ 2021-04-01T18:21:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Monique-Dozier.jpg https://bostonlifesciencestimes.com/2021/04/13-new-rare-gene-variants-of-alzheimers-identified/ 2021-04-02T15:27:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/doctor.jpg https://bostonlifesciencestimes.com/2021/04/new-five-minute-treatment-for-breast-cancer-rolled-out-in-uk/ 2021-04-05T18:56:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/breast-cancer.jpg https://bostonlifesciencestimes.com/2021/04/bp-pills-may-raise-heart-disease-risk-in-people-with-hiv-study/ 2021-04-05T19:00:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/health-placeholder.jpg https://bostonlifesciencestimes.com/2021/04/design-a-cheap-innovative-face-mask-win-up-to-500000/ 2021-04-06T17:43:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/facemask.jpg https://bostonlifesciencestimes.com/2021/04/david-evans-shaw-invests-in-maxwell-biosciences/ 2021-04-06T17:46:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/David-Evans-Shaw.jpg https://bostonlifesciencestimes.com/2021/04/quidel-taps-ics-to-collaborate-on-next-gen-diagnostic-instruments-for-covid-pathogen-detection/ 2021-04-06T17:48:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Peter-Winston.jpg https://bostonlifesciencestimes.com/2021/04/spectrum-solutions-names-rohit-k-gupta-as-chief-medical-officer/ 2021-04-06T17:51:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Rohit-K.-Gupta.jpg https://bostonlifesciencestimes.com/2021/04/better-masks-adequate-ventilation-must-to-curb-covid-indoors/ 2021-04-07T17:09:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/mask2.jpg https://bostonlifesciencestimes.com/2021/04/astrazenecas-uk-vaccine-trial-on-kids-comes-to-a-halt/ 2021-04-07T17:11:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/AstraZeneca3.jpg https://bostonlifesciencestimes.com/2021/04/all-us-adults-will-be-eligible-for-vax-by-april-19/ 2021-04-07T17:13:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Joe-Biden2.jpg https://bostonlifesciencestimes.com/2021/04/covid-antibodies-spike-in-breast-milk-after-vaccination-study/ 2021-04-07T17:14:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/breast-milk.jpg https://bostonlifesciencestimes.com/2021/04/oxford-finance-closes-credit-facility-with-renalogic/ 2021-04-08T18:41:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Lisa-Moody.jpg https://bostonlifesciencestimes.com/2021/04/908-devices-provides-handheld-mass-spec-to-u-s-border-patrol/ 2021-04-08T18:46:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Screenshot_2021-04-08-About-Us-908-Devices.png https://bostonlifesciencestimes.com/2021/04/trisalus-life-sciences-and-md-anderson-announce-strategic-research-collaboration/ 2021-04-08T18:50:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Steven-Katz.jpg https://bostonlifesciencestimes.com/2021/04/dicerna-sells-oxlumo-lumasiran-royalty-interest-to-royalty-pharma-for-up-to-240-million/ 2021-04-08T18:56:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Douglas-Fambrough-Ph.D-scaled-e1617908111430.jpg https://bostonlifesciencestimes.com/2021/04/lucira-covid-19-test-kit-identifies-viral-variants/ 2021-04-09T19:03:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Lucira-Health.jpg https://bostonlifesciencestimes.com/2021/04/exscientia-announces-first-ai-designed-immuno-oncology-drug-to-enter-clinical-trials/ 2021-04-09T19:08:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Screenshot_2021-04-09-Meet-The-Team-Our-World-Class-Scientists-Exscientia.png https://bostonlifesciencestimes.com/2021/04/calviri-appoints-marc-wolff-chief-executive-officer/ 2021-04-12T18:56:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Marc-Wolff.jpg https://bostonlifesciencestimes.com/2021/04/suffolk-hires-wan-li-zhu-as-managing-director-of-suffolk-technologies/ 2021-04-12T18:59:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Wan-Li-Zhu.jpg https://bostonlifesciencestimes.com/2021/04/kezar-life-sciences-presents-preclinical-data-with-ind-candidate-kzr-26/ 2021-04-12T19:03:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Screenshot_2021-04-12-Management-Team.png https://bostonlifesciencestimes.com/2021/04/imvax-inc-has-extended-and-expanded-its-lease-with-keystone-property-group/ 2021-04-13T18:39:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Keystone-Property-Group.jpg https://bostonlifesciencestimes.com/2021/04/neoprogen-inc-receives-first-granted-patent-for-method-to-treat-cardiac-conditions/ 2021-04-13T18:42:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Screenshot_2021-04-13-Founders-NeoProgen.png https://bostonlifesciencestimes.com/2021/04/trisalus-life-sciences-presents-data-at-american-association-of-cancer-research/ 2021-04-14T16:57:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Steven-Katz.jpg https://bostonlifesciencestimes.com/2021/04/innocoll-biotherapeutics-plc-announces-phase-3-trials-for-label-expansion-of-xaracoll-implant/ 2021-04-14T17:01:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Louis-Pascarella.jpg https://bostonlifesciencestimes.com/2021/04/komodo-health-launches-prism-and-sentinel/ 2021-04-14T17:04:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Screenshot_2021-01-11-Komodo-Health-Values-and-Mission.png https://bostonlifesciencestimes.com/2021/04/scineuro-pharmaceuticals-announces-exclusive-licensing-agreement-with-eli-lilly-company/ 2021-04-14T17:09:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Min-Li-Ph.D..jpg https://bostonlifesciencestimes.com/2021/04/solesis-announces-investment-from-altaris-capital-partners/ 2021-04-15T16:42:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Karen-West.jpg https://bostonlifesciencestimes.com/2021/04/aceto-aquires-ac/ 2021-04-15T16:51:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/AcetoLogo.jpg https://bostonlifesciencestimes.com/2021/04/first-patient-enrolled-in-protect-iv-randomized-controlled-trial-of-impella/ 2021-04-15T16:56:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/ambio.png https://bostonlifesciencestimes.com/2021/04/spineguard-strengthens-its-us-organization/ 2021-04-16T18:33:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Pierre-Jerome.jpg https://bostonlifesciencestimes.com/2021/04/bpoc-completes-sale-of-healthpro-heritage/ 2021-04-16T18:42:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Grant-Patrick.jpg https://bostonlifesciencestimes.com/2021/04/u-s-fda-approves-nextstellis-new-oral-contraceptive/ 2021-04-16T18:46:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Scott-Richards.jpg https://bostonlifesciencestimes.com/2021/04/proxima-clinical-research-experiences-fast-growth-following-brief-covid-19-dip/ 2021-04-16T18:52:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Proxima-Clinical-Research.jpg https://bostonlifesciencestimes.com/2021/04/divcowest-brings-cambridge-crossings-250-water-st-to-fully-leased-as-bristol-myers-squibb-expands-into-remaining-space/ 2021-04-19T15:39:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/250-Water-Street.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Mark-Roopenian.jpg https://bostonlifesciencestimes.com/2021/04/iqhq-announces-start-construction-on-1-billion-fenway-center-life-sciences-campus/ 2021-04-19T15:48:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/IQHQ-Fenway-tower.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/IQHQ-Fenway.jpg https://bostonlifesciencestimes.com/2021/04/inflammasome-therapeutics-kamuvudines-may-be-answer-to-preventing-blindness-in-aging-population/ 2021-04-19T19:41:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Dr.-Paul-Ashton.jpg https://bostonlifesciencestimes.com/2021/04/gyroscope-therapeutics-files-registration-statement-for-proposed-initial-public-offering-in-the-united-states/ 2021-04-19T19:44:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Gyroscope-Therapeutics.jpg https://bostonlifesciencestimes.com/2021/04/new-study-establishes-cytovale-intellisep-test-in-the-rapid-diagnosis-of-sepsis/ 2021-04-19T19:48:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Screenshot_2021-04-19-Cytovale.png https://bostonlifesciencestimes.com/2021/04/deerfield-management-announces-winners-of-the-first-annual-xseed-award/ 2021-04-20T18:20:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Screenshot_2021-04-20-People.png https://bostonlifesciencestimes.com/2021/04/oxford-finance-closes-50-million-credit-facility-with-mainstay-medical/ 2021-04-20T18:22:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Screenshot_2021-04-20-Meet-the-Team-Oxford-Finance.png https://bostonlifesciencestimes.com/2021/04/battelle-funds-internships-for-hbcu-students/ 2021-04-21T19:03:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/wes-hall-2018.jpg https://bostonlifesciencestimes.com/2021/04/labcorp-launches-covid-19-test-kits-for-small-businesses/ 2021-04-21T19:42:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Pixel_home_med_res_950h_CQ3A0049.jpg https://bostonlifesciencestimes.com/2021/04/the-221b-foundation-grants-licenses-to-multiple-organizations-to-develop-and-distribute-crispr-covid-19-diagnostic-kits-globally/ 2021-04-21T19:46:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Screenshot_2021-04-21-Team-%E2%80%A2-Sherlock-Biosciences.png https://bostonlifesciencestimes.com/2021/04/stonehill-strengthens-pace-platform-with-key-appointments-to-meet-growing-demand-for-energy-efficient-buildings/ 2021-04-21T19:54:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Jared_Schloser_-_SVP_and_Head_of_Stonehill_PACE.jpg https://bostonlifesciencestimes.com/2021/04/a-5-acre-life-science-campus-near-watertown-square-to-break-ground-in-may/ 2021-04-22T16:05:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Davis-Watertown-Life-Sciences.jpg https://bostonlifesciencestimes.com/2021/04/jim-corrigan-named-chief-executive-officer-of-connectiverx/ 2021-04-22T18:17:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Screenshot_2021-04-22-About-us-%E2%80%94-ConnectiveRx.png https://bostonlifesciencestimes.com/2021/04/medchart-raises-17m-to-meet-demand-for-frictionless-digital-business-practices-across-north-america/ 2021-04-22T18:24:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/James-Bateman.jpg https://bostonlifesciencestimes.com/2021/04/latticework-capital-management-sells-american-veterinarian-group/ 2021-04-22T18:31:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Screenshot_2021-04-22-About-American-Veterinary-Group-Partner-of-Choice-for-Animal-Hospitals.png https://bostonlifesciencestimes.com/2021/04/edge-surgical-granted-u-s-patent-for-next-generation-awl-in-one-tap/ 2021-04-22T18:39:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Christopher-Wilson.jpg https://bostonlifesciencestimes.com/2021/04/sga-selected-for-proposed-seaport-lab-rd-building-with-nod-to-locations-marine-industry-roots/ 2021-04-23T17:09:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/SGA-24-Drydock-Rendering.jpg https://bostonlifesciencestimes.com/2021/04/bioutah-statement-on-house-democrat-leaders-drug-pricing-legislation/ 2021-04-23T19:38:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Kelvyn-Cullimore.jpg https://bostonlifesciencestimes.com/2021/04/airehealth-appoints-kien-nguyen-as-chief-executive-officer/ 2021-04-26T17:34:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Kien-Nguyen.jpg https://bostonlifesciencestimes.com/2021/04/vector-raises-12-5-million-in-series-a-funding-to-accelerate-the-adoption-of-digital-health-and-remote-care-in-cardiology/ 2021-04-26T17:41:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/vectorupdata-banner-300x157-1.jpg https://bostonlifesciencestimes.com/2021/04/catamaran-bio-announces-appointment-of-scott-holmes-as-chief-financial-officer/ 2021-04-26T17:45:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Scott-Holmes.jpg https://bostonlifesciencestimes.com/2021/04/leo-pharma-receives-positive-chmp-opinion-of-adtralza-for-the-treatment-of-moderate-to-severe-atopic-dermatitis/ 2021-04-26T17:51:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Jorg-Moller.jpg https://bostonlifesciencestimes.com/2021/04/james-r-tobin-former-ceo-of-boston-scientific-joins-xenter-inc/ 2021-04-27T18:33:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Jim-Tobin-1.jpg https://bostonlifesciencestimes.com/2021/04/fractyl-announces-fda-breakthrough-device-designation-for-revita-dmr-in-insulin-treated-type-2-diabetes/ 2021-04-27T18:40:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Harith-Rajagopalan-M.D.-Ph.D.jpg https://bostonlifesciencestimes.com/2021/04/canbridge-pharmaceuticals-announces-strategic-collaboration-with-logicbio-therapeutics/ 2021-04-27T18:48:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/James-Xue.jpg https://bostonlifesciencestimes.com/2021/04/mayor-de-blasio-joins-brooklyn-navy-yard-development-corporation-nanotronics-new-york-state-to-open-high-tech-manufacturing-center/ 2021-04-28T18:08:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Mayor-de-Blasio.png https://bostonlifesciencestimes.com/2021/04/jcri-abts-and-usmi-successfully-treat-cholangiocarcinoma/ 2021-04-28T18:12:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Jerome-Canady-MD-and-Chief-Science-Officer.jpg https://bostonlifesciencestimes.com/2021/04/elastrin-therapeutics-strengthens-its-leadership-team-by-appointing-pedro-m-quintana-diez-as-chief-medical-officer/ 2021-04-28T18:16:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Pedro-M.-Quintana-Diez.jpg https://bostonlifesciencestimes.com/2021/04/worldwide-clinical-trials-taps-steve-chriscoe-as-executive-director-oncology/ 2021-04-29T18:55:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Steve-Chriscoe.jpg https://bostonlifesciencestimes.com/2021/04/aerie-pharmaceuticals-completes-enrollment-of-its-phase-2b-clinical-trial-of-ophthalmic-solution-for-the-treatment-of-dry-eye-disease/ 2021-04-29T19:00:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Vicente-Anido-Jr.-Ph.D..jpg https://bostonlifesciencestimes.com/2021/04/immunomic-therapeutics-announces-license-agreement-for-cancer-immunotherapy/ 2021-04-29T20:32:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Dr.-William-Hearl.jpg https://bostonlifesciencestimes.com/2021/05/63-of-us-infectious-disease-physicians-surveyed-remain-confident-in-adenovirus-vector-vaccines/ 2021-05-03T18:49:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Daniel-S.-Fitzgerald.jpg https://bostonlifesciencestimes.com/2021/05/while-there-are-still-unknowns-monoclonal-antibodies-can-help-in-the-fight-against-covid-19/ 2021-05-03T19:01:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/fink.jpg https://bostonlifesciencestimes.com/2021/05/gyroscope-therapeutics-announces-launch-of-initial-public-offering/ 2021-05-03T19:05:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Gyroscope-Therapeutics.png https://bostonlifesciencestimes.com/2021/05/valgenesis-inc-secures-24-million-investment-from-morgan-stanley-expansion-capital/ 2021-05-04T17:23:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Dr.-Siva.png https://bostonlifesciencestimes.com/2021/05/neuroelectrics-raises-17-5m-to-advance-clinical-trials-for-the-treatment-of-epilepsy-and-major-depressive-disorder/ 2021-05-04T17:25:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Giulio-Ruffini.jpg https://bostonlifesciencestimes.com/2021/05/harvard-university-licenses-its-nasal-swab-collection-technology/ 2021-05-04T17:31:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/RichardNovakPHD-291x300-1.png https://bostonlifesciencestimes.com/2021/05/908-devices-and-bio-techne-announce-joint-collaboration/ 2021-05-04T17:41:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Screenshot_2021-05-04-About-Us-908-Devices.png https://bostonlifesciencestimes.com/2021/05/nanostrings-digital-spatial-profiling-platform-used-to-create-foundational-dataset-revealing-insights-into-covid-19/ 2021-05-04T17:52:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/NanoString-Technologies.jpg https://bostonlifesciencestimes.com/2021/05/azitra-appoints-francisco-salva-as-chief-executive-officer/ 2021-05-04T18:09:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Francisco-Salva.jpg https://bostonlifesciencestimes.com/2021/05/affinia-therapeutics-closes110millionseries-b-financing/ 2021-05-04T20:25:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/affinia.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Rick-Modi.jpg https://bostonlifesciencestimes.com/2021/05/nanthealth-launches-eviti-connect-for-autoimmune-diseases/ 2021-05-05T18:29:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/NantHealth.png https://bostonlifesciencestimes.com/2021/05/cognito-therapeutics-appoints-jonathan-lieber-as-chief-financial-officer/ 2021-05-05T18:33:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Cognito-Therapeutics.png https://bostonlifesciencestimes.com/2021/05/esker-therapeutics-launches-to-transform-the-treatment-of-autoimmune-diseases/ 2021-05-05T18:42:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/June-Lee-MD.jpg https://bostonlifesciencestimes.com/2021/05/verge-genomics-names-robert-scannevin-ph-d-chief-scientific-officer/ 2021-05-05T18:45:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Robert-Scannevin-Ph.D..jpg https://bostonlifesciencestimes.com/2021/05/eikon-therapeutics-closes-148-million-series-a-financing-to-develop-high-throughput-super-resolution-microscopy-for-drug-discovery/ 2021-05-05T18:55:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Screenshot_2021-05-05-Eikon.png https://bostonlifesciencestimes.com/2021/05/confluent-medical-announces-strategic-investment-in-the-electrospinning-company/ 2021-05-05T18:58:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Confluent-Medical.jpg https://bostonlifesciencestimes.com/2021/05/venture-capitalist-darshana-zaveri-to-speak-at-life-sciences-and-medical-devices-summit-on-june-9/ 2021-05-06T00:01:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Darshana-Zaveri-Large.png https://bostonlifesciencestimes.com/2021/05/maxwell-biosciences-hires-john-lord-ph-d-as-vice-president/ 2021-05-06T14:32:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/John-Lord-Ph.D..jpg https://bostonlifesciencestimes.com/2021/05/jasper-therapeutics-and-amplitude-healthcare-acquisition-corporation-announce-merger/ 2021-05-06T14:34:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Bill-Lis.jpg https://bostonlifesciencestimes.com/2021/05/generational-equity-advises-design-space-inpharmatics-in-its-sale-to-productlife-group/ 2021-05-06T14:40:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Generational-Equity.jpg https://bostonlifesciencestimes.com/2021/05/aptorum-group-enters-into-an-agreement-with-exeltis-to-develop-aptorums-novel-preclinical-candidate/ 2021-05-06T14:45:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Dr.-Clark-Cheng.jpg https://bostonlifesciencestimes.com/2021/05/florence-announces-80-million-series-c-led-by-scaleup-investor-insight-partners/ 2021-05-06T14:49:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Screenshot_2021-05-06-Team.png https://bostonlifesciencestimes.com/2021/05/pfizer-and-biontech-to-provide-covid-19-vaccine-doses-for-olympic-athletes-at-the-2020-tokyo-games/ 2021-05-06T14:53:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Vaccine-COVID-NZ.jpg https://bostonlifesciencestimes.com/2021/05/doctor-on-demand-named-best-overall-digital-health-company-in-2021/ 2021-05-06T14:59:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Doc-on-demand.jpg https://bostonlifesciencestimes.com/2021/05/gilgamesh-pharmaceuticals-closes-on-27-million-series-a-round/ 2021-05-06T15:25:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/GilgameshlogowhiteBGlarge.jpg https://bostonlifesciencestimes.com/2021/05/twistle-appoints-matt-revis-as-president/ 2021-05-06T15:30:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Matt-Revis.jpg https://bostonlifesciencestimes.com/2021/05/eag-expands-medical-device-testing-services-with-new-laboratory/ 2021-05-07T17:30:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/EAG-Laboratories.jpg https://bostonlifesciencestimes.com/2021/05/908-devices-increases-focus-on-biotherapeutics-with-expansion-of-scientific-advisory-board/ 2021-05-07T17:34:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Screenshot_2021-05-07-About-Us-908-Devices.png https://bostonlifesciencestimes.com/2021/05/science-37-to-become-publicly-listed-via-merger-with-lifesci-acquisition-ii-corp/ 2021-05-07T17:37:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/David-Coman.jpg https://bostonlifesciencestimes.com/2021/05/pfizer-and-biontech-initiate-rolling-submission-of-biologics-license-application-for-u-s-fda-approval-of-their-covid-19-vaccine/ 2021-05-07T17:39:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Pfizer.jpg https://bostonlifesciencestimes.com/2021/05/white-oak-healthcare-finance-closes-25-million-financing-for-aspen-skilled-healthcare/ 2021-05-10T18:05:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Screenshot_2021-05-10-https-whiteoaksf-com.png https://bostonlifesciencestimes.com/2021/05/fore-biotherapeutics-opens-u-s-headquarters-in-philadelphias-biotech-hub/ 2021-05-10T18:10:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Usama-Malik.png https://bostonlifesciencestimes.com/2021/05/fsd-pharma-announces-investigational-new-animal-drug-filing-with-the-fda-to-treat-dogs-with-enteropathy/ 2021-05-10T18:19:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/FSD-Pharma.jpg https://bostonlifesciencestimes.com/2021/05/edge-surgical-receives-ce-mark-certification-for-edg-ortho-65mm-electronic-depth-gauge/ 2021-05-10T18:22:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/EDGe-Surgical.jpg https://bostonlifesciencestimes.com/2021/05/open-orphan-plc-announces-3m-covid-19-challenge-virus-manufacturing-contract/ 2021-05-10T18:26:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Screenshot_2021-05-10-Leadership-Team.png https://bostonlifesciencestimes.com/2021/05/attralus-therapeutics-appoints-mark-timney-as-ceo-and-expands-leadership-team-with-new-executives/ 2021-05-10T18:30:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Mark-Timney.png https://bostonlifesciencestimes.com/2021/05/crescendo-biologics-appoints-dr-michael-booth-as-chief-financial-officer/ 2021-05-10T18:34:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Dr-Michael-Booth.jpg https://bostonlifesciencestimes.com/2021/05/amazentis-pioneers-first-sports-nutrition-program-with-mitopure/ 2021-05-11T17:21:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Joel-Embiid.jpg https://bostonlifesciencestimes.com/2021/05/servicenow-enhances-vaccine-administration-management-unveils-new-product/ 2021-05-11T17:25:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/ServiceNow.jpg https://bostonlifesciencestimes.com/2021/05/iqhq-demonstrates-its-commitment-to-sustainable-development-with-strategic-hire/ 2021-05-11T17:30:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Jenny-Whitson.jpg https://bostonlifesciencestimes.com/2021/05/908-devices-launches-new-aerosol-module-for-handheld-mx908/ 2021-05-11T17:33:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Screenshot_2021-05-11-About-Us-908-Devices.png https://bostonlifesciencestimes.com/2021/05/alvotech-seeks-to-end-abbvies-wrongful-monopoly-on-humira-and-bring-affordable-arthritis-treatment-to-u-s/ 2021-05-11T17:39:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Screenshot_2021-05-11-Meet-the-Chairman.png https://bostonlifesciencestimes.com/2021/05/autobahn-therapeutics-acquires-clinical-stage-faah-inhibitor-from-astellas/ 2021-05-11T17:44:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Kevin-Finney.jpg https://bostonlifesciencestimes.com/2021/05/oxford-finance-provides-125-million-credit-facility-to-kala-pharmaceuticals/ 2021-05-12T15:55:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/Screenshot_2021-04-20-Meet-the-Team-Oxford-Finance.png https://bostonlifesciencestimes.com/2021/05/tellus-therapeutics-secures-seed-financing-to-develop-the-first-treatment-for-newborns-with-white-matter-brain-injury/ 2021-05-12T15:59:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Chris-Garabedian.jpg https://bostonlifesciencestimes.com/2021/05/shifa-launches-with-seed-financing-to-address-cardiovascular-disease-by-developing-orally-bioavailable-drugs-for-the-treatment-of-dyslipidemia/ 2021-05-12T16:02:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Shifa-Biomedical-Corporation.jpg https://bostonlifesciencestimes.com/2021/05/juno-diagnostics-announces-closing-of-25-million-series-a-financing-led-by-perceptive-xontogeny-venture-fund/ 2021-05-12T16:08:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Screenshot_2021-05-12-About-us.png https://bostonlifesciencestimes.com/2021/05/labcorp-and-the-u-s-department-of-health-and-human-services-join-forces-to-raise-awareness-of-covid-19-treatments/ 2021-05-12T17:17:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Screenshot_2021-05-12-Executive-Team-Labcorp.png https://bostonlifesciencestimes.com/2021/05/50-million-follow-on-equity-investment-from-sixth-street-growth-caps-135-million/ 2021-05-12T17:22:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/James-F.-Chen.png https://bostonlifesciencestimes.com/2021/05/nuclera-acquires-e-ink-digital-microfluidics-unit/ 2021-05-12T17:24:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Nuclera.jpg https://bostonlifesciencestimes.com/2021/05/flare-therapeutics-launches-with-82-million-series-a-financing/ 2021-05-13T17:52:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Flare-Therapeutics.jpg https://bostonlifesciencestimes.com/2021/05/ilc-therapeutics-announces-board-changes-and-funding-round-to-accelerate-covid-19-drug/ 2021-05-13T17:57:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/ILC-Therapeutics.png https://bostonlifesciencestimes.com/2021/05/clarify-health-launches-real-world-evidence-on-health-disparities/ 2021-05-13T18:03:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Jean-Drouin.jpg https://bostonlifesciencestimes.com/2021/05/lunaphore-announces-appointment-of-matthias-weber-former-president-of-leica-biosystems-to-board-of-directors/ 2021-05-13T18:09:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Matthias-Weber.jpg https://bostonlifesciencestimes.com/2021/05/fsd-pharma-announces-filing-of-criminal-complaint-against-former-chief-financial-officer/ 2021-05-13T18:15:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/FSD-Pharma2.jpg https://bostonlifesciencestimes.com/2021/05/the-rare-disease-company-coalition-launches-to-share-the-unique-challenges-and-promise-of-rare-disease-therapy-development/ 2021-05-13T18:20:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Rare-Disease-Company-Coalition.jpg https://bostonlifesciencestimes.com/2021/05/intrance-medical-systems-establishes-u-s-operations-and-names-patrick-shea-chief-executive-officer/ 2021-05-13T18:33:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Patrick-Shea.jpg https://bostonlifesciencestimes.com/2021/05/lennham-pharmaceuticals-announces-issuance-of-u-s-patent-covering-deuterated-psilocybin-products/ 2021-05-14T18:32:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Lennham-Pharmaceuticals.jpg https://bostonlifesciencestimes.com/2021/05/kelso-combines-with-existing-investments-in-c-l-smith-and-inmark/ 2021-05-14T18:36:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Screenshot_2021-05-14-Team-Kelso.png https://bostonlifesciencestimes.com/2021/05/india-globalization-capital-igc-completes-cohort-1-of-its-phase-1-thc-based-clinical-trial-on-alzheimers-patients/ 2021-05-14T18:39:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/India-Globalization-Capital-Inc..png https://bostonlifesciencestimes.com/2021/05/nationwide-survey-by-averitas-reveals-painful-realities-of-living-with-diabetic-nerve-pain/ 2021-05-14T18:42:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Dr.-Rodica-Pop-Busui.jpg https://bostonlifesciencestimes.com/2021/05/aceto-expands-life-science-manufacturing-with-acquisition-of-finar-limited/ 2021-05-17T14:55:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Screenshot_2021-05-17-Aceto-Leadership-Team.png https://bostonlifesciencestimes.com/2021/05/propanc-biopharma-publishes-key-data-in-peer-reviewed-journal-confirming-anti-tumor-potential-of-proenzymes/ 2021-05-17T15:01:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Main-anti-tumor-effects-of-Proenzymes.jpg https://bostonlifesciencestimes.com/2021/05/deerfield-management-and-baylor-college-of-medicine-announce-blue-square-discoveries-to-advance-novel-therapeutic-treatments/ 2021-05-17T15:04:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Screenshot_2021-05-17-Deerfield.png https://bostonlifesciencestimes.com/2021/05/akroswiss-takes-a-step-forward-in-the-interest-of-patients-closing-a-multi-million-chf-seed-series-funding-round/ 2021-05-17T15:10:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Akroswiss.jpg https://bostonlifesciencestimes.com/2021/05/humanigen-and-chime-biologics-enter-into-manufacturing-agreement-for-covid-19-therapeutic-candidate-lenzilumab/ 2021-05-17T15:20:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Screenshot_2021-05-17-Humanigen-Inc-.png https://bostonlifesciencestimes.com/2021/05/aavantibio-rounds-out-leadership-team-with-appointment-of-jessie-hanrahan-ph-d-as-chief-regulatory-officer/ 2021-05-17T15:24:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/AavantiBio.jpg https://bostonlifesciencestimes.com/2021/05/people-using-voice-technology-for-medication-info-still-get-the-most-accurate-results-from-google-assistant/ 2021-05-19T18:47:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/Klick-Health.jpg https://bostonlifesciencestimes.com/2021/05/waters-corporation-celebrates-the-life-and-legacy-of-its-founder-jim-waters/ 2021-05-19T18:50:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Jim-Waters.jpg https://bostonlifesciencestimes.com/2021/05/new-england-cancer-specialists-adopt-deep-lens-clinical-trial-matching-solution-viper-to-expand-clinical-trial-offering/ 2021-05-19T18:52:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Christian-Thomas-M.D..jpg https://bostonlifesciencestimes.com/2021/05/harris-williams-advises-transaction-data-systems-on-its-sale-to-blackrock-long-term-private-capital/ 2021-05-19T18:56:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Screenshot_2021-05-19-Leadership-Transaction-Data-Systems.png https://bostonlifesciencestimes.com/2021/05/veteran-technology-executive-joins-synthace-to-accelerate-its-mission-to-revolutionize-the-life-science-research-market/ 2021-05-19T19:00:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Synthace-Ltd.png https://bostonlifesciencestimes.com/2021/05/worldwide-clinical-trials-announces-strategic-leadership-promotions/ 2021-05-19T19:02:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Dave-Bowser.jpg https://bostonlifesciencestimes.com/2021/05/white-oak-healthcare-mob-reit-has-acquired-class-a-medical-office-building-in-atlanta-metropolitan-area/ 2021-05-20T17:38:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/David-Lynn.jpg https://bostonlifesciencestimes.com/2021/05/argenta-enters-30-million-product-financing-agreement-with-novaquest-to-accelerate-new-veterinary-product-development/ 2021-05-20T17:41:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/novaQuest.jpg https://bostonlifesciencestimes.com/2021/05/biomax-informatics-universities-use-neuroxm-to-study-the-connectome-in-drug-resistant-epilepsy/ 2021-05-20T17:43:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Dr.-Marcus-Kaiser.jpg https://bostonlifesciencestimes.com/2021/05/numab-therapeutics-completes-oversubscribed-chf-100-million-series-c-financing/ 2021-05-20T17:47:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/David-Urech.jpg https://bostonlifesciencestimes.com/2021/05/rukers-molecular-phenomics-research-tools-enable-new-insights-into-long-covid-and-post-acute-metabolic-abnormalities/ 2021-05-20T17:52:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/ANPC-impact-II-QTOF-MS-Lab.jpg https://bostonlifesciencestimes.com/2021/05/pfizer-and-biontech-to-supply-the-european-union-with-up-to-1-8-billion-additional-doses-of-comirnaty/ 2021-05-20T17:54:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Pfizer-Inc.jpg https://bostonlifesciencestimes.com/2021/05/sensyne-health-signs-first-us-strategic-research-agreement-with-st-lukes-university-health-network/ 2021-05-21T16:43:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Sensyne-Health.png https://bostonlifesciencestimes.com/2021/05/giiant-pharma-inc-announced-the-closing-of-us11m-in-seed-financing-to-develop-its-precision-delivery-technology-platform-in-gastroenterology/ 2021-05-21T16:46:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Maxime-Ranger.jpg https://bostonlifesciencestimes.com/2021/05/beigene-announces-positive-topline-results-from-phase-3-trial-of-tislelizumab-in-combination-with-chemotherapy/ 2021-05-21T16:50:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Yong-Ben-Ben-M.D..png https://bostonlifesciencestimes.com/2021/05/more-than-a-third-of-surveyed-ibs-c-patients-reported-that-their-symptoms-worsened-during-covid-19/ 2021-05-24T15:26:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Screenshot_2021-05-24-Brian-E-Lacy-M-D-Ph-D-.png https://bostonlifesciencestimes.com/2021/05/eurofins-empowerdx-at-home-covid-19-testing-kit-receives-eua-for-children-three-years-and-older/ 2021-05-24T15:37:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Eurofins.png https://bostonlifesciencestimes.com/2021/05/climate-vault-launches-with-new-solution-for-carbon-reductions/ 2021-05-24T15:42:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Screenshot_2021-05-24-Don-Wilson.png https://bostonlifesciencestimes.com/2021/05/ppd-opens-multipurpose-clinical-research-laboratory-in-suzhou-china/ 2021-05-24T15:44:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Christopher-Fikry-M.D..png https://bostonlifesciencestimes.com/2021/05/moderna-and-south-korea-explore-collaboration-on-mrna-vaccines/ 2021-05-24T15:48:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Moderna-Inc.jpg https://bostonlifesciencestimes.com/2021/05/noveome-biotherapeutics-inc-announces-christopher-j-p-velis-as-chief-executive-officer/ 2021-05-24T15:50:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Christopher-J.-P.-Velis.jpg https://bostonlifesciencestimes.com/2021/05/libtayo-receives-positive-chmp-opinion-for-the-treatment-in-europe-of-two-advanced-cancers/ 2021-05-24T17:35:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Libtayo.png https://bostonlifesciencestimes.com/2021/05/biogen-and-ginkgo-bioworks-announce-collaboration-develop-novel-gene-therapy-manufacturing-platform/ 2021-05-24T18:33:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Alphonse-Galdes.jpg https://bostonlifesciencestimes.com/2021/05/pfizer-initiates-study-exploring-coadministration-of-its-20-valent-pneumococcal-conjugate-vaccine-candidate-along-with-a-third-dose-of-the-pfizer-biontech-covid-19-vaccine-in-older-adults/ 2021-05-25T16:22:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Covid-pfizer.jpg https://bostonlifesciencestimes.com/2021/05/geneoscopy-announces-publication-of-peer-reviewed-article-highlighting-effective-noninvasive-screening-test-for-colorectal-cancer-prevention/ 2021-05-25T17:13:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Dr.-Erica-Barnell.jpg https://bostonlifesciencestimes.com/2021/05/cushman-wakefield-advises-magdalen-college-oxford-on-search-for-strategic-partner-for-the-oxford-science-park/ 2021-05-25T17:16:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Rory-Maw-Bursar-at-Magdalen-College-Oxford.jpg https://bostonlifesciencestimes.com/2021/05/battelle-and-catahoula-resources-forge-partnership-to-accelerate-carbon-capture-utilization-and-storage/ 2021-05-25T17:21:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Catahoula-Resources.png https://bostonlifesciencestimes.com/2021/05/john-cullivan-joins-pci-pharma-services-as-chief-corporate-development-officer/ 2021-05-25T17:23:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/John-Cullivan.jpg https://bostonlifesciencestimes.com/2021/05/waters-introduces-the-sars-cov-2-lc-ms-kit-ruo-to-advance-clinical-research-of-infectious-diseases/ 2021-05-25T17:30:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Waters-SARS-CoV-2-LC-MS-Kit.jpg https://bostonlifesciencestimes.com/2021/05/foldax-announces-successful-first-human-use-of-tria-biopolymer-mitral-heart-valve/ 2021-05-25T17:36:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/David-Heimansohn-MD.jpg https://bostonlifesciencestimes.com/2021/05/the-bristol-myers-squibb-foundation-announces-first-global-cancer-disparities-grants-in-brazil/ 2021-05-26T17:15:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/john-damonti2.jpg https://bostonlifesciencestimes.com/2021/05/social-health-research-center-and-quest-diagnostics-team-up-to-address-childhood-hunger-and-obesity-exacerbated-by-covid-19/ 2021-05-26T17:32:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Screenshot_2021-05-26-Social-Health-Research-Center-About.png https://bostonlifesciencestimes.com/2021/05/ocular-therapeutix-to-participate-at-three-upcoming-investor-conferences/ 2021-05-26T17:46:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Ocular-Therapeutix.png https://bostonlifesciencestimes.com/2021/05/torus-biosystems-announces-25-million-series-a-financing-to-advance-infectious-disease-diagnostics-across-healthcare-settings/ 2021-05-26T17:49:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Shawn-Marcell.jpg https://bostonlifesciencestimes.com/2021/05/tranquis-therapeutics-strengthens-leadership-team-with-appointments-of-frederic-godderis-as-chief-operating-officer-and-jonas-hannestad-as-chief-medical-officer/ 2021-05-26T17:52:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Frederic-Godderis.png https://bostonlifesciencestimes.com/2021/05/smart-eye-acquires-affectiva-to-solidify-stronghold-on-interior-sensing-market/ 2021-05-27T16:16:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/smart-eye.jpg https://bostonlifesciencestimes.com/2021/05/welsh-lighthouse-laboratory-extends-contract-with-perkinelmer-for-its-covid-19-solutions/ 2021-05-27T16:24:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/1200px-PerkinElmer_logo.svg_.png https://bostonlifesciencestimes.com/2021/05/precision-biosciences-appoints-alex-kelly-as-chief-financial-officer/ 2021-05-27T16:49:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Alex-Kelly.jpg https://bostonlifesciencestimes.com/2021/05/talkdesk-integrates-with-epic-joins-epic-app-orchard-marketplace/ 2021-05-27T16:55:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Jeff-Sturman.jpg https://bostonlifesciencestimes.com/2021/05/vetster-raises-12-25m-cad-to-revolutionize-global-pet-care-industry/ 2021-05-27T17:00:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Vetster.jpg https://bostonlifesciencestimes.com/2021/05/transgene-and-bioinvent-receive-ind-approval-from-the-u-s-fda-for-bt-001-a-novel-oncolytic-virus-for-the-treatment-of-solid-tumors/ 2021-05-27T17:07:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Hedi-Ben-Brahim.jpg https://bostonlifesciencestimes.com/2021/05/cubio-innovation-center-and-creagen-enter-into-partnership-agreement/ 2021-05-28T17:37:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Raj-Rajur.jpg https://bostonlifesciencestimes.com/2021/05/accelerator-life-science-partners-portfolio-company-lodo-therapeutics-acquired-by-zymergen-inc/ 2021-05-28T17:46:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Accelerator-Life-Science-Partners.jpg https://bostonlifesciencestimes.com/2021/06/solesis-completes-investment-from-altaris-capital-partners/ 2021-06-01T18:54:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Solesis.jpg https://bostonlifesciencestimes.com/2021/06/selexis-appoints-roland-hoffmann-hecht-phd-as-chief-business-officer/ 2021-06-01T18:56:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Roland-Hoffmann-Hecht.jpg https://bostonlifesciencestimes.com/2021/06/agilent-presents-thought-leader-award-to-professor-chris-elliott/ 2021-06-01T18:58:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Chris-Elliott.jpg https://bostonlifesciencestimes.com/2021/06/ambys-medicines-appoints-ronald-park-m-d-chief-executive-officer/ 2021-06-01T19:03:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Screenshot_2021-06-01-About-Us-%E2%80%A2-Ambys-Medicines1.png https://bostonlifesciencestimes.com/2021/06/bruker-launches-timstof-truescp-for-unbiased-single-cell-4d-proteomics-and-next-gen-timstof-pro-2-with-unprecedented-proteomic-depth/ 2021-06-01T19:08:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Bruker.jpg https://bostonlifesciencestimes.com/2021/06/cushmans-east-region-life-sciences-lead-dan-hackett-to-speak-at-life-sciences-summit-on-june-9/ 2021-06-02T18:05:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Dan-Hackett.jpg https://bostonlifesciencestimes.com/2021/06/sgas-science-technology-director-matthew-fickett-to-speak-at-life-sciences-facilities-summit/ 2021-06-02T18:09:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Matthew-Fickett.jpg https://bostonlifesciencestimes.com/2021/06/inspira-health-appoints-warren-e-moore-fache-as-the-new-executive-vice-president-chief-operating-officer/ 2021-06-02T18:30:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Warren-E.-Moore.jpg https://bostonlifesciencestimes.com/2021/06/oxford-finance-provides-24-million-credit-facility-to-lantern-group/ 2021-06-02T18:43:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Jean-Makesh-scaled.jpg https://bostonlifesciencestimes.com/2021/06/nayya-raises-37-million-in-series-b-growth-capital-co-led-by-svb-capital-and-iconiq-growth/ 2021-06-02T18:50:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/nayya.jpg https://bostonlifesciencestimes.com/2021/06/cytovale-begins-enrollment-in-fda-510k-clinical-validation-study-of-intellisep-rapid-sepsis-test/ 2021-06-02T18:57:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Daniel-Henning-MD-MPH.jpg https://bostonlifesciencestimes.com/2021/06/harvard-licenses-technology-to-obatala-sciences-to-advance-discovery-in-obesity-diabetes-and-cancer/ 2021-06-02T19:06:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Obatala-Science.png https://bostonlifesciencestimes.com/2021/06/blackstone-has-acquired-desotec/ 2021-06-03T18:25:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Blackstone.jpg https://bostonlifesciencestimes.com/2021/06/bayer-acquires-noria-and-psma-therapeutics-to-expand-pipeline-in-prostate-cancer/ 2021-06-03T18:28:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Bayer.jpg https://bostonlifesciencestimes.com/2021/06/venbio-raises-550-million-venture-capital-fund-focused-on-life-sciences/ 2021-06-03T18:31:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Screenshot_2021-06-03-venBio.png https://bostonlifesciencestimes.com/2021/06/janux-therapeutics-appoints-dr-wayne-godfrey-as-chief-medical-officer/ 2021-06-03T18:38:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Janux-Therapeutics.jpg https://bostonlifesciencestimes.com/2021/06/kites-tecartus-demonstrates-high-response-rate-in-adults-with-relapsed-or-refractory-b-cell-acute-lymphoblastic-leukemia/ 2021-06-04T20:39:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Frank-Neumann-MD-PhD.jpg https://bostonlifesciencestimes.com/2021/06/cell-free-dna-guided-targeted-therapy-leads-to-better-survival-in-advanced-non-small-cell-lung-cancer/ 2021-06-04T20:41:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Agilent-Technologies-Inc.jpg https://bostonlifesciencestimes.com/2021/06/boston-properties-builds-on-its-growing-life-sciences-portfolio-acquires-lab-properties-in-waltham-massachusetts/ 2021-06-04T20:44:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Bryan-Koop.jpg https://bostonlifesciencestimes.com/2021/06/entegris-expands-life-sciences-production-capacity-and-capabilities/ 2021-06-07T18:56:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Entegris.jpg https://bostonlifesciencestimes.com/2021/06/lennham-pharmaceuticals-announces-topline-results-from-pharmacokinetic-study-of-d9-caffeine-versus-caffeine/ 2021-06-07T19:01:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Lennham-Pharmaceuticals.jpg https://bostonlifesciencestimes.com/2021/06/biomedical-informatics-leader-erich-huang-joins-onduo-as-chief-science-and-innovation-officer/ 2021-06-07T19:04:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Erich-Huang.jpg https://bostonlifesciencestimes.com/2021/06/waters-sets-new-standard-in-high-resolution-mass-spectrometry-with-select-series-multi-reflecting-time-of-flight-platform/ 2021-06-08T19:52:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/The-Waters-SELECT-SERIES-MRT.jpg https://bostonlifesciencestimes.com/2021/06/medtech-accelerator-sofinnova-md-start-iii-launches-a-call-for-early-stage-medical-device-projects/ 2021-06-08T19:59:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Screenshot_2021-06-08-Anne-Osdoit-Sofinnova-Partners.png https://bostonlifesciencestimes.com/2021/06/harrison-street-announces-1-6-billion-in-transformational-medical-office-and-senior-housing-transactions/ 2021-06-08T20:02:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Harrison-Street.png https://bostonlifesciencestimes.com/2021/06/biotech-and-pharma-labs-performing-endpoint-pcr-can-reduce-amplification-time-to-15-minutes/ 2021-06-08T20:06:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Promega-GoTaq%C2%AE.jpg https://bostonlifesciencestimes.com/2021/06/gmh-communities-capitalizes-on-growing-life-sciences-sector-with-new-innovative-living-vertical-announces-first-projects/ 2021-06-09T19:22:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/GMH.jpg https://bostonlifesciencestimes.com/2021/06/datavant-and-ciox-health-announce-merger-creating-the-largest-neutral-and-secure-health-data-ecosystem/ 2021-06-09T19:25:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Datavant.jpg https://bostonlifesciencestimes.com/2021/06/sars-cov-2-antibody-test-developed-by-promega-receives-ce-mark/ 2021-06-09T19:27:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Promega.jpg https://bostonlifesciencestimes.com/2021/06/kojin-therapeutics-launches-with-60-million-series-a-to-develop-new-category-of-drugs-based-on-cell-state-biology/ 2021-06-09T19:30:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Kojin-Therapeutics.jpg https://bostonlifesciencestimes.com/2021/06/anji-pharma-launches-phase-3-trial-for-anj900-to-treat-type-2-diabetes-patients-with-kidney-disease/ 2021-06-10T19:20:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Anji-Pharma.jpg https://bostonlifesciencestimes.com/2021/06/icosavax-appoints-thomas-j-russo-chief-financial-officer/ 2021-06-10T19:22:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Thomas-J.-Russo.jpg https://bostonlifesciencestimes.com/2021/06/owl-peak-labs-closes-seed-round/ 2021-06-10T19:26:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Tim-Harvey.jpg https://bostonlifesciencestimes.com/2021/06/elevatebio-announces-margo-roberts-ph-d-joins-as-scientific-advisor-for-companys-immunotherapy-platform-expansion/ 2021-06-10T19:29:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Margo-Roberts-Ph.D..jpg https://bostonlifesciencestimes.com/2021/06/story3-capital-partners-completes-structured-growth-equity-investment-in-renew-anchored-dentures/ 2021-06-11T17:45:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/STORY3-Capital-Partners.png https://bostonlifesciencestimes.com/2021/06/u-s-food-and-drug-administration-approves-new-formulation-of-epclusa-expanding-pediatric-indication-to-treat-children-ages-3-and-older-with-chronic-hepatitis-c/ 2021-06-11T17:49:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Epclusa.jpg https://bostonlifesciencestimes.com/2021/06/beigene-presents-long-term-efficacy-and-safety-results-from-three-pivotal-trials-of-brukinsa/ 2021-06-11T17:53:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/BRUKINSA.png https://bostonlifesciencestimes.com/2021/06/accenture-receives-three-partner-of-the-year-awards-from-adobe/ 2021-06-14T17:52:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Accenture.jpg https://bostonlifesciencestimes.com/2021/06/agilent-presents-thought-leader-award-to-dr-stephane-bayen/ 2021-06-14T17:55:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Dr.-Stephane-Bayen.jpg https://bostonlifesciencestimes.com/2021/06/aurinia-announces-addition-of-dr-brinda-balakrishnan-to-the-board-of-directors/ 2021-06-14T17:59:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Dr.-Brinda-Balakrishnan.jpg https://bostonlifesciencestimes.com/2021/06/higher-education-technology-company-ellucian-to-be-acquired-by-blackstone-and-vista-equity-partners/ 2021-06-14T18:01:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Eli-Nagler.jpg https://bostonlifesciencestimes.com/2021/06/waters-arc-premier-system-delivers-increased-precision-and-certainty-in-chromatographic-results/ 2021-06-15T18:51:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/The-Waters-Arc-Premier-System.jpg https://bostonlifesciencestimes.com/2021/06/arnaud-lacoste-is-named-chief-scientific-officer-of-aurion-biotech/ 2021-06-15T18:54:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Arnaud-Lacoste.jpg https://bostonlifesciencestimes.com/2021/06/vectory-raises-e31-million-in-seed-financing-to-develop-next-generation-gene-therapies-aimed-at-muscular-and-cns-disorders/ 2021-06-15T18:57:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/VectorY-Therapeutics.jpg https://bostonlifesciencestimes.com/2021/06/alentis-therapeutics-raises-usd-67-million-in-series-b-financing/ 2021-06-15T19:01:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Alentis-Therapeutics.jpg https://bostonlifesciencestimes.com/2021/06/biolog-id-partners-with-airmed-to-help-enhance-visibility-availability-and-traceability-of-life-saving-blood-components/ 2021-06-16T17:01:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Biolog-id.png https://bostonlifesciencestimes.com/2021/06/veranex-announces-investment-from-summit-partners-to-form-medtech-services-company/ 2021-06-16T17:03:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/David-W.-Dockhorn-M.S.-Ph.D..jpg https://bostonlifesciencestimes.com/2021/06/amalgam-rx-receives-ce-mark-for-basal-insulin-titration/ 2021-06-16T17:05:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Amalgam-Rx.jpg https://bostonlifesciencestimes.com/2021/06/ksana-health-secures-2m-seed-round-to-launch-advanced-mental-health-monitoring-platform/ 2021-06-16T17:11:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Screenshot-2021-06-16-at-13-11-17-Ksana-Health.png https://bostonlifesciencestimes.com/2021/06/lunaphore-appoints-dr-carlo-bifulco-to-scientific-advisory-board/ 2021-06-17T17:20:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Dr.-Carlo-Bifulco.jpg https://bostonlifesciencestimes.com/2021/06/sema4-appoints-andrew-kasarskis-health-data-expert-and-precision-medicine-scientist-as-chief-data-officer/ 2021-06-17T17:22:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Andrew-Kasarskis.jpg https://bostonlifesciencestimes.com/2021/06/kite-and-shoreline-biosciences-enter-into-strategic-partnership-to-develop-novel-allogeneic-cell-therapies/ 2021-06-17T17:24:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Kite-a-Gilead-Company.jpg https://bostonlifesciencestimes.com/2021/06/outcome-capital-announces-veranex-has-acquired-boston-healthcare-associates/ 2021-06-17T17:25:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Joseph-Ferrara.jpg https://bostonlifesciencestimes.com/2021/06/moderna-reaffirms-commitment-to-job-creation-in-massachusetts/ 2021-06-18T16:45:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Stephane-Bancel-Chief-Executive-Officer-of-Moderna.jpg https://bostonlifesciencestimes.com/2021/06/hydrosat-raises-5m-to-take-on-climate-change-from-space/ 2021-06-18T16:46:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Thermal-Infrared-Image.jpg https://bostonlifesciencestimes.com/2021/06/alzamend-neuro-announces-closing-of-initial-public-offering/ 2021-06-18T16:48:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Alzamend-Neuro.png https://bostonlifesciencestimes.com/2021/06/evaluate-group-limited-appoints-cem-baydar-as-chief-consulting-officer/ 2021-06-21T19:31:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Evaluate_Logo.jpg https://bostonlifesciencestimes.com/2021/06/harris-williams-advises-h-i-g-capital-on-its-acquisition-of-cora-physical-therapy/ 2021-06-21T19:35:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Screenshot-2021-06-21-at-15-34-50-Andy-Dixon.png https://bostonlifesciencestimes.com/2021/06/barnes-thornburg-expands-national-footprint-ip-and-life-sciences-teams-with-new-boston-office/ 2021-06-22T18:28:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Screenshot-2021-06-22-at-14-28-02-Barnes-Thornburg-Expands-National-Footprint-IP-and-Life-Sciences-Teams-With-New-Boston-O....png https://bostonlifesciencestimes.com/2021/06/optomec-announces-7-million-in-new-orders-from-repeat-customers/ 2021-06-22T18:30:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Optomec.jpg https://bostonlifesciencestimes.com/2021/06/infinity-biologix-announces-new-senior-team-members-including-robin-grimwood-as-ceo/ 2021-06-22T18:32:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Robin-Grimwood.jpg https://bostonlifesciencestimes.com/2021/06/perkinelmer-agrees-to-acquire-viral-vector-gene-delivery-leader-sirion-biotech/ 2021-06-22T18:35:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Dr.-Christian-Thirion.jpg https://bostonlifesciencestimes.com/2021/06/healthcare-triangle-unveils-dataez-platform-to-harness-big-data/ 2021-06-23T16:33:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Healthcare-Triangle.jpg https://bostonlifesciencestimes.com/2021/06/strand-therapeutics-raises-52m-in-oversubscribed-series-a-round/ 2021-06-23T16:53:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Strand-Therapeutics.jpg https://bostonlifesciencestimes.com/2021/06/glycomine-closes-68-million-series-b-to-advance-into-clinical-trials-a-novel-treatment-for-pmm2-cdg-a-rare-glycosylation-disease/ 2021-06-23T17:02:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Glycomine.jpg https://bostonlifesciencestimes.com/2021/06/quanta-raises-245-million-to-accelerate-commercialization-of-its-sc-portable-hemodialysis-system/ 2021-06-23T17:06:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Quanta.png https://bostonlifesciencestimes.com/2021/06/citiustech-acquires-sdlc-partners-extends-payer-market-leadership/ 2021-06-24T18:40:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/citiustech.jpg https://bostonlifesciencestimes.com/2021/06/treatment-with-hepcludex-bulevirtide-was-shown-to-achieve-significant-response-in-chronic-hepatitis-delta-virus-after-24-weeks/ 2021-06-24T18:47:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Gilead-Sciences.png https://bostonlifesciencestimes.com/2021/06/vida-ventures-closes-825-million-vida-iii-fund-to-advance-transformative-biomedical-innovations/ 2021-06-24T18:57:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Vida-Ventures-Leadership.jpg https://bostonlifesciencestimes.com/2021/06/transperfect-life-sciences-welcomes-industry-veteran-kaarin-gordon/ 2021-06-28T17:02:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Kaarin-Gordon.jpg https://bostonlifesciencestimes.com/2021/06/healthverity-raises-100m-to-scale-ipge-platform-market-leading-technology-and-real-world-data-infrastructure/ 2021-06-28T17:08:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Andrew-Kress.png https://bostonlifesciencestimes.com/2021/06/lengo-therapeutics-appoints-enoch-k-kariuki-as-chief-executive-officer/ 2021-06-28T17:12:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Screenshot-2021-06-28-at-13-12-03-Lengo-Therapeutics-Precision-Oncology-Therapeutics-by-Design.png https://bostonlifesciencestimes.com/2021/06/optomec-receives-new-patents-for-3d-micro-printing-with-aerosol-jet/ 2021-06-29T18:59:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Aerosol-Jet.jpg https://bostonlifesciencestimes.com/2021/06/hospital-iq-raises-25-million-to-meet-market-demand-for-its-software-which-optimizes-health-system-operations/ 2021-06-29T19:03:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Hospital-IQ.jpg https://bostonlifesciencestimes.com/2021/06/spotivity-closes-1m-seed-funding-round/ 2021-06-29T19:10:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Spotivity.jpg https://bostonlifesciencestimes.com/2021/06/kelso-combines-with-existing-investments-in-c-l-smith-inmark-and-silver-spur/ 2021-06-30T18:07:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Kelso_092316_Osborne_024_800x942.jpg https://bostonlifesciencestimes.com/2021/06/hyperfine-names-paykel-and-teisseyre-to-executive-leadership-positions/ 2021-06-30T18:21:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Neela-Paykel.jpg https://bostonlifesciencestimes.com/2021/06/amsa-and-sunovion-neuroscience-peer-teaching-program-reaches-more-than-400-students-over-three-years/ 2021-06-30T18:23:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/AMSA.jpg https://bostonlifesciencestimes.com/2021/07/osmind-closes-15-million-series-a-round-to-help-clinicians-and-researchers-bring-innovative-mental-health-treatments-to-more-patients/ 2021-07-01T18:38:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Lucia-Huang-CEO-and-co-founder-of-Osmind.jpeg https://bostonlifesciencestimes.com/2021/07/articulate-raises-1-5-billion-in-series-a-round-led-by-general-atlantic/ 2021-07-01T18:41:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Adam-Schwartz.jpg https://bostonlifesciencestimes.com/2021/07/philip-morris-international-announces-agreement-to-acquire-fertin-pharma/ 2021-07-01T18:48:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Screenshot-2021-07-01-at-14-46-47-Our-leadership-team-e1625165275837.png https://bostonlifesciencestimes.com/2021/07/boston-tops-the-nation-in-life-sciences-space-demand-capital-investment-and-new-construction-in-progress/ 2021-07-02T17:48:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Screenshot-2021-07-02-at-13-48-16-Boston-Tops-the-Nation-in-Life-Sciences-Space-Demand-Capital-Investment-and-New-Construc....png https://bostonlifesciencestimes.com/2021/07/sga-designs-four-story-life-science-addition-to-88-black-falcon/ 2021-07-02T17:50:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Screenshot-2021-07-02-at-13-49-47-SGA-Designs-Four-Story-Life-Science-Addition-to-88-Black-Falcon-Boston-Real-Estate-Times.png https://bostonlifesciencestimes.com/2021/07/designing-exceptional-life-sciences-facilities-for-innovation-and-growth/ 2021-07-02T17:52:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Screenshot-2021-07-02-at-13-51-27-Designing-Exceptional-Life-Sciences-Facilities-for-Innovation-and-Growth-Boston-Real-Es....png https://bostonlifesciencestimes.com/2021/07/dentons-partner-david-masson-departs-to-join-ecommerce-solution-scalefast-as-chief-legal-officer/ 2021-07-02T17:55:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/David-Masson.jpg https://bostonlifesciencestimes.com/2021/07/ge-healthcare-and-sophia-genetics-to-collaborate-to-match-treatments-to-multimodal-patient-data-and-cancer-type/ 2021-07-06T19:39:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/SOPHiA-GENETICS.jpg https://bostonlifesciencestimes.com/2021/07/worlds-first-magnetic-robotic-assisted-surgeries-performed-with-levita-magnetics-newest-platform/ 2021-07-06T19:41:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/The-Levita-Robotic-Platform.jpg https://bostonlifesciencestimes.com/2021/07/lpc-west-acquires-pasadena-office-campus-at-465-north-halstead-xencor-to-relocate-headquarters-to-the-property/ 2021-07-07T18:34:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/LPC-West.jpg https://bostonlifesciencestimes.com/2021/07/spotsee-hires-reuben-isbitsky-as-temperature-business-director/ 2021-07-07T18:36:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Reuben-Isbitsky.jpg https://bostonlifesciencestimes.com/2021/07/mymd-pharmaceuticals-announces-new-data-from-comparative-study-on-lead-compound-mymd-1/ 2021-07-07T18:39:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Chris-Chapman-M.D..jpg https://bostonlifesciencestimes.com/2021/07/hyperfine-inc-and-liminal-sciences-inc-to-be-listed-on-nasdaq/ 2021-07-08T18:18:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Hyperfine.jpg https://bostonlifesciencestimes.com/2021/07/veracyte-announces-key-appointments-to-executive-leadership-team-supporting-global-expansion/ 2021-07-08T18:54:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Rob-Brainin.jpg https://bostonlifesciencestimes.com/2021/07/gnubiotics-announces-self-affirmed-gras-designation-of-gnubiome-fi/ 2021-07-12T18:56:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Gnubiotics-Sciences.jpg https://bostonlifesciencestimes.com/2021/07/circle-pharma-appoints-evelyn-wang-phd-as-its-vice-president-translational-medicine/ 2021-07-12T19:01:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Circle-Pharma.png https://bostonlifesciencestimes.com/2021/07/prime-medicine-launches-with-315-million-financing-to-deliver-on-the-promise-of-prime-editing/ 2021-07-13T18:15:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Prime-Medicine.jpg https://bostonlifesciencestimes.com/2021/07/oxford-finance-closes-credit-facility-with-paradigm-health/ 2021-07-13T18:20:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/1522158226409.png https://bostonlifesciencestimes.com/2021/07/checkit-appoints-new-ceo-kit-kyte-to-drive-continuing-company-growth/ 2021-07-13T18:24:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Kit-Kyte.jpg https://bostonlifesciencestimes.com/2021/07/withers-continues-boston-area-momentum-with-new-office-space-in-kendall-square/ 2021-07-14T18:11:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Screenshot-2021-07-14-at-14-10-08-Withersworldwide-People-Find-the-right-lawyer-for-you.png https://bostonlifesciencestimes.com/2021/07/axonis-therapeutics-announces-5-million-in-funding/ 2021-07-14T18:15:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Joanna-Stanicka.jpg https://bostonlifesciencestimes.com/2021/07/entos-raises-53-million-series-a-round-led-by-coatue-and-catalio/ 2021-07-14T18:18:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Entos.jpg https://bostonlifesciencestimes.com/2021/07/aws-announces-general-availability-of-amazon-healthlake/ 2021-07-15T18:18:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/aws.jpg https://bostonlifesciencestimes.com/2021/07/novel-saliva-assay-by-accure-health-tracks-covid-19-vaccine-response-in-proof-of-concept-study/ 2021-07-15T18:37:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Accure-Healths-TiMES.jpg https://bostonlifesciencestimes.com/2021/07/imperative-care-raises-260-million-to-advance-innovations-that-elevate-stroke-care/ 2021-07-15T18:44:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Mike-Buck.jpg https://bostonlifesciencestimes.com/2021/07/smithers-announces-appointment-of-vice-president-of-operations-north-america-environmental-risk-sciences/ 2021-07-15T19:02:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/James-Klippel.jpg https://bostonlifesciencestimes.com/2021/07/therma-holdings-announces-acquisitions-to-expand-energy-and-sustainability-solutions-platform/ 2021-07-16T16:31:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Therma-Holdings.png https://bostonlifesciencestimes.com/2021/07/komodo-health-names-bill-madigan-as-chief-revenue-officer/ 2021-07-19T19:28:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Bill-Madigan.jpg https://bostonlifesciencestimes.com/2021/07/biontech-to-acquire-kites-neoantigen-tcr-cell-therapy-rd-platform-and-manufacturing-facility-in-gaithersburg-md/ 2021-07-19T19:32:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/BioNTech.jpg https://bostonlifesciencestimes.com/2021/07/canovation-wins-prestigious-red-dot-design-awards/ 2021-07-19T19:36:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Canovation.jpg https://bostonlifesciencestimes.com/2021/07/fda-approves-octapharmas-octagam-10-for-adult-dermatomyositis/ 2021-07-20T17:36:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Octagam.jpg https://bostonlifesciencestimes.com/2021/07/amylyx-pharmaceuticals-closes-135m-series-c-financing/ 2021-07-20T17:41:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Amylyx-Pharmaceuticals.jpg https://bostonlifesciencestimes.com/2021/07/quantori-expands-executive-team-appoints-sean-murphy-as-vice-president-client-services/ 2021-07-20T17:43:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Sean-Murphy.jpg https://bostonlifesciencestimes.com/2021/07/alloy-therapeutics-and-echo-investment-capital-create-wheeler-bio-to-accelerate-the-development-of-new-antibody-therapeutics/ 2021-07-21T18:12:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/wheeler-bio.jpg https://bostonlifesciencestimes.com/2021/07/pfizer-and-biontech-to-provide-u-s-government-with-an-additional-200-million-doses-of-covid-19-vaccine/ 2021-07-23T15:31:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Pfizer-Inc.jpg https://bostonlifesciencestimes.com/2021/07/google-cloud-announces-healthcare-data-engine-to-enable-interoperability-in-healthcare/ 2021-07-23T19:24:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Google-Cloud.png https://bostonlifesciencestimes.com/2021/07/hemab-raises-us-55m-series-a-to-advance-next-generation-therapeutics-for-bleeding-and-thrombosis-disorders/ 2021-07-23T19:27:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Hemab-ApS.jpg https://bostonlifesciencestimes.com/2021/07/ey-announces-andy-park-as-new-los-angeles-office-managing-partner/ 2021-07-23T19:29:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Andy-Park.jpg https://bostonlifesciencestimes.com/2021/07/cognizant-acquires-tqs-integration/ 2021-07-23T19:45:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Cognizant.jpg https://bostonlifesciencestimes.com/2021/07/zyus-life-sciences-strengthens-software-patent-portfolio-supporting-clinical-development/ 2021-07-26T16:36:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/ZYUS-Life-Sciences.png https://bostonlifesciencestimes.com/2021/07/generate-life-sciences-establishes-newborn-stem-cell-manufacturing-facility/ 2021-07-26T16:41:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Jaime-Shamonki-MD.jpeg https://bostonlifesciencestimes.com/2021/07/komodo-health-acquires-breakaway-partners/ 2021-07-26T16:52:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Komodo-Health-co-founders.jpg https://bostonlifesciencestimes.com/2021/07/polarityte-submits-investigational-new-drug-application-for-skinte-in-chronic-cutaneous-ulcers/ 2021-07-26T16:57:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Screenshot_2021-07-26-Management-Team-PolarityTE-Inc-PTE.png https://bostonlifesciencestimes.com/2021/07/lineages-opc1-cell-therapy-for-the-treatment-of-spinal-cord-injury-to-return-to-clinical-testing/ 2021-07-26T17:02:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Screenshot_2021-07-26-Leadership-Lineage-Cell-Therapeutics.png https://bostonlifesciencestimes.com/2021/07/brookline-capital-markets-hosts-biotech-symposium-today/ 2021-07-26T17:06:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Brookline-Capital-Markets.png https://bostonlifesciencestimes.com/2021/07/new-mountain-capital-to-acquire-flexan/ 2021-07-26T17:07:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Flexan-.jpg https://bostonlifesciencestimes.com/2021/07/pulmosim-therapeutics-announces-strategic-partnership-with-top-respiratory-hospitals/ 2021-07-26T17:12:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Dr.-Jo-Varshney-DVM-PhD.webp https://bostonlifesciencestimes.com/2021/07/beigene-announces-approval-in-canada-of-brukinsa-zanubrutinib/ 2021-07-26T17:17:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Jane-Huang-M.D..png https://bostonlifesciencestimes.com/2021/07/tesseract-health-names-diagnostics-innovator-dr-vicky-demas-ceo/ 2021-07-27T15:03:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Dr.-Vicky-Demas.jpg https://bostonlifesciencestimes.com/2021/07/steven-p-cohen-chief-of-pain-medicine-at-johns-hopkins-joins-releviate-therapeutics-as-head-of-its-scientific-advisory-board/ 2021-07-27T15:05:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Dr.-Steven-P.-Cohen-.jpg https://bostonlifesciencestimes.com/2021/07/iacta-pharmaceuticals-appoints-yogesh-bahl-as-chief-financial-officer-and-eric-carter-m-d-ph-d-as-chief-medical-officer/ 2021-07-27T15:07:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/IACTA-Pharmaceuticals-Inc.png https://bostonlifesciencestimes.com/2021/07/carenext-launches-doc360-consumers-source-of-truth-for-grading-providers/ 2021-07-27T15:19:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Screenshot-2021-07-27-at-11-18-46-About-Us-careNext.png https://bostonlifesciencestimes.com/2021/07/prokarium-appoints-kristen-albright-as-chief-executive-officer/ 2021-07-27T15:22:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Kristen-Albright.jpg https://bostonlifesciencestimes.com/2021/07/fsd-pharma-inc-announces-termination-of-chief-executive-officer-dr-raza-bokhari-for-cause/ 2021-07-27T15:25:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/FSD-Pharma2.jpg https://bostonlifesciencestimes.com/2021/07/mirum-pharmaceuticals-and-gc-pharma-enter-into-exclusive-licensing-agreement/ 2021-07-27T15:28:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Chris-Peetz.png https://bostonlifesciencestimes.com/2021/07/biologyworks-names-hunt-ramsbottom-ceo-to-lead-molecular-testing-company/ 2021-07-27T15:31:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Hunt-Ramsbottom.jpg https://bostonlifesciencestimes.com/2021/07/iggenix-announces-25m-in-series-a1-funding/ 2021-07-27T15:34:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Jessica-Grossman-M.D.jpeg https://bostonlifesciencestimes.com/2021/07/cerba-research-awarded-nih-contract-for-central-lab-services/ 2021-07-27T15:37:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Cerba-Research.jpeg https://bostonlifesciencestimes.com/2021/07/kbs-assists-in-the-acquisition-of-sorrento-towers/ 2021-07-27T15:40:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Sorrento-Towers.jpg https://bostonlifesciencestimes.com/2021/07/insulet-to-present-at-upcoming-investor-conferences/ 2021-07-27T15:45:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Insulet.png https://bostonlifesciencestimes.com/2021/07/mirus-raises-65-million-for-expansion-of-rhenium-based-medical-devices/ 2021-07-27T15:48:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/MiRus-scaled-e1627400874499.jpg https://bostonlifesciencestimes.com/2021/07/hcl-technologies-names-jill-kouri-as-global-chief-marketing-officer/ 2021-07-28T13:53:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Jill-Kouri.jpg https://bostonlifesciencestimes.com/2021/07/data-cro-expands-its-virtual-learning-portfolio-with-new-life-sciences-courses/ 2021-07-28T13:59:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/MMS-Holdings.png https://bostonlifesciencestimes.com/2021/07/zs-elects-pratap-khedkar-to-ceo/ 2021-07-28T14:01:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Pratap-Khedkar.jpg https://bostonlifesciencestimes.com/2021/07/eurofins-abraxis-announces-the-worlds-first-rapid-glyphosate-method-to-achieve-aoac-performance-test-method/ 2021-07-28T14:06:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Eurofins-Abraxis.png https://bostonlifesciencestimes.com/2021/07/voxneuro-receives-health-canada-class-ii-medical-device-designation/ 2021-07-28T14:10:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Dr.-John-F.-Connolly.jpg https://bostonlifesciencestimes.com/2021/07/mycovia-pharmaceuticals-announces-u-s-fda-acceptance-and-priority-review-of-new-drug-application-for-oteseconazole/ 2021-07-28T14:14:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/PatrickJordan.jpg https://bostonlifesciencestimes.com/2021/07/kriya-therapeutics-completes-renovation-of-its-facility/ 2021-07-28T14:22:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Group_photo_RTP.jpg https://bostonlifesciencestimes.com/2021/07/biomind-labs-begins-trading-on-the-neo-exchange/ 2021-07-28T14:26:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Alejandro-Antalich.png https://bostonlifesciencestimes.com/2021/07/perkinelmer-expands-kras-oncology-drug-discovery-assays/ 2021-07-28T14:31:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/1200px-PerkinElmer_logo.svg_.png https://bostonlifesciencestimes.com/2021/07/agilent-early-career-professor-award-presented-to-jason-h-yang/ 2021-07-28T14:35:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Jason-H.-Yang-Ph.D.webp https://bostonlifesciencestimes.com/2021/07/protera-announces-final-close-of-its-10m-series-a-financing/ 2021-07-28T14:39:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Leonardo-Alvarez.png https://bostonlifesciencestimes.com/2021/07/asc-therapeutics-announces-partnership-with-university-of-massachusetts-medical-school-to-co-develop-novel-gene-therapy/ 2021-07-28T14:43:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Dr.-Guangping-Gao-PhD.jpg https://bostonlifesciencestimes.com/2021/07/takeda-and-frazier-healthcare-partners-announce-collaboration-to-launch-hillevax/ 2021-07-29T13:33:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Rajeev-Venkayya-Headshot.jpg https://bostonlifesciencestimes.com/2021/07/4d-pharma-announces-30-million-credit-facility-with-oxford-finance/ 2021-07-29T13:39:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/4dpharma.png https://bostonlifesciencestimes.com/2021/07/fda-clears-promega-oncomate-msi-dx-analysis-system/ 2021-07-29T13:50:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/James-Eshleman-MD-PhD-Professor-of-Pathology-and-Oncology-Johns-Hopkins-University-School-of-Medicine-1.jpg https://bostonlifesciencestimes.com/2021/07/macomics-the-macrophage-based-drug-discovery-company-secures-4-24m-expansion-financing/ 2021-07-29T13:54:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Macomics-Ltd.jpg https://bostonlifesciencestimes.com/2021/07/aptar-enters-into-agreement-with-weihai-hengyu-medical-products/ 2021-07-29T13:59:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Stephan-B.-Tanda.png https://bostonlifesciencestimes.com/2021/07/mycovia-pharmaceuticals-announces-presentation-of-oteseconazole-vt-1161-phase-3-data/ 2021-07-29T14:01:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Mycovia-Pharmaceutical.png https://bostonlifesciencestimes.com/2021/07/biotools-innovator-selects-ten-leading-life-science-startups-for-inaugural-accelerator/ 2021-07-29T14:04:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/BioTools-Innovator.png https://bostonlifesciencestimes.com/2021/07/introducing-landmark-bio-and-appointment-of-ran-zheng-as-ceo/ 2021-07-29T14:14:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Ran-Zheng.png https://bostonlifesciencestimes.com/2021/07/alnylam-reports-positive-topline-results-from-illuminate-c-phase-3-study-of-lumasiran/ 2021-07-29T14:18:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Alnylam-Pharmaceuticals.png https://bostonlifesciencestimes.com/2021/07/onera-raises-e10-5m-in-series-b-funding/ 2021-07-29T14:22:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Onera-Health.jpg https://bostonlifesciencestimes.com/2021/07/kevin-harbour-joins-oxford-finances-healthcare-services-team/ 2021-07-29T14:25:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Kevin-Harbou.jpg https://bostonlifesciencestimes.com/2021/07/cambridge-savings-bank-expands-credit-facility-to-purity-services/ 2021-07-29T14:47:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Cambridge-Savings-Bank.png https://bostonlifesciencestimes.com/2021/07/copd-foundation-condemns-big-tobacco-acquisition-of-pharmaceutical-company/ 2021-07-30T13:08:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Byron-Thomashow-M.D..jpg https://bostonlifesciencestimes.com/2021/07/boston-properties-marks-groundbreaking-of-180-citypoint/ 2021-07-30T13:10:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/180-CityPoint.jpg https://bostonlifesciencestimes.com/2021/07/sixty-two-percent-of-biopharma-executives-say-their-organization-does-not-prioritize-diversity-equity-and-inclusion-when-selecting-a-vendor/ 2021-07-30T13:14:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Screenshot-2021-07-30-at-09-12-53-Leadership-Trinity.png https://bostonlifesciencestimes.com/2021/07/astellas-and-minovia-therapeutics-announce-strategic-collaboration-for-novel-mitochondrial-cell-therapy-programs/ 2021-07-30T13:16:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Astellas.jpg https://bostonlifesciencestimes.com/2021/07/enyo-pharma-announces-16-weeks-vonafexor-top-line-interim-results-from-two-on-going-phase-2a-studies-in-chronic-hepatitis-b-patients/ 2021-07-30T13:19:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Pietro-Scalfaro.jpg https://bostonlifesciencestimes.com/2021/07/alzamend-neuro-announces-pre-ind-submission-for-al002-as-a-cell-based-therapeutic-vaccine-that-seeks-to-combat-alzheimers/ 2021-07-30T13:22:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Stephan-Jackman.jpg https://bostonlifesciencestimes.com/2021/07/bloom-energy-achieves-key-milestones-on-its-path-to-decarbonize-the-marine-industry/ 2021-07-30T13:28:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Bloom-Energy.jpg https://bostonlifesciencestimes.com/2021/07/vnlife-announces-series-b-funding-round-led-by-general-atlantic-and-dragoneer/ 2021-07-30T13:32:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/VNLIFE-Corporation.jpeg https://bostonlifesciencestimes.com/2021/07/montrium-secures-2m-funding-from-bdc-capital-growth-and-transition-capital-division/ 2021-07-30T13:35:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Montrium.jpg https://bostonlifesciencestimes.com/2021/07/the-worldwide-medical-device-contract-manufacturing-industry-is-expected-to-reach-113-3-billion-by-2026-at-a-cagr-of-11-5-from-2021/ 2021-07-30T13:40:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Research-and-Market.jpg https://bostonlifesciencestimes.com/2021/08/sensyne-grows-medical-research-dataset-to-60-million-patients/ 2021-08-02T13:59:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Sensyne-Health.png https://bostonlifesciencestimes.com/2021/08/radicle-science-launches-largest-longitudinal-real-world-evidence-study-to-determine-effectiveness-of-cbd-products/ 2021-08-02T14:02:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Pelin-Thorogood.jpg https://bostonlifesciencestimes.com/2021/08/hercules-capital-reaches-1-0-billion-milestone-in-annual-debt-and-equity-commitments-for-the-fourth-consecutive-year/ 2021-08-02T14:06:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Screenshot-2021-08-02-at-10-05-44-Person-Archive-Hercules-Capital.png https://bostonlifesciencestimes.com/2021/08/synthace-unveils-first-life-sciences-rd-cloud-addressing-complexity-speed-reproducibility-for-scientists/ 2021-08-02T14:08:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Synthace.png https://bostonlifesciencestimes.com/2021/08/overland-pharmaceuticals-appoints-roger-luo-ph-d-as-chief-development-officer/ 2021-08-02T14:11:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Roger-Luo-Ph.D..jpg https://bostonlifesciencestimes.com/2021/08/sanotize-inks-agreement-with-indian-biotech-glenmark-to-commercialize-nitric-oxide-nasal-spray-for-covid-19-treatment-in-asian-markets/ 2021-08-02T14:15:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Dr.-Gilly-Regev-PhD.jpg https://bostonlifesciencestimes.com/2021/08/ultrasound-disruptor-exo-secures-220m-in-series-c-funding-round/ 2021-08-02T14:20:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Exo.jpg https://bostonlifesciencestimes.com/2021/08/orthofix-announces-first-patient-implant-in-the-m6-c-artificial-cervical-disc-two-level-ide-study/ 2021-08-02T14:23:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Orthofix-Medical.jpg https://bostonlifesciencestimes.com/2021/08/in-support-of-the-international-summer-games-in-tokyo-everbridge-providing-new-risk-data-intelligence-feed/ 2021-08-02T14:29:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Everbridge.jpg https://bostonlifesciencestimes.com/2021/08/citiustech-launches-medictiv-a-first-of-its-kind-open-healthcare-ai-model-directory-to-drive-healthcare-industry-collaboration/ 2021-08-03T13:40:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Bhaskar-Sambasivan.webp https://bostonlifesciencestimes.com/2021/08/nanthealth-appoints-dr-tiffany-avery-as-chief-medical-officer/ 2021-08-03T13:42:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Dr.-Tiffany-Avery.jpg https://bostonlifesciencestimes.com/2021/08/iterative-scopes-raises-30-million-series-a-financing/ 2021-08-03T13:47:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/JONATHAN-NG-MBBS.webp https://bostonlifesciencestimes.com/2021/08/resolve-biosciences-and-zeiss-announce-co-development-collaboration-to-enhance-highest-resolution-view-of-subcellular-spatial-biology/ 2021-08-03T13:51:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Jason-T.-Gammack-e1627998689472.jpg https://bostonlifesciencestimes.com/2021/08/meissa-appoints-robert-walker-m-d-chief-medical-officer/ 2021-08-03T13:55:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Robert-Walker-M.D..webp https://bostonlifesciencestimes.com/2021/08/beigene-announces-plans-to-build-new-manufacturing-and-clinical-rd-center/ 2021-08-03T13:59:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/John-V.-Oyler-Co-Founder-Chairman-and-CEO-of-BeiGene.png https://bostonlifesciencestimes.com/2021/08/pfizer-greed-kills-says-ahf/ 2021-08-03T14:04:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Terri-Ford.webp https://bostonlifesciencestimes.com/2021/08/kestra-medical-technologies-receives-fda-premarket-approval-for-assure-wearable-cardioverter-defibrillator/ 2021-08-03T14:07:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Brian-Webster.jpg https://bostonlifesciencestimes.com/2021/08/antibe-therapeutics-provides-clinical-update-for-otenaproxesul/ 2021-08-03T14:10:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Antibe-Therapeutics-.png https://bostonlifesciencestimes.com/2021/08/modivcare-announces-acquisition-of-vri-a-leading-provider-of-remote-patient-monitoring-solutions-in-the-united-states/ 2021-08-03T14:13:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Daniel-E.-Greenleaf.jpg https://bostonlifesciencestimes.com/2021/08/dovel-ceo-damon-griggs-named-ey-entrepreneur-of-the-year/ 2021-08-04T13:00:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Damon-Griggs.jpg https://bostonlifesciencestimes.com/2021/08/clarify-health-acquires-apervitas-value-optimization-business-creating-one-unified-value-platform-for-health-plans/ 2021-08-04T13:02:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Jean-Drouin.jpg https://bostonlifesciencestimes.com/2021/08/tsingyuan-ventures-rebrands-to-foothill-ventures-closes-oversubscribed-100m-fund/ 2021-08-04T13:06:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Tsingyuan-Ventures.png https://bostonlifesciencestimes.com/2021/08/biontech-completes-acquisition-of-kites-neoantigen-tcr-cell-therapy-rd-platform-and-manufacturing-facility/ 2021-08-04T13:07:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/BioNTech.jpg https://bostonlifesciencestimes.com/2021/08/mitsubishi-electric-us-inc-expands-in-boston-area/ 2021-08-04T13:18:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Render-of-400-Summer-Street.jpg https://bostonlifesciencestimes.com/2021/08/sonoma-biotherapeutics-raises-265-million-in-an-oversubscribed-series-b-financing/ 2021-08-04T13:19:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Sonoma-Biotherapeutics.jpg https://bostonlifesciencestimes.com/2021/08/alzamend-neuro-announces-additional-investment-under-its-investigational-new-drug-application-for-dementia-related-to-alzheimers/ 2021-08-04T13:25:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Alzamend-Neuro.png https://bostonlifesciencestimes.com/2021/08/exscientia-builds-automated-laboratories-in-oxford-to-expand-pipeline/ 2021-08-04T13:30:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Dr.-David-Hallett.webp https://bostonlifesciencestimes.com/2021/08/kite-and-appia-bio-announce-collaboration-to-research-and-develop-allogeneic-cell-therapies-for-cancer/ 2021-08-05T13:32:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/JJ-KANG-PHD.webp https://bostonlifesciencestimes.com/2021/08/excelera-and-aptitude-health-offer-new-specialty-pharmacy-focused-educational-resources-for-cancer-care/ 2021-08-05T13:37:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Kerry-Bradley-2021-color.jpg https://bostonlifesciencestimes.com/2021/08/pillar-biosciences-receives-premarket-approval-from-fda-for-its-oncoreveal-dx-lung-and-colon-cancer-assay/ 2021-08-05T13:40:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Gang-Song.jpg https://bostonlifesciencestimes.com/2021/08/encellin-closes-5-9m-seed-financing-co-led-by-khosla-ventures-and-sv-latam-capital/ 2021-08-05T13:44:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/khoslaventures.png https://bostonlifesciencestimes.com/2021/08/veranex-announces-acquisition-of-experien-group/ 2021-08-05T13:47:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/David-W.-Dockhorn-M.S.-Ph.D..jpg https://bostonlifesciencestimes.com/2021/08/smi-source-projected-to-hit-over-one-million-views/ 2021-08-05T13:52:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/SMi-Source.jpg https://bostonlifesciencestimes.com/2021/08/national-kidney-foundation-and-labcorp-data-show-millions-arent-tested-for-kidney-disease/ 2021-08-05T13:56:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/National-Kidney-Foundation.jpg https://bostonlifesciencestimes.com/2021/08/as-industrial-automation-market-explodes-third-wave-automation-closes-40m-series-b/ 2021-08-05T13:59:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Third-Wave-Automation.jpg https://bostonlifesciencestimes.com/2021/08/colgate-palmolive-to-leverage-verilys-baseline-platform-for-innovative-study-in-oral-health-research/ 2021-08-06T13:59:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Colgate.jpg https://bostonlifesciencestimes.com/2021/08/eqrx-to-accelerate-growth-with-1-8-billion-raise-through-proposed-combination-with-cm-life-sciences-iii/ 2021-08-06T14:00:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/EQRx.png https://bostonlifesciencestimes.com/2021/08/amring-pharmaceuticals-inc-announces-the-approval-and-launch-of-generic-isoproterenol-hydrochloride-injection-usp/ 2021-08-06T14:02:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Amring-Pharmaceuticals.jpg https://bostonlifesciencestimes.com/2021/08/moderna-named-fast-companys-2021-best-workplace-for-innovators/ 2021-08-06T14:04:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/KO_LOGO.jpg https://bostonlifesciencestimes.com/2021/08/tesa-medicals-cordaset-rapid-graft-tensioning-system-successful-in-second-cadaver-study/ 2021-08-06T14:06:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Tesa-Medical.jpg https://bostonlifesciencestimes.com/2021/08/philip-morris-international-acquires-inhaled-drug-specialist-otitopic-growing-pipeline-of-beyond-nicotine-inhaled-therapeutic-products/ 2021-08-09T13:34:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Jacek-Olczak.png https://bostonlifesciencestimes.com/2021/08/qiagen-receives-u-s-fda-emergency-use-authorization-for-rapid-portable-test-for-sars-cov-2-antigen/ 2021-08-09T13:38:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/QIAGEN.jpeg https://bostonlifesciencestimes.com/2021/08/colgate-palmolive-to-leverage-verilys-baseline-platform-for-innovative-study-in-oral-health-research-2/ 2021-08-09T13:41:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Verily.jpg https://bostonlifesciencestimes.com/2021/08/eqrx-to-accelerate-growth-with-1-8-billion-raise-through-proposed-combination-with-cm-life-sciences-iii-2/ 2021-08-09T13:47:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Alexis-Borisy.png https://bostonlifesciencestimes.com/2021/08/amring-pharmaceuticals-inc-announces-the-approval-and-launch-of-generic-isoproterenol-hydrochloride-injection-usp-2/ 2021-08-09T13:51:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Daniel-Carbery.jpg https://bostonlifesciencestimes.com/2021/08/lucid-lane-raises-16-million-series-a-from-accel-and-battery-ventures-to-help-people-living-with-medication-dependence/ 2021-08-09T13:53:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Lucid-Lane.jpg https://bostonlifesciencestimes.com/2021/08/rheos-medicines-appoints-nirupama-subramanian-as-chief-operating-officer/ 2021-08-09T13:57:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Nirupama-Subramanian.jpg https://bostonlifesciencestimes.com/2021/08/advanced-clinical-continues-global-expansion-into-europe-with-new-ireland-office/ 2021-08-09T14:01:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Julie-Ross.jpg https://bostonlifesciencestimes.com/2021/08/canadian-health-authority-grants-extheras-seraph-100-blood-filter-an-interim-order-for-treatment-of-covid-19/ 2021-08-09T14:04:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Bob-Ward-ExThera-Medical-Chairman-and-CEO.png https://bostonlifesciencestimes.com/2021/08/dalrada-health-and-vivera-pharmaceuticals-announce-new-diagnostic-laboratory-joint-venture/ 2021-08-09T14:09:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Brian-Bonar.jpg https://bostonlifesciencestimes.com/2021/08/sydnexis-secures-45-million-series-b-financing-led-by-visionary-ventures-and-blue-stem-capital/ 2021-08-10T13:24:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Sydnexis.jpg https://bostonlifesciencestimes.com/2021/08/dermavant-announces-fda-acceptance-for-filing-of-new-drug-application/ 2021-08-10T14:07:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Dermavant-e1628604447659.png https://bostonlifesciencestimes.com/2021/08/daniela-drago-joins-aurion-biotech-as-chief-regulatory-officer/ 2021-08-10T14:10:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Daniela-Drago-.jpg https://bostonlifesciencestimes.com/2021/08/visus-therapeutics-secures-20-million-in-additional-financing-led-by-new-investor-lsp-with-participation-from-sage-partners/ 2021-08-10T14:13:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Ben-Bergo.jpeg https://bostonlifesciencestimes.com/2021/08/happify-health-adds-experienced-healthcare-cio-as-chief-information-officer-to-drive-platform-expansion/ 2021-08-10T14:15:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Andy-Palan.jpg https://bostonlifesciencestimes.com/2021/08/sinovac-announces-positive-data-on-booster-shots-of-coronavac/ 2021-08-10T14:20:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/SINOVAC-Biotech-Ltd.jpeg https://bostonlifesciencestimes.com/2021/08/intelligencia-raises-12m-to-reduce-the-risk-of-clinical-research-improve-rd-productivity-and-accelerate-scientific-breakthroughs/ 2021-08-10T14:23:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Vangelis-Vergetis.png https://bostonlifesciencestimes.com/2021/08/in-an-up-to-200m-acquisition-by-nanox-zebra-medical-vision-brings-its-ai-to-reimagine-radiology-globally/ 2021-08-10T14:25:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Zebra-Medical-Vision-.jpg https://bostonlifesciencestimes.com/2021/08/medical-microinstruments-symani-surgical-system-performs-lymph-node-transfer-and-lymphovenous-anastomosis/ 2021-08-10T14:28:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Medical-Microinstruments.png https://bostonlifesciencestimes.com/2021/08/pavmed-subsidiary-lucid-diagnostics-launches-first-lucid-test-centers/ 2021-08-10T14:32:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Lishan-Aklog-M.D.png https://bostonlifesciencestimes.com/2021/08/sesen-bio-strengthens-executive-leadership-team-as-the-company-approaches-the-potential-approval-and-commercial-launch-of-vicineum/ 2021-08-11T13:03:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Dr.-Thomas-Cannell.jpg https://bostonlifesciencestimes.com/2021/08/mahana-therapeutics-secures-61-million-series-b-financing/ 2021-08-11T13:05:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Steven-Basta.jpg https://bostonlifesciencestimes.com/2021/08/avacta-announces-first-patient-dosed-in-ava6000-pro-doxorubicin-phase-i-clinical-trial/ 2021-08-11T13:08:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Avacta-Group.jpg https://bostonlifesciencestimes.com/2021/08/atum-announces-issuance-of-us-patents-covering-novel-enzymes-critical-to-genome-engineering-applications/ 2021-08-11T13:10:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/ATUM-.png https://bostonlifesciencestimes.com/2021/08/merz-and-israeli-start-up-vensica-launch-partnership-for-needleless-treatment-of-overactive-bladder/ 2021-08-11T13:12:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Merz-Therapeutics.jpg https://bostonlifesciencestimes.com/2021/08/immunetune-strengthens-team-by-appointing-sijme-zeilemaker-as-chief-executive-officer/ 2021-08-11T13:14:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Immunetune-Strengthens.png https://bostonlifesciencestimes.com/2021/08/be-bio-appoints-leading-cell-gene-therapy-executives-krishnan-viswanadhan-as-president-chief-operating-officer-and-brad-hartman-as-chief-people-officer/ 2021-08-11T13:17:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/k.webp https://bostonlifesciencestimes.com/2021/08/3nt-medical-announces-fda-clearance-for-single-use-peregrine-sinus-endoscope/ 2021-08-11T13:23:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Peregrine.jpg https://bostonlifesciencestimes.com/2021/08/gentibio-announces-157m-series-a-financing/ 2021-08-11T13:28:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/GentiBio.png https://bostonlifesciencestimes.com/2021/08/medigate-wins-seven-awards-in-2021-continues-to-advance-healthcare-cybersecurity/ 2021-08-11T13:39:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Medigate-scaled.jpg https://bostonlifesciencestimes.com/2021/08/sonoma-biotherapeutics-raises-265-million-in-an-oversubscribed-series-b-financing-2/ 2021-08-11T15:43:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Jeffrey-Bluestone-Ph.D.jpg https://bostonlifesciencestimes.com/2021/08/fannin-innovation-studio-awarded-2m-nih-grant-for-development-of-a-novel-antivenom-therapeutic/ 2021-08-11T16:41:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Leo-Linbeck-III.jpg https://bostonlifesciencestimes.com/2021/08/asymmetrex-plans-to-review-tissue-stem-cell-reports-that-need-stem-cell-counting/ 2021-08-11T16:55:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/James-Sherley.jpg https://bostonlifesciencestimes.com/2021/08/researchers-link-brain-memory-signals-to-blood-sugar-levels/ 2021-08-11T17:02:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Screenshot-2021-08-11-at-13-01-37-Gyorgy-Buzsaki.png https://bostonlifesciencestimes.com/2021/08/human-studies-begin-on-artificial-intelligence-discovered-covid-19-treatment-with-up-to-97-percent-effectiveness/ 2021-08-11T17:08:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Dr.-Kishor-M.-Wasan.jpg https://bostonlifesciencestimes.com/2021/08/alverno-laboratories-selects-ibexs-ai-solution-for-cancer-diagnostics/ 2021-08-11T17:11:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Ibex.jpg https://bostonlifesciencestimes.com/2021/08/sab-biotherapeutics-announces-nonclinical-data-demonstrating-sab-185-potently-neutralizes-delta-and-lambda-sars-cov-2-variants/ 2021-08-11T17:28:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/SAB-Biotherapeutics.png https://bostonlifesciencestimes.com/2021/08/urovant-sciences-appoints-betzy-estrada-as-executive-vice-president-and-chief-human-resources-officer/ 2021-08-12T13:10:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Betzy-Estrada.jpg https://bostonlifesciencestimes.com/2021/08/tenax-announces-new-publication-highlighting-novel-levosimendan-mechanism-of-action-in-pulmonary-hypertension-patients/ 2021-08-12T13:17:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Tenax-Therapeutics.jpg https://bostonlifesciencestimes.com/2021/08/pro-bono-ultra-rare-disease-regulatory-assistance-program-created-by-mms-for-patient-advocacy-groups-with-the-greatest-need/ 2021-08-12T13:27:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/MMS-Holdings-Inc.png https://bostonlifesciencestimes.com/2021/08/biomind-labs-files-patent-application-in-the-united-states-patent-and-trademark-office-its-4th-patent-application/ 2021-08-12T13:32:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Alejandro-Antalich.png https://bostonlifesciencestimes.com/2021/08/artiva-biotherapeutics-establishes-u-s-research-and-manufacturing-facility-for-nk-cell-therapy-pipeline-development-and-clinical-supply/ 2021-08-12T13:39:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Artivas-San-Diego-NK-cell-therapy-research-and-GMP-manufacturing-facility.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Peter-Flynn.jpg https://bostonlifesciencestimes.com/2021/08/exactech-announces-full-launch-of-its-truliant-porous-knee-system/ 2021-08-12T13:43:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Exactech.jpg https://bostonlifesciencestimes.com/2021/08/rsip-vision-announces-patient-specific-intraoperative-registration-module-for-orthopedic-surgery/ 2021-08-12T13:50:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/screenshot.jpg https://bostonlifesciencestimes.com/2021/08/medx-health-corp-appoints-sylvain-desjeans-as-chief-executive-officer/ 2021-08-12T13:54:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/MedX-Health-Corp.jpeg https://bostonlifesciencestimes.com/2021/08/resource-label-expands-california-presence-with-the-acquisition-of-teklabel/ 2021-08-12T13:56:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Resource-Label-.jpg https://bostonlifesciencestimes.com/2021/08/butterfly-network-and-caption-health-announce-exclusive-strategic-partnership-to-enable-earlier-disease-detection-and-management/ 2021-08-12T13:58:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Butterfly-Network-.jpg https://bostonlifesciencestimes.com/2021/08/insulet-introduces-omnipod-dash-system-at-australasian-diabetes-congress/ 2021-08-12T14:00:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Omnipod-DASH.jpg https://bostonlifesciencestimes.com/2021/08/labcorp-extends-leadership-in-womens-health-with-acquisition-of-ovia-health/ 2021-08-13T13:39:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Labcorp.jpg https://bostonlifesciencestimes.com/2021/08/mcdermotts-health-practice-launches-in-atlanta-with-partner-counsel-additions/ 2021-08-13T13:47:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/McDermott-Will-Emery.jpeg https://bostonlifesciencestimes.com/2021/08/kromatid-appoints-nathan-wood-as-chief-executive-officer/ 2021-08-13T13:57:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/kroma.png https://bostonlifesciencestimes.com/2021/08/pharmaceutical-robots-market-to-exceed-usd-383-91-million-by-2028/ 2021-08-13T14:04:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/The-Insight-Partners-.jpg https://bostonlifesciencestimes.com/2021/08/aquity-solutions-welcomes-tim-albury-as-cfo-to-support-rapid-growth-and-expansion/ 2021-08-13T14:13:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Tim-Albury.jpg https://bostonlifesciencestimes.com/2021/08/turtletree-and-solar-biotech-enter-strategic-partnership/ 2021-08-13T14:19:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Screenshot-2021-08-13-at-10-19-04-Our-Team-%E2%80%94-Synbio-Hyperintegration.png https://bostonlifesciencestimes.com/2021/08/memic-innovative-surgery-ltd-and-medtech-acquisition-corporation-announce-proposed-business-combination/ 2021-08-13T14:27:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Memic-Innovative-Surgery-Ltd.png https://bostonlifesciencestimes.com/2021/08/550000-sf-life-sciences-project-to-kick-off-in-bostons-seaport-jll-to-lead-the-leasing-efforts/ 2021-08-13T16:43:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/0-World-Trade-Photo-10-World-Trade-website.webp https://bostonlifesciencestimes.com/2021/08/two-thirds-of-americans-have-had-a-negative-health-care-experience/ 2021-08-16T13:10:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/hospital.webp https://bostonlifesciencestimes.com/2021/08/wastewater-testing-labs-can-detect-sars-cov-2-in-less-than-four-hours-with-new-methods/ 2021-08-16T13:19:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/promega-e1629119946577.jpg https://bostonlifesciencestimes.com/2021/08/taysha-gene-therapies-secures-up-to-100-million-non-dilutive-term-loan-financing/ 2021-08-16T13:22:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/RA-Session-II.png https://bostonlifesciencestimes.com/2021/08/rocket-pharmaceuticals-announces-fda-lifts-clinical-hold-on-danon-disease-trial-of-rp-a501/ 2021-08-16T13:25:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Rocket-Pharma.webp https://bostonlifesciencestimes.com/2021/08/recode-therapeutics-appoints-angele-maki-ph-d-as-senior-vice-president-of-business-development/ 2021-08-16T13:32:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/ReCode-Therapeutics.jpg https://bostonlifesciencestimes.com/2021/08/immunitybio-appoints-dr-patrick-soon-shiong-to-global-chief-scientific-and-medical-officer/ 2021-08-16T13:38:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Dr.-Patrick-Soon-Shiong.jpg https://bostonlifesciencestimes.com/2021/08/larvol-ceo-launches-one-year-in-the-metaverse/ 2021-08-16T13:41:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Bruno-Larvol-.jpg https://bostonlifesciencestimes.com/2021/08/hdt-bio-announces-agreement-with-koreas-quratis-to-co-develop-innovative-covid-19-vaccine-in-asia/ 2021-08-16T13:55:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Steve-Reed.jpg https://bostonlifesciencestimes.com/2021/08/virios-therapeutics-ceo-highlights-novel-therapeutic-approach-for-treating-fibromyalgia-and-ibs/ 2021-08-16T13:58:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Greg-Duncan.jpg https://bostonlifesciencestimes.com/2021/08/pbs-biotech-raises-10m-to-provide-scale-up-manufacturing-solutions-for-cell-therapies/ 2021-08-16T14:01:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/pbsbiotech.png https://bostonlifesciencestimes.com/2021/08/aerin-medical-announces-positive-one-year-results-from-rhinaer-pivotal-trial-for-the-treatment-of-chronic-rhinitis/ 2021-08-16T14:04:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/RhinAer.jpg https://bostonlifesciencestimes.com/2021/08/new-study-evaluates-the-use-of-masimo-bridge-as-an-alternative-to-opioids/ 2021-08-16T14:06:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Masimo-Bridge.jpg https://bostonlifesciencestimes.com/2021/08/part-analytics-raises-3m-venture-round-to-accelerate-digital-transformation-of-sourcing/ 2021-08-16T14:09:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Part-Analytics.png https://bostonlifesciencestimes.com/2021/08/worlds-first-surgery-using-virtual-incisions-mira-miniature-robotic-system-performed-at-bryan-medical-center-in-lincoln-nebraska/ 2021-08-16T14:11:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/MIRA-Surgical-Platform.jpg https://bostonlifesciencestimes.com/2021/08/harris-williams-advises-rqm-on-its-sale-to-linden-capital-partners/ 2021-08-17T13:34:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Paul-Hepper.jpg https://bostonlifesciencestimes.com/2021/08/receptor-life-sciences-announces-publication-of-proof-of-principle-clinical-pharmacokinetics-study-of-rls103/ 2021-08-17T13:37:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Andrea-Leone-Bay-PhD.jpg https://bostonlifesciencestimes.com/2021/08/beigene-and-eusa-pharma-announce-china-nmpa-approval-of-qarziba-for-patients-with-high-risk-neuroblastoma/ 2021-08-17T13:45:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/LOGO_EUSAPHARMA.jpg https://bostonlifesciencestimes.com/2021/08/virpax-pharmaceuticals-receives-fda-response-and-guidance-on-mms019/ 2021-08-17T13:50:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Anthony-P.-Mack.jpg https://bostonlifesciencestimes.com/2021/08/aurinia-acquires-novel-pipeline-assets-targeting-autoimmune-and-kidney-related-diseases/ 2021-08-17T13:53:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Peter-Greenleaf.jpg https://bostonlifesciencestimes.com/2021/08/happify-health-and-higi-partner-to-create-an-ai-driven-patient-engagement-ecosystem-to-make-value-based-healthcare-accessible-worldwide/ 2021-08-17T14:10:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Happify-Health.jpg https://bostonlifesciencestimes.com/2021/08/lumen-health-tech-reveals-60-of-employed-users-lost-weight-during-the-pandemic-by-measuring-their-metabolism-daily/ 2021-08-17T14:32:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Lumen-Corporate-Wellness-Virgin-Pulse.jpg https://bostonlifesciencestimes.com/2021/08/mersana-therapeutics-appoints-tushar-misra-as-chief-manufacturing-officer/ 2021-08-17T14:41:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Tushar-Misra-.jpg https://bostonlifesciencestimes.com/2021/08/jll-expands-life-sciences-project-development-group-with-new-hire/ 2021-08-18T17:10:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Chris-Maciejczak.png https://bostonlifesciencestimes.com/2021/08/always-and-thrive-global-launch-first-period-tracker-and-wellness-app-that-helps/ 2021-08-18T17:49:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Always.jpg https://bostonlifesciencestimes.com/2021/08/eqrx-appoints-richard-buckley-as-chief-corporate-affairs-officer/ 2021-08-18T18:08:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Richard-Buckley.png https://bostonlifesciencestimes.com/2021/08/ccc-now-offering-subscriptions-to-wiley-content-for-emerging-life-science-and-biotech-companies/ 2021-08-18T18:11:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/ccc.png https://bostonlifesciencestimes.com/2021/08/epiendo-pharmaceuticals-secures-eur-20-million-series-a-funding/ 2021-08-18T18:12:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Maria-Bech.jpg https://bostonlifesciencestimes.com/2021/08/nexus-pharmaceuticals-receives-patent-for-emerphed-ready-to-use-ephedrine-sulfate-injection/ 2021-08-18T18:20:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Nexus-Pharmaceuticals.png https://bostonlifesciencestimes.com/2021/08/biomind-labs-to-advance-a-phase-ii-clinical-trial-on-dmt-for-treatment-resistant-depression/ 2021-08-18T18:22:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Biomind.png https://bostonlifesciencestimes.com/2021/08/osaro-raises-30-million-series-c-round-led-by-octave-ventures/ 2021-08-18T18:25:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Derik-Pridmore.jpg https://bostonlifesciencestimes.com/2021/08/med-institute-receives-accreditation-through-the-fda-accreditation-scheme-for-conformity-assessment-asca-pilot-program/ 2021-08-18T18:28:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/MED-Institute.jpg https://bostonlifesciencestimes.com/2021/08/national-nurse-led-care-consortium-launches-covid-19-vaccine-confidence-campaign/ 2021-08-18T18:32:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/National-Nurse-Led-Care-Consortium.jpg https://bostonlifesciencestimes.com/2021/08/sensyne-health-and-sentara-healthcare-form-new-partnership-for-ethical-data-sharing-and-design-of-new-clinical-algorithms/ 2021-08-19T15:36:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Sentara-Healthcare.jpg https://bostonlifesciencestimes.com/2021/08/perkinelmer-expands-automated-mycotoxin-detection-kits-portfolio/ 2021-08-19T15:38:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/1200px-PerkinElmer_logo.svg_.png https://bostonlifesciencestimes.com/2021/08/researchers-develop-covid-19-severity-screening-method/ 2021-08-19T15:40:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/Agilent-Technologies.jpg https://bostonlifesciencestimes.com/2021/08/curia-to-expand-u-s-commercial-manufacturing-capability/ 2021-08-19T15:43:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Curia.jpg https://bostonlifesciencestimes.com/2021/08/pharmacyte-biotech-announces-70-million-registered-direct-offering-priced-at-the-market-under-nasdaq-rules/ 2021-08-19T15:48:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/PharmaCyte-Biotech.png https://bostonlifesciencestimes.com/2021/08/sonoma-pharmaceuticals-announces-expanded-dental-care-line-with-a-new-product-for-professional-care/ 2021-08-19T15:51:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Sonoma-Pharmaceuticals.jpg https://bostonlifesciencestimes.com/2021/08/nice-issues-a-positive-medtech-innovation-briefing-for-endomags-magtrace-breast-cancer-lymphatic-tracer/ 2021-08-19T15:54:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/A-vial-of-the-Magtrace-lymphatic-tracer.jpg https://bostonlifesciencestimes.com/2021/08/echonous-receives-fda-clearance-for-lexsa-linear-probe/ 2021-08-19T16:06:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/EchoNous.jpg https://bostonlifesciencestimes.com/2021/08/ucla-extension-announces-new-program-director-of-teacher-education/ 2021-08-19T16:08:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Dr.-Allison-Leggett.jpg https://bostonlifesciencestimes.com/2021/08/edmund-optics-named-the-exclusive-global-distributor-for-everix-ultra-thin-filters/ 2021-08-19T16:41:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Edmund-Optics.jpg https://bostonlifesciencestimes.com/2021/08/moderna-announces-supply-agreement-with-canada-for-expanded-supply-of-modernas-covid-19-vaccine-in-2022-in-2023-and-in-2024/ 2021-08-19T23:27:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Stephane-Bancel-Twitter.jpg https://bostonlifesciencestimes.com/2021/08/labcorp-and-community-clinical-oncology-research-network-collaborate-to-assess-social-and-economic-impacts-of-disparities-in-cancer-care/ 2021-08-20T13:06:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/lapcorp.jpg https://bostonlifesciencestimes.com/2021/08/spectrum-chemical-mfg-corp-turns-50/ 2021-08-20T13:09:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Spectrum-Chemical.jpg https://bostonlifesciencestimes.com/2021/08/glancy-prongay-murray-llp-a-leading-securities-fraud-law-firm-continues-its-investigation-of-sesen-bio-inc-sesn-on-behalf-of-investors/ 2021-08-20T13:12:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Glancy-Prongay-Murray-LLP.jpg https://bostonlifesciencestimes.com/2021/08/ethos-asset-management-inc-usa-expands-and-incorporates-subsidiary-in-turkey/ 2021-08-20T13:14:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Carlos-Santos.jpeg https://bostonlifesciencestimes.com/2021/08/aspen-dental-partners-with-forward-science-to-offer-professional-rinse-line-nationwide/ 2021-08-20T13:19:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Robert-Whitman-e1629465564459.jpg https://bostonlifesciencestimes.com/2021/08/pulse-biosciences-announces-appointment-of-mitchell-e-levinson-as-chief-strategy-officer/ 2021-08-20T13:22:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Pulse-Biosciences.png https://bostonlifesciencestimes.com/2021/08/bridge-to-life-announces-first-close-of-56-million-growth-financing-led-by-perceptive-advisors/ 2021-08-20T13:26:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Stevan-Schweighardt.png https://bostonlifesciencestimes.com/2021/08/kezar-life-sciences-announces-completion-of-enrollment-of-its-phase-2-presidio-clinical-trial-of-kzr-616/ 2021-08-23T13:03:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Screenshot-2021-08-23-at-09-01-58-Management-Team.png https://bostonlifesciencestimes.com/2021/08/somalogic-provides-2021-financial-guidance-exceeding-initial-merger-combination-projections/ 2021-08-23T13:05:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Roy-Smythe-M.D..jpg https://bostonlifesciencestimes.com/2021/08/genevant-sciences-announces-global-collaboration-and-license-agreement-with-takeda-to-develop-novel-nonviral-gene-therapies-for-two-rare-liver-diseases/ 2021-08-23T13:08:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Pete-Lutwyche-Ph.D.jpg https://bostonlifesciencestimes.com/2021/08/mmit-and-evaluate-join-forces-to-offer-an-end-to-end-view-of-the-pharmaceutical-market-landscape/ 2021-08-23T13:13:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/MMIT.png https://bostonlifesciencestimes.com/2021/08/the-law-offices-of-frank-r-cruz-reminds-investors-of-looming-deadline-in-the-class-action-lawsuit-against-athira-pharma-inc/ 2021-08-23T13:30:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Frank-R.-Cruz-scaled.jpg https://bostonlifesciencestimes.com/2021/08/lucira-health-hires-ghazi-kashmolah-as-chief-quality-officer-and-evp-regulatory-affairs/ 2021-08-23T13:33:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Lucira-Health.jpg https://bostonlifesciencestimes.com/2021/08/medical-device-company-lazurite-to-exhibit-its-arthrofree-wireless-arthroscopic-camera-system-at-upcoming-events/ 2021-08-23T13:39:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/ArthroFree.jpg https://bostonlifesciencestimes.com/2021/08/henry-schein-announces-new-1-billion-credit-facility/ 2021-08-23T13:42:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Steven-Paladino.jpg https://bostonlifesciencestimes.com/2021/08/dendreon-pharmaceuticals-appoints-sherry-saurini-as-vice-president-of-quality/ 2021-08-23T13:53:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Dendreon-Pharmaceuticals.png https://bostonlifesciencestimes.com/2021/08/new-study-evaluates-the-use-of-masimo-pvi-to-monitor-volume-status-in-spontaneously-breathing-hemodialysis-patients/ 2021-08-23T13:59:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Masimo-Root%C2%AE-with-PVi.jpg https://bostonlifesciencestimes.com/2021/08/everbridge-wins-2021-service-to-the-citizentm-award-for-return-to-work-and-vaccine-distribution-solutions-deployed-across-the-u-s/ 2021-08-23T14:05:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/everbridge-1.jpg https://bostonlifesciencestimes.com/2021/08/atavistik-bio-announces-60-million-series-a-financing/ 2021-08-24T13:15:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/John-A.-Josey-PhD-Acting-CEO-of-Atavistik-Bio-and-Marion-Dorsch-PhD-President-and-CSO.jpg https://bostonlifesciencestimes.com/2021/08/the-national-psoriasis-foundation-selects-the-happify-health-digital-health-platform-kopa-as-official-online-community/ 2021-08-24T13:19:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Kopa.jpg https://bostonlifesciencestimes.com/2021/08/stryker-launches-t2-alpha-femur-retrograde-nailing-system/ 2021-08-24T13:22:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Stryker.jpg https://bostonlifesciencestimes.com/2021/08/hyperfine-announces-appointment-of-alok-gupta-as-chief-financial-officer/ 2021-08-24T13:31:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Alok-Gupta.jpg https://bostonlifesciencestimes.com/2021/08/college-students-support-campus-covid-19-vaccine-and-mask-mandates-new-survey-by-timelymd-finds/ 2021-08-24T13:40:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/Covid-19-vaccine.jpg https://bostonlifesciencestimes.com/2021/08/allstripes-announces-50-million-series-b-financing-to-advance-global-rare-disease-research/ 2021-08-24T15:31:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Nancy-Yu.jpg https://bostonlifesciencestimes.com/2021/08/innovative-partnerships-group-taps-eric-marton-to-lead-new-ipg-health-division/ 2021-08-24T15:39:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Eric-Marton.jpg https://bostonlifesciencestimes.com/2021/08/azurity-pharmaceuticals-to-acquire-and-merge-with-arbor-pharmaceuticals/ 2021-08-24T15:40:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Azurity-Pharmaceuticals.png https://bostonlifesciencestimes.com/2021/08/numat-technologies-and-sumitomo-chemical-announce-partnership-to-develop-chemical-separation-technologies-to-drive-industrial-carbon-neutrality/ 2021-08-24T15:43:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Ben-Hernandez.webp https://bostonlifesciencestimes.com/2021/08/real-chemistry-and-aktana-partner-to-combine-social-and-claims-data-with-ai-insights-to-drive-better-healthcare-provider-experiences-with-life-sciences-companies/ 2021-08-24T15:44:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Adam-Cossman.png https://bostonlifesciencestimes.com/2021/08/fsd-pharma-announces-definitive-agreement-to-acquire-lucid-psycheceuticals/ 2021-08-25T13:04:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/FSD-Pharma2.jpg https://bostonlifesciencestimes.com/2021/08/blade-therapeutics-announces-fda-activation-of-ind-application-to-investigate-cudetaxestat/ 2021-08-25T13:07:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Wendye-Robbins-M.D.jpg https://bostonlifesciencestimes.com/2021/08/last-day-for-shareholders-to-actively-participate-in-athira-pharma-inc-atha-class-action/ 2021-08-25T13:09:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Bronstein-Gewirtz-Grossman.jpg https://bostonlifesciencestimes.com/2021/08/bridgebio-pharma-and-lianbio-announce-first-patient-treated-in-phase-2a-trial-of-infigratinib/ 2021-08-25T13:12:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/LianBio.jpg https://bostonlifesciencestimes.com/2021/08/11m-expansion-at-cic-philadelphia-will-double-lab-footprint-making-it-one-of-largest-shared-lab-hubs-in-the-u-s/ 2021-08-25T13:21:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Tim-Rowe.jpg https://bostonlifesciencestimes.com/2021/08/cardior-raises-e64m-series-b-to-advance-clinical-pipeline-of-rna-therapeutics-to-treat-cardiac-disease/ 2021-08-25T13:25:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Dr.-Claudia-Ulbrich.jpg https://bostonlifesciencestimes.com/2021/08/the-davis-companies-and-boston-development-group-break-ground-on-5-acre-life-science-campus-near-watertown-square/ 2021-08-25T13:27:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/66-Galen-Street-in-Watertown.webp https://bostonlifesciencestimes.com/2021/08/scout-clinical-announces-rare-disease-clinical-trial-participant-focus-group-findings/ 2021-08-25T13:29:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Scout-Clinical.jpg https://bostonlifesciencestimes.com/2021/08/flat-medical-selected-to-exhibit-epifaith-for-epidural-at-vizient-innovative-technology-exchange/ 2021-08-25T13:33:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Debbie-Archer.jpg https://bostonlifesciencestimes.com/2021/08/provectus-algae-expands-into-new-large-scale-microalgae-biomanufacturing-facility/ 2021-08-25T13:37:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Nusqe-Spanton.png https://bostonlifesciencestimes.com/2021/08/forge-biologics-announces-key-hires-in-cdmo-operations-and-medical-affairs-company-presentations-at-world-orphan-drug-congress/ 2021-08-25T13:51:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Ruiz_Juan_8-21.jpg https://bostonlifesciencestimes.com/2021/08/clarify-health-welcomes-jeff-meister-as-chief-financial-officer/ 2021-08-26T13:28:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Jeff-Meister.jpg https://bostonlifesciencestimes.com/2021/08/pfizer-and-biontech-announce-collaboration-with-brazils-eurofarma-to-manufacture-covid-19-vaccine-doses-for-latin-america/ 2021-08-26T13:29:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Pfizer-Inc.jpg https://bostonlifesciencestimes.com/2021/08/neurogastrx-secures-60-million-in-series-b-financing/ 2021-08-26T13:31:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Neurogastrx.jpg https://bostonlifesciencestimes.com/2021/08/amneal-announces-positive-topline-results-from-pivotal-phase-3-rise-pd-clinical-trial-of-ipx-203-in-patients-with-parkinsons-disease/ 2021-08-26T13:34:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Amneal-Pharmaceuticals.jpg https://bostonlifesciencestimes.com/2021/08/avestria-ventures-closes-fund-i/ 2021-08-26T13:40:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Screenshot-2021-08-26-at-09-40-18-AVESTRIA-VENTURES-Avestria-Ventures-Management-Homepage.png https://bostonlifesciencestimes.com/2021/08/mayo-clinic-verily-to-build-advanced-clinical-decision-support-to-enhance-care/ 2021-08-26T13:47:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Bradley-Leibovich-M.D..webp https://bostonlifesciencestimes.com/2021/08/hyperfines-portable-mri-system-demonstrates-high-accuracy-for-detection-of-brain-hemorrhage/ 2021-08-26T13:58:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Hyperfine.jpg https://bostonlifesciencestimes.com/2021/08/aditxt-announces-pricing-of-11-0-million-registered-direct-offering-priced-at-the-market-under-nasdaq-rules/ 2021-08-26T14:02:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Aditxt-Inc.jpg https://bostonlifesciencestimes.com/2021/08/agfunder-closes-21-million-alternative-protein-fund-oversubscribed/ 2021-08-26T14:06:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Rob-Leclerc.jpg https://bostonlifesciencestimes.com/2021/08/society-for-the-advancement-of-patient-blood-management-sabm-publication-recommends-continuous-hemoglobin-monitoring/ 2021-08-26T14:10:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Masimo-Root%C2%AE-with-PVi.jpg https://bostonlifesciencestimes.com/2021/08/nih-backs-synchron-brain-computer-interface-with-10m-grant-to-launch-first-u-s-clinical-trial/ 2021-08-26T14:12:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Screenshot-2021-08-26-at-10-12-00-Team-%E2%80%94-Synchron.png https://bostonlifesciencestimes.com/2021/08/texas-medical-center-launches-worlds-largest-life-science-campus/ 2021-08-31T13:19:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Texas-Medical-Center.jpg https://bostonlifesciencestimes.com/2021/08/hyperfine-appoints-kyla-pavlina-j-d-as-chief-people-officer/ 2021-08-31T13:20:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Kyla-Pavlina-J.D..jpg https://bostonlifesciencestimes.com/2021/08/xeomin-receives-european-approval-for-the-treatment-of-chronic-sialorrhea-in-children/ 2021-08-31T13:25:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Stefan-Brinkmann-CEO-Merz-Therapeutics.jpg https://bostonlifesciencestimes.com/2021/08/eagle-pharmaceuticals-granted-additional-patent-for-bendamustine-franchise/ 2021-08-31T13:30:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/eagle.jpg https://bostonlifesciencestimes.com/2021/08/lung-therapeutics-inc-appoints-biopharmaceutical-veteran-william-c-fairey-to-board-of-directors/ 2021-08-31T13:33:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/William-C.-Fairey.jpg https://bostonlifesciencestimes.com/2021/08/activists-to-protest-modernas-pandemic-profiteering-aug-31st-in-cambridge/ 2021-08-31T13:36:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Moderna.jpg https://bostonlifesciencestimes.com/2021/08/milla-pharmaceuticals-announces-approval-and-launch-of-a-generic-version-of-sodium-acetate-injection-2meq-ml-by-pfizer-inc/ 2021-08-31T13:40:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Filip-Van-de-Vliet.jpg https://bostonlifesciencestimes.com/2021/08/pay-governance-hires-25-year-veteran-as-partner-in-its-boston-office/ 2021-08-31T13:45:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Olivia-Wakefield.jpg https://bostonlifesciencestimes.com/2021/08/revelation-biosciences-inc-a-life-sciences-company-developing-therapeutics-and-diagnostics-for-respiratory-viral-infections-to-become-publicly-traded-through-a-merger-with-petra-acquisition-inc/ 2021-08-31T13:48:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Revelation-Biosciences.jpg https://bostonlifesciencestimes.com/2021/08/medical-device-company-lazurite-announces-agreement-with-uh-ventures-to-conduct-formative-human-factors-study-on-its-wireless-surgical-camera/ 2021-08-31T13:53:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Wireless-Surgical-Camera.jpg https://bostonlifesciencestimes.com/2021/08/harvard-medtech-announces-breakthrough-in-treatment-of-trauma-and-pain-virtual-reality-technology-behavioral-intervention-and-ai/ 2021-08-31T13:56:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Harvard-MedTech.jpg https://bostonlifesciencestimes.com/2021/09/gho-capital-invests-in-clearview-healthcare-partners/ 2021-09-01T13:13:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/GHO-Capital.jpg https://bostonlifesciencestimes.com/2021/09/photopharmics-appoints-dr-karl-kieburtz-as-chief-medical-officer/ 2021-09-01T13:15:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Dr.-Kieburtz.jpg https://bostonlifesciencestimes.com/2021/09/exone-and-fraunhofer-ifam-deepen-partnership-on-metal-binder-materials-development/ 2021-09-01T13:18:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Fraunhofer-IFAM.jpg https://bostonlifesciencestimes.com/2021/09/fractyl-announces-tenth-trial-site-opened-in-revita-t2di-study-of-revita-dmr-for-type-2-diabetes/ 2021-09-01T13:20:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Juan-Carlos-Lopez-Talavera-M.D.-Ph.D..webp https://bostonlifesciencestimes.com/2021/09/stemcell-technologies-launches-human-pluripotent-stem-cell-characterization-and-banking-services-in-partnership-with-wicell/ 2021-09-01T13:33:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/STEMCELL-Technologies.png https://bostonlifesciencestimes.com/2021/09/instem-acquires-pds-life-sciences-to-help-clients-bring-life-enhancing-products-to-market-faster/ 2021-09-01T13:36:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Instem.jpg https://bostonlifesciencestimes.com/2021/09/treatment-for-critically-ill-covid-patients-begins-1st-randomized-clinical-trial/ 2021-09-01T13:41:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Col.-Kevin-K.-Chung-MD.jpg https://bostonlifesciencestimes.com/2021/09/chilisleep-pan-pacific-london-partner-to-elevate-sleep-wellbeing-in-luxury-hotel-market/ 2021-09-01T13:47:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/ChiliSleep.jpg https://bostonlifesciencestimes.com/2021/09/thrive-global-appoints-veteran-product-leader-christopher-odonnell-chief-product-officer-on-the-heels-of-80-million-series-c-raise/ 2021-09-01T13:50:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Thrive-Global-scaled.jpg https://bostonlifesciencestimes.com/2021/09/northwell-health-event-provides-help-for-people-communities-struggling-with-substance-use-disorder/ 2021-09-01T13:51:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Northwell-Health.jpg https://bostonlifesciencestimes.com/2021/09/weconnect-health-management-gives-free-access-to-the-more-than-70-million-americans-dealing-with-substance-misuse-and-mental-health-issues/ 2021-09-01T13:55:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/WEconnect-Health.jpg https://bostonlifesciencestimes.com/2021/09/curia-completes-acquisition-of-lakepharma/ 2021-09-02T13:08:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/curia.jpg https://bostonlifesciencestimes.com/2021/09/sunovion-and-bial-enter-european-licensing-agreement-for-apomorphine-sublingual-film-for-the-treatment-of-parkinsons-disease/ 2021-09-02T13:10:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Sunovion-Pharmaceuticals.png https://bostonlifesciencestimes.com/2021/09/u-s-fda-grants-brukinsa-zanubrutinib-approval-in-waldenstroms-macroglobulinemia/ 2021-09-02T13:13:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/BRUKINSA.jpg https://bostonlifesciencestimes.com/2021/09/saint-gobain-life-sciences-acquires-equflow-b-v/ 2021-09-02T13:17:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Saint-Gobain-Life-Sciences.jpg https://bostonlifesciencestimes.com/2021/09/homeowners-concerned-about-pest-activity-as-they-return-to-the-workplace/ 2021-09-02T13:34:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/National-Pest-Management-Association.png https://bostonlifesciencestimes.com/2021/09/pfizer-announces-start-of-phase-3-clinical-trial-in-adults-for-its-investigational-vaccine-against-respiratory-syncytial-virus/ 2021-09-02T13:37:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Pfizer.jpg https://bostonlifesciencestimes.com/2021/09/baxter-to-acquire-hillrom-expanding-connected-care-and-medical-innovation-globally/ 2021-09-02T13:46:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Baxter.jpg https://bostonlifesciencestimes.com/2021/09/bluereg-reinforce-further-its-european-footprint-by-opening-a-new-office-in-zug-switzerland/ 2021-09-02T14:18:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/BlueReg.jpg https://bostonlifesciencestimes.com/2021/09/thermo-fisher-scientific-awarded-192-5-million-u-s-government-contract-to-expand-domestic-pipette-tip-manufacturing/ 2021-09-02T14:20:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Thermo-Fisher.jpg https://bostonlifesciencestimes.com/2021/09/high-end-global-computed-tomography-purchases-to-propel-the-high-end-ct-segment-revenue/ 2021-09-02T14:22:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Global-Computed-Tomography.jpg https://bostonlifesciencestimes.com/2021/09/urovant-sciences-to-present-new-ambulatory-blood-pressure-data-in-patients-dosed-with-gemtesa-vibegron-75-mg-for-overactive-bladder/ 2021-09-03T13:08:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Cornelia-Haag-Molkenteller-MD-PhD.webp https://bostonlifesciencestimes.com/2021/09/enpro-continues-portfolio-reshaping-divests-polymer-components-business/ 2021-09-03T13:11:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Eric-Vaillancourt.jpg https://bostonlifesciencestimes.com/2021/09/flow-robotics-brings-automated-pipetting-robot-to-north-america/ 2021-09-03T13:13:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Flow-Robotics.jpg https://bostonlifesciencestimes.com/2021/09/confluent-offers-best-in-class-lead-times-for-high-precision-polymer-tubing/ 2021-09-03T13:15:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Polymer-Tubing.jpg https://bostonlifesciencestimes.com/2021/09/skywater-is-now-accepting-design-submissions-for-its-90-nm-roic-multi-project-wafer-program/ 2021-09-03T13:18:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/SkyWater-Technology.jpg https://bostonlifesciencestimes.com/2021/09/r3-vascular-reports-the-initiation-of-its-first-in-human-clinical-study/ 2021-09-03T13:21:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/R3-Vascular.jpg https://bostonlifesciencestimes.com/2021/09/blue-sun-mycology-group-announces-filing-of-2-us-patents-for-methods-related-to-inventing-impossible-novel-species-of-psychoactive-fungi/ 2021-09-03T13:26:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Blue-Sun-Mycology-Group.jpg https://bostonlifesciencestimes.com/2021/09/matan-inks-another-progress-labs-deal-in-manassas-virginia/ 2021-09-03T13:51:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Parkway-66.png https://bostonlifesciencestimes.com/2021/09/trisalus-life-sciences-announces-first-patient-enrolled-in-perio-01-clinical-trial-to-evaluate-delivery-of-sd-101/ 2021-09-07T13:14:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/TriSalus-Life-Sciences.jpg https://bostonlifesciencestimes.com/2021/09/medable-hires-chief-strategy-officer-to-expand-global-partner-and-innovation-ecosystem-for-decentralized-clinical-trials/ 2021-09-07T13:29:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/medable.jpg https://bostonlifesciencestimes.com/2021/09/rocket-pharmaceuticals-appoints-isabel-carmona-j-d-as-chief-human-resources-officer/ 2021-09-07T13:31:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Rocket-Pharmaceuticals.jpg https://bostonlifesciencestimes.com/2021/09/inversago-pharma-initiates-a-phase-1-clinical-trial-on-inv-202-a-next-generation-peripherally-acting-cb1-blocker/ 2021-09-07T13:37:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Dr.-Glenn-Crater-MD.jpg https://bostonlifesciencestimes.com/2021/09/emulate-closes-82-million-series-e-financing-to-scale-amid-rapid-growth-in-organ-on-a-chip-market/ 2021-09-07T13:43:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Jim-Corbet.jpg https://bostonlifesciencestimes.com/2021/09/flash-therapeutics-scales-up-becoming-a-leader-in-the-bioproduction-of-dna-and-rna-lentiviral-technologies/ 2021-09-07T13:59:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Flash-Therapeutics.png https://bostonlifesciencestimes.com/2021/09/azura-ophthalmics-appoints-biopharma-industry-veteran-steven-altschuler-m-d-as-chair-of-the-board/ 2021-09-07T14:02:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Steven-Altschuler-M.D..jpg https://bostonlifesciencestimes.com/2021/09/median-technologies-announces-outstanding-performance-for-its-ibiopsy-lung-cancer-screening/ 2021-09-07T14:09:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Median-Technologies.jpg https://bostonlifesciencestimes.com/2021/09/new-study-investigates-the-ability-of-masimo-ori-to-provide-early-warning-of-hypoxemia-during-endotracheal-intubation-in-icu-patients/ 2021-09-07T14:14:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Masimo-ORi.jpg https://bostonlifesciencestimes.com/2021/09/definitive-healthcare-announces-launch-of-initial-public-offering/ 2021-09-07T14:18:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Definitive-Healthcare.jpg https://bostonlifesciencestimes.com/2021/09/university-of-massachusetts-announces-175-million-transformational-gift-to-its-medical-school/ 2021-09-07T15:55:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/University-of-Massachusetts.jpg https://bostonlifesciencestimes.com/2021/09/dnanexus-strengthens-leadership-team-with-appointment-of-dr-asha-s-collins-as-general-manager-of-biobanks/ 2021-09-08T13:01:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Dr.-Asha-S.-Collins.jpg https://bostonlifesciencestimes.com/2021/09/hillevax-closes-135-million-crossover-financing-to-advance-clinical-stage-norovirus-vaccine-candidate/ 2021-09-08T13:07:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/hillevax.jpg https://bostonlifesciencestimes.com/2021/09/nanthealth-and-intraprise-health-announce-collaboration-to-help-providers-meet-hipaa-compliance-requirements-and-protect-patient-data/ 2021-09-08T13:09:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Sean-Friel.jpg https://bostonlifesciencestimes.com/2021/09/promega-launches-oncomate-msi-dx-analysis-system-in-us/ 2021-09-08T13:13:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/OncoMate.jpg https://bostonlifesciencestimes.com/2021/09/quantori-strengthens-global-leadership-team-names-senior-business-leader-solman-rahman-as-executive-vice-president-europe/ 2021-09-08T13:16:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Solman-Rahman.jpg https://bostonlifesciencestimes.com/2021/09/igc-completes-its-phase-1-clinical-trial-on-alzheimers-patients-reports-safety-and-tolerability/ 2021-09-08T13:17:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/India-Globalization-Capital-Inc.png https://bostonlifesciencestimes.com/2021/09/premier-inc-and-11-leading-health-systems-invest-in-exela-pharma-sciences-to-secure-and-support-u-s-based-drug-supply-and-manufacturing/ 2021-09-08T13:24:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Exela%C2%AE-Pharma-Sciences-LLC.jpg https://bostonlifesciencestimes.com/2021/09/keystone-property-group-announces-over-287000-square-feet-of-leases-with-infinity-biologix-lixil-and-paychex-at-middlesex-science-center/ 2021-09-08T13:28:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Keystone-Property-Group.jpg https://bostonlifesciencestimes.com/2021/09/virios-therapeutics-granted-new-patent-for-antiviral-inhibitor-combination/ 2021-09-08T13:35:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Greg-Duncan.jpg https://bostonlifesciencestimes.com/2021/09/womens-health-tech-startup-womed-showcases-clinical-trial-results-of-first-fertility-preserving-intrauterine-technology-product/ 2021-09-08T13:51:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Womed.jpg https://bostonlifesciencestimes.com/2021/09/cha-partners-announces-livia-a-new-upscale-senior-living-community/ 2021-09-08T13:58:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/LIVIA.jpg https://bostonlifesciencestimes.com/2021/09/national-essential-medicine-shortage-awareness-day-highlights-a-critical-public-health-issue-that-demands-americas-attention/ 2021-09-08T18:26:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/natlessmedday.webp https://bostonlifesciencestimes.com/2021/09/giiant-pharma-appoints-christophe-mellon-phd-as-vice-president-discovery-chemistry/ 2021-09-09T13:22:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Giiant-Pharma.jpg https://bostonlifesciencestimes.com/2021/09/sensyne-launches-sensight/ 2021-09-09T13:27:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Sensyne.jpg https://bostonlifesciencestimes.com/2021/09/dynamo-software-announces-strategic-growth-investment-from-blackstone-growth/ 2021-09-09T13:32:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Hank-Boughner.jpg https://bostonlifesciencestimes.com/2021/09/gensight-biologics-announces-publication-analyzing-visual-parameters-of-nd4-lhon-subjects-before-lumevoq-treatment-in-phase-iii-trials/ 2021-09-09T13:38:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Dr.-Mark-L.-Moster-MD-Department-of-Neuro-Ophthalmology-e1631194663443.jpg https://bostonlifesciencestimes.com/2021/09/mammoth-biosciences-raises-195-million-to-build-next-generation-crispr-products-in-therapeutics-and-diagnostics/ 2021-09-09T13:48:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Screenshot-2021-09-09-at-09-47-32-Our-Team-Mammoth-Biosciences.png https://bostonlifesciencestimes.com/2021/09/gempharmatech-presents-humanized-mouse-models-to-support-bispecific-antibody-and-covid-19-preclinic-development/ 2021-09-09T13:59:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/GemPharmatech.jpg https://bostonlifesciencestimes.com/2021/09/new-research-on-sinovacs-covid-19-vaccine-shows-third-dose-more-effective-against-covid-19-including-the-delta-variant/ 2021-09-09T14:01:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/SINOVAC-Biotech.jpg https://bostonlifesciencestimes.com/2021/09/nexa3d-and-henkel-team-up-with-wemed-to-produce-the-worlds-first-additively-manufactured-connected-stethoscope-for-tele-medicine/ 2021-09-09T14:04:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/WeMed-Base.jpg https://bostonlifesciencestimes.com/2021/09/usmi-to-announce-successful-results-of-phase-i-clinical-trial-using-cold-atmospheric-plasma-for-the-treatment-of-solid-tumors/ 2021-09-09T14:07:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/US-Medical-Innovations.jpg https://bostonlifesciencestimes.com/2021/09/vonco-products-receives-fda-510k-clearance-for-novel-closed-loop-enteral-feeding-solution-enteraloc-flow/ 2021-09-09T14:10:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Vonco-Product.jpg https://bostonlifesciencestimes.com/2021/09/tony-hodges-m-d-facp-fccp-appointed-chief-medical-officer-of-la-jolla-pharmaceutical-company/ 2021-09-10T12:57:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/La-Jolla-Pharmaceutical-Company.jpg https://bostonlifesciencestimes.com/2021/09/biomedevice-boston-and-massmedic-sign-a-strategic-partnership/ 2021-09-10T13:06:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/BIOMEDevice.jpg https://bostonlifesciencestimes.com/2021/09/vektor-medicals-vmap-mapping-system-reported-as-feasible-and-effective/ 2021-09-10T13:21:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Vektor-Medical.jpg https://bostonlifesciencestimes.com/2021/09/health-catalyst-unveils-new-solution-to-bring-clinical-research-to-routine-healthcare/ 2021-09-10T13:41:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Health-Catalyst.png https://bostonlifesciencestimes.com/2021/09/oncomine-dx-target-test-receives-mhlw-approval-as-a-companion-diagnostic-for-eli-lillys-ret-inhibitor/ 2021-09-10T13:49:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Thermo-Fisher-1.jpg https://bostonlifesciencestimes.com/2021/09/endo-settles-new-york-state-opioid-cases-and-provides-update-on-remaining-opioid-litigation/ 2021-09-10T13:54:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Endo.jpg https://bostonlifesciencestimes.com/2021/09/croma-pharma-presents-juvenus-a-new-polynucleotide-based-injectable-for-skin-hydration-and-tissue-elasticity-restoration/ 2021-09-13T13:18:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Croma-Pharma.jpg https://bostonlifesciencestimes.com/2021/09/trane-technologies-to-acquire-farrar-scientific-a-leader-in-ultra-low-temperature-control-for-biopharmaceutical-and-other-life-science-industries/ 2021-09-13T13:22:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Dave-Regnery.jpg https://bostonlifesciencestimes.com/2021/09/alzamend-neuro-announces-initiation-of-phase-i-first-in-human-clinical-trial-for-al001-for-dementia-related-to-alzheimers-disease/ 2021-09-13T13:24:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Stephan-Jackman.jpg https://bostonlifesciencestimes.com/2021/09/beigene-announces-u-s-fda-acceptance-of-biologics-license-application-for-tislelizumab-in-esophageal-squamous-cell-carcinoma/ 2021-09-13T13:26:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/BeiGene.png https://bostonlifesciencestimes.com/2021/09/walking-fish-therapeutics-launches-with-50-million-in-series-a-financing-to-accelerate-development-of-b-cell-therapies-for-multiple-diseases/ 2021-09-13T13:39:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Walking-Fish-Therapeutics.png https://bostonlifesciencestimes.com/2021/09/accuradx-launches-research-kits-to-enable-genome-wide-view-of-transcription-in-cells/ 2021-09-13T13:45:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/KAS-Direct.jpg https://bostonlifesciencestimes.com/2021/09/recent-fluvoxamine-covid-benefits-discovered-using-cytel-designed-platform-trial/ 2021-09-13T13:50:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Joshua-Schultz.webp https://bostonlifesciencestimes.com/2021/09/sensome-begins-human-trial-for-its-ai-powered-stroke-guidewire/ 2021-09-13T13:54:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Sensome.jpg https://bostonlifesciencestimes.com/2021/09/results-published-from-rhintrac-randomized-controlled-trial-demonstrate-safety-and-efficacy-of-aerin-medicals-rhinaer/ 2021-09-13T13:56:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/RhinAer.jpg https://bostonlifesciencestimes.com/2021/09/masimo-launches-single-patient-use-rainbow-supersensor/ 2021-09-13T14:00:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/SuperSensor.jpg https://bostonlifesciencestimes.com/2021/09/nectero-medical-completes-19-5-million-series-c-financing/ 2021-09-13T14:02:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Jack-Springer.png https://bostonlifesciencestimes.com/2021/09/reform-biologics-names-neal-muni-md-msph-executive-vice-president-and-chief-operating-officer/ 2021-09-14T12:54:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Neal-Muni-MD-MSPH.jpg https://bostonlifesciencestimes.com/2021/09/rocket-pharmaceuticals-presents-clinical-data-from-rp-a501-trial-in-danon-disease/ 2021-09-14T12:56:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Jonathan-Schwartz.webp https://bostonlifesciencestimes.com/2021/09/prospection-secures-45-million-to-accelerate-growth-of-its-powerful-healthcare-insights-technology/ 2021-09-14T12:59:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Eric-Chung.jpg https://bostonlifesciencestimes.com/2021/09/emergn-study-highlights-importance-of-human-machine-relationship-to-realize-potential-of-intelligent-automation/ 2021-09-14T13:03:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Emergn-1.webp https://bostonlifesciencestimes.com/2021/09/cem-corporation-ambiopharm-form-u-s-partnership-for-gmp-peptide-production/ 2021-09-14T13:04:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Michael-Collins-Founder-and-CEO-of-CEM-Corporation-and-Chris-Bai-Co-Founder-and-CEO-of-AmbioPharm.jpg https://bostonlifesciencestimes.com/2021/09/waters-bioaccord-system-with-acquity-premier-brings-greater-simplicity-accuracy-and-reproducibility-to-multi-attribute-monitoring-of-biopharmaceuticals/ 2021-09-14T13:06:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/The-Waters-BioAccord-System-with-ACQUITY-Premier.jpg https://bostonlifesciencestimes.com/2021/09/onedigital-hires-vinay-gidwaney-as-chief-product-officer/ 2021-09-14T13:18:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/OneDigitalLogo-8-17-16.jpg https://bostonlifesciencestimes.com/2021/09/adm-lg-chem-expand-relationship-with-mou-for-us-production-of-lactic-acid-and-polylactic-acid-for-bioplastics-other-plant-based-solutions/ 2021-09-14T13:21:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/ADM-LG-Chem.jpg https://bostonlifesciencestimes.com/2021/09/rome-therapeutics-secures-77-million-in-series-b-financing/ 2021-09-14T13:24:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Screenshot-2021-09-14-at-09-23-49-About-Us-%E2%80%93-ROME-Therapeutics.png https://bostonlifesciencestimes.com/2021/09/the-innovation-space-expands-lab-and-office-space-available-to-startups/ 2021-09-14T13:28:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/delaware.jpg https://bostonlifesciencestimes.com/2021/09/scientist-com-announces-acquisition-of-insidescientific-a-life-science-webinar-virtual-event-and-content-creation-company/ 2021-09-14T13:32:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Kevin-Lustig-PhD.jpg https://bostonlifesciencestimes.com/2021/09/keros-therapeutics-leases-35662-sf-at-revolution-labs-in-lexington/ 2021-09-14T14:47:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Revolution-Labs-in-Lexington.webp https://bostonlifesciencestimes.com/2021/09/meitheal-pharmaceuticals-announces-findings-from-research-study-with-premier-inc-evaluating-anticoagulant-treatment-of-covid-19-patients/ 2021-09-15T13:16:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Tom-Shea.jpg https://bostonlifesciencestimes.com/2021/09/u-s-fda-grants-brukinsa-zanubrutinib-accelerated-approval-in-relapsed-or-refractory-marginal-zone-lymphoma/ 2021-09-15T13:18:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/BRUKINSA.jpg https://bostonlifesciencestimes.com/2021/09/am-pharma-appoints-lars-boesgaard-as-chief-financial-officer-and-establishes-u-s-affiliate-am-pharma-inc/ 2021-09-15T13:22:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/AM-Pharma.jpg https://bostonlifesciencestimes.com/2021/09/alpine-immune-sciences-announces-91-million-private-placement/ 2021-09-15T13:30:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Alpine-Immune-Sciences.jpeg https://bostonlifesciencestimes.com/2021/09/flywheel-raises-22m-in-series-c-funding/ 2021-09-15T13:36:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Jim-Olson.jpg https://bostonlifesciencestimes.com/2021/09/augmented-reality-pioneer-augmedics-announces-raj-asarpota-as-executive-vice-president-and-chief-financial-officer/ 2021-09-15T13:39:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Augmedics.jpg https://bostonlifesciencestimes.com/2021/09/blue-cross-nc-unc-health-join-forces-for-new-clinical-study-to-improve-food-security-chronic-health-conditions/ 2021-09-15T13:42:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Darren-DeWalt-Seth-Berkowitz-Alice-Ammerman.jpg https://bostonlifesciencestimes.com/2021/09/northwell-appoints-dr-said-ibrahim-to-oversee-medicine-service-line/ 2021-09-15T13:45:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Dr.-Said-Ibrahim.jpg https://bostonlifesciencestimes.com/2021/09/sab-biotherapeutics-announces-completion-of-enrollment-in-phase-2a-challenge-trial-of-sab-176-for-the-treatment-of-seasonal-influenza/ 2021-09-15T13:49:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/SAB-Biotherapeutics.jpg https://bostonlifesciencestimes.com/2021/09/stryker-launches-new-tendon-fixation-device-system/ 2021-09-15T14:01:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Citrelock.jpg https://bostonlifesciencestimes.com/2021/09/vifor-pharma-and-travere-therapeutics-announce-licensing-agreement-for-the-commercialization-of-sparsentan-in-europe-australia-and-new-zealand/ 2021-09-16T13:12:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Vifor-Pharma-Group.jpg https://bostonlifesciencestimes.com/2021/09/aerie-pharmaceuticals-announces-novel-dry-eye-product-candidate-ar-15512/ 2021-09-16T13:15:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Vicente-Anido-Jr.-Ph.D..jpg https://bostonlifesciencestimes.com/2021/09/trodelvy-significantly-improved-quality-of-life-over-standard-of-care-in-2l-metastatic-triple-negative-breast-cancer-in-phase-3/ 2021-09-16T13:18:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Trodelvy.webp https://bostonlifesciencestimes.com/2021/09/aptinyx-secures-50-million-growth-capital-credit-facility-from-k2-healthventures/ 2021-09-16T13:22:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Norbert-Riedel-Ph.D..jpg https://bostonlifesciencestimes.com/2021/09/pharmacyte-biotech-announces-positive-results-of-biocompatibility-study-for-fda/ 2021-09-16T13:26:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Kenneth-L.-Waggoner.jpg https://bostonlifesciencestimes.com/2021/09/iaso-biotherapeutics-secures-108-million-series-c-funding-to-advance-global-development-of-innovative-cell-therapies/ 2021-09-16T13:32:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/IASO-Biotherapeutics.jpg https://bostonlifesciencestimes.com/2021/09/cardialen-awarded-3-million-federal-grant-to-advance-therapy-designed-to-treat-atrial-fibrillation-for-improved-heart-failure-outcomes/ 2021-09-16T13:40:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Cardialen.png https://bostonlifesciencestimes.com/2021/09/radialis-medical-submits-fda-510k-premarket-notification-for-its-organ-targeted-pet-camera/ 2021-09-16T13:42:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Michael-Waterston.jpg https://bostonlifesciencestimes.com/2021/09/vizient-expands-capabilities-in-bill-only-surgery-workflows-to-address-clinical-supply-chain-needs/ 2021-09-16T13:50:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Vizient.jpg https://bostonlifesciencestimes.com/2021/09/announcing-the-use-of-gunzes-meniscal-repair-biodegradable-scaffolds-for-a-clinical-trial-to-improve-the-outcome-of-medial-meniscal-injury-patients/ 2021-09-16T13:51:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Biodegradable-scaffold.jpg https://bostonlifesciencestimes.com/2021/09/alvotech-welcomes-positive-chmp-opinion-for-avt02-a-proposed-biosimilar-to-humira/ 2021-09-17T13:34:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Alvotech.jpg https://bostonlifesciencestimes.com/2021/09/imfinzi-combined-with-novel-immunotherapies-improved-clinical-outcomes-for-patients-with-unresectable-stage-iii-non-small-cell-lung-cancer/ 2021-09-17T13:38:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Roy-S.-Herbst-MD-PhD-e1631885870806.jpg https://bostonlifesciencestimes.com/2021/09/eqrx-announces-presentation-of-phase-3-data-demonstrating-a-progression-free-survival-benefit-with-sugemalimab-consolidation-therapy/ 2021-09-17T13:42:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/EQRx.jpg https://bostonlifesciencestimes.com/2021/09/jsr-agrees-to-acquire-euv-pioneer-inpria-corporation/ 2021-09-17T13:45:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Eric-Johnson.jpg https://bostonlifesciencestimes.com/2021/09/hercules-capital-closes-public-offering-of-325-0-million-2-625-notes-due-2026/ 2021-09-17T13:48:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Hercules-Capital.webp https://bostonlifesciencestimes.com/2021/09/spectrum-chemical-launches-biocertified-cleaning-in-place-solutions/ 2021-09-17T13:51:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Spectrum-Chemical-bioCERTIFIED%E2%84%A2-product..jpg https://bostonlifesciencestimes.com/2021/09/carmat-receives-final-approval-from-the-patient-protection-committee-for-the-use-of-the-commercial-version-of-the-aeson-heart-in-the-eficas-study-in-france/ 2021-09-17T13:54:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/CARMAT.jpg https://bostonlifesciencestimes.com/2021/09/first-ever-executive-leadership-change-spells-next-era-of-innovation-for-twin-cities-health-plan-leader-healthez/ 2021-09-17T13:56:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Jeff-Bakke.jpg https://bostonlifesciencestimes.com/2021/09/medical-grade-ecg-now-available-for-all-consumer-wearable-devices/ 2021-09-17T13:58:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/B-Secur.jpg https://bostonlifesciencestimes.com/2021/09/medavail-appoints-ramona-seabaugh-as-chief-financial-officer/ 2021-09-20T13:03:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/MedAvail.jpg https://bostonlifesciencestimes.com/2021/09/pfizer-and-biontech-announce-positive-topline-results-from-pivotal-trial-of-covid-19-vaccine-in-children-5-to-11-years/ 2021-09-20T13:04:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/pfizer.jpg https://bostonlifesciencestimes.com/2021/09/spectrumxs-spc-069-respiratory-treatment-shows-unprecedented-efficacy-against-multiple-coronavirus-variants/ 2021-09-20T13:06:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Damien-Hancox.png https://bostonlifesciencestimes.com/2021/09/exelixis-announces-detailed-phase-1b-results-from-cohort-6-of-cosmic-021-trial/ 2021-09-20T13:08:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Michael-M.-Morrissey-Ph.D.jpg https://bostonlifesciencestimes.com/2021/09/invetx-announces-initiation-of-first-clinical-study-in-dogs-with-ivx-01-its-novel-monoclonal-antibody-featuring-half-life-extension/ 2021-09-20T13:10:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Dr.-Robert-Zolynas.jpg https://bostonlifesciencestimes.com/2021/09/illumina-ventures-closes-325-million-fund/ 2021-09-20T13:12:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Nick-Naclerio.webp https://bostonlifesciencestimes.com/2021/09/thomas-h-lee-partners-to-acquire-automation-business-from-brooks-automation-for-3-billion-in-cash/ 2021-09-20T13:14:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Screenshot-2021-09-20-at-09-13-48-Our-Team-THL.png https://bostonlifesciencestimes.com/2021/09/3d-biofibr-inc-raises-new-capital-to-scale-up-manufacturing-in-an-oversubscribed-round/ 2021-09-20T13:16:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Kevin-Sullivan.jpg https://bostonlifesciencestimes.com/2021/09/nextgen-healthcare-appoints-david-sides-president-and-chief-executive-officer/ 2021-09-20T13:18:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/David-Sides.jpg https://bostonlifesciencestimes.com/2021/09/soleo-health-selected-by-houston-methodist-as-exclusive-in-home-provider-of-infused-monoclonal-antibodies-for-treatment-of-covid-19/ 2021-09-20T13:23:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Soleo-Health.jpg https://bostonlifesciencestimes.com/2021/09/happify-health-to-distribute-its-clinical-grade-intelligent-healing-platform-through-microsoft-azure/ 2021-09-21T13:22:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Happify-Health.jpg https://bostonlifesciencestimes.com/2021/09/clinical-investigation-shows-herb-pharmas-virostop-spray-effective-in-reducing-impact-of-covid-19/ 2021-09-21T13:25:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/ViroStop.jpg